
<html lang="en"     class="pb-page"  data-request-id="2d250360-7ce1-458a-936d-8a421c3b9507"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2006.49.issue-22;website:website:acspubs;article:article:10.1021/jm0606138;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity" /></meta><meta name="dc.Creator" content="Xin-Jie  Chu,*,†" /></meta><meta name="dc.Creator" content="Wanda  DePinto,‡" /></meta><meta name="dc.Creator" content="David  Bartkovitz,†" /></meta><meta name="dc.Creator" content="Sung-Sau  So,†" /></meta><meta name="dc.Creator" content="Binh T.  Vu,†" /></meta><meta name="dc.Creator" content="Kathryn  Packman,‡" /></meta><meta name="dc.Creator" content="Christine  Lukacs,†" /></meta><meta name="dc.Creator" content="Qingjie  Ding,†" /></meta><meta name="dc.Creator" content="Nan  Jiang,†" /></meta><meta name="dc.Creator" content="Ka  Wang,§" /></meta><meta name="dc.Creator" content="Petra  Goelzer,§" /></meta><meta name="dc.Creator" content="Xuefeng  Yin,‡" /></meta><meta name="dc.Creator" content="Melissa A.  Smith,‡" /></meta><meta name="dc.Creator" content="Brian X.  Higgins,‡" /></meta><meta name="dc.Creator" content="Yingsi  Chen,‖" /></meta><meta name="dc.Creator" content="Qing  Xiang,‖" /></meta><meta name="dc.Creator" content="John  Moliterni,†" /></meta><meta name="dc.Creator" content="Gerald  Kaplan,†" /></meta><meta name="dc.Creator" content="Bradford  Graves,†" /></meta><meta name="dc.Creator" content="Allen  Lovey,*,† and" /></meta><meta name="dc.Creator" content="Nader  Fotouhi†" /></meta><meta name="dc.Description" content="The cyclin-dependent kinases (CDKs) and their cyclin partners are key regulators of the cell cycle. Since deregulation of CDKs is found with high frequency in many human cancer cells, pharmacologic..." /></meta><meta name="Description" content="The cyclin-dependent kinases (CDKs) and their cyclin partners are key regulators of the cell cycle. Since deregulation of CDKs is found with high frequency in many human cancer cells, pharmacologic..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="September 30, 2006" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm0606138" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-49-22-6549" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(06)00613-3" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2006 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm0606138" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm0606138" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm0606138" /></link>
        
    
    

<title>Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm0606138" /></meta><meta property="og:title" content="Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138n00001.jpeg" /></meta><meta property="og:description" content=" The cyclin-dependent kinases (CDKs) and their cyclin partners are key regulators of the cell cycle. Since deregulation of CDKs is found with high frequency in many human cancer cells, pharmacological inhibition of CDKs with small molecules has the potential to provide an effective strategy for the treatment of cancer. The 2,4-diamino-5-ketopyrimidines 6 reported here represent a novel class of potent and ATP-competitive inhibitors that selectively target the cyclin-dependent kinase family. This diaminopyrimidine core with a substituted 4-piperidine moiety on the C2-amino position and 2-methoxybenzoyl at the C5 position has been identified as the critical structure responsible for the CDK inhibitory activity. Further optimization has led to a good number of analogues that show potent inhibitory activities against CDK1, CDK2, and CDK4 but are inactive against a large panel of serine/threonine and tyrosine kinases (Ki &gt; 10 μM). As one of these representative analogues, compound 39 (R547) has the best CDK inhibitory activities (Ki = 0.001, 0.003, and 0.001 μM for CDK1, CDK2, and CDK4, respectively) and excellent in vitro cellular potency, inhibiting the growth of various human tumor cell lines including an HCT116 cell line (IC50 = 0.08 μM). An X-ray crystal structure of 39 bound to CDK2 has been determined in this study, revealing a binding mode that is consistent with our SAR. Compound 39 demonstrates significant in vivo efficacy in the HCT116 human colorectal tumor xenograft model in nude mice with up to 95% tumor growth inhibition. On the basis of its superior overall profile, 39 was chosen for further evaluation and has progressed into Phase I clinical trial for the treatment of cancer.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm0606138"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm0606138">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm0606138&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm0606138&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm0606138&amp;href=/doi/10.1021/jm0606138" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2006</span><span class="cit-fg-volume">, 49</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 6549-6560</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/49/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm060967z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm060299h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin-Jie++Chu">Xin-Jie Chu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wanda++DePinto">Wanda DePinto</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Bartkovitz">David Bartkovitz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sung-Sau++So">Sung-Sau So</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Binh+T.++Vu">Binh T. Vu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathryn++Packman">Kathryn Packman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Lukacs">Christine Lukacs</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingjie++Ding">Qingjie Ding</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nan++Jiang">Nan Jiang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ka++Wang">Ka Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Petra++Goelzer">Petra Goelzer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xuefeng++Yin">Xuefeng Yin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa+A.++Smith">Melissa A. Smith</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+X.++Higgins">Brian X. Higgins</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yingsi++Chen">Yingsi Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qing++Xiang">Qing Xiang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Moliterni">John Moliterni</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerald++Kaplan">Gerald Kaplan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bradford++Graves">Bradford Graves</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allen++Lovey">Allen Lovey</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nader++Fotouhi">Nader Fotouhi</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm0606138&amp;href=/doi/10.1021%2Fjm0606138" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2006</span></span><span class="cit-volume">, 49</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 6549–6560</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 30, 2006</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 May 2006</li><li><span class="item_label"><b>Published</b> online</span>30 September 2006</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 November 2006</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm0606138" title="DOI URL">https://doi.org/10.1021/jm0606138</a></div><div class="article_header-article-copyright"><strong>Copyright © 2006 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6549%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXin-Jie%2BChu%252C%2BWanda%2BDePinto%252C%2BDavid%2BBartkovitz%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D49%26issueNum%3D22%26contentID%3Djm0606138%26title%3DDiscovery%2Bof%2B%255B4-Amino-2-%25281-methanesulfonylpiperidin-4-ylamino%2529pyrimidin-5-yl%255D%25282%252C3-difluoro-6-%2Bmethoxyphenyl%2529methanone%2B%2528R547%2529%252C%2BA%2BPotent%2Band%2BSelective%2BCyclin-Dependent%2BKinase%2BInhibitor%2Bwith%2BSignificant%2Bin%2BVivo%2BAntitumor%2BActivity%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6560%26publicationDate%3DNovember%2B2006">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm0606138"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2694</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">77</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm0606138" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xin-Jie&quot;,&quot;last_name&quot;:&quot;Chu&quot;},{&quot;first_name&quot;:&quot;Wanda&quot;,&quot;last_name&quot;:&quot;DePinto&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Bartkovitz&quot;},{&quot;first_name&quot;:&quot;Sung-Sau&quot;,&quot;last_name&quot;:&quot;So&quot;},{&quot;first_name&quot;:&quot;Binh&quot;,&quot;last_name&quot;:&quot;T. Vu&quot;},{&quot;first_name&quot;:&quot;Kathryn&quot;,&quot;last_name&quot;:&quot;Packman&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Lukacs&quot;},{&quot;first_name&quot;:&quot;Qingjie&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Nan&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Ka&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Petra&quot;,&quot;last_name&quot;:&quot;Goelzer&quot;},{&quot;first_name&quot;:&quot;Xuefeng&quot;,&quot;last_name&quot;:&quot;Yin&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;A. Smith&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;X. Higgins&quot;},{&quot;first_name&quot;:&quot;Yingsi&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Qing&quot;,&quot;last_name&quot;:&quot;Xiang&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Moliterni&quot;},{&quot;first_name&quot;:&quot;Gerald&quot;,&quot;last_name&quot;:&quot;Kaplan&quot;},{&quot;first_name&quot;:&quot;Bradford&quot;,&quot;last_name&quot;:&quot;Graves&quot;},{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;Lovey&quot;},{&quot;first_name&quot;:&quot;Nader&quot;,&quot;last_name&quot;:&quot;Fotouhi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2006&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;49&quot;,&quot;pages&quot;:&quot;6549-6560&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm0606138&quot;},&quot;abstract&quot;:&quot;The cyclin-dependent kinases (CDKs) and their cyclin partners are key regulators of the cell cycle. Since deregulation of CDKs is found with high frequency in many human cancer cells, pharmacological inhibition of CDKs with small molecules has the potential to provide an effective strategy for the treatment of cancer. The 2,4-diamino-5-ketopyrimidines 6 reported here represent a novel class of potent and ATP-competitive inhibitors that selectively target the cyclin-dependent kinase family. This diaminopyrimidine core with a substituted 4-piperidine moiety on the C2-amino position and 2-methoxybenzoyl at the C5 position has been identified as the critical structure responsible for the CDK inhibitory activity. Further optimization has led to a good number of analogues that show potent inhibitory activities against CDK1, CDK2, and CDK4 but are inactive against a large panel of serine/threonine and tyrosine kinases (Ki &gt; 10 μM). As one of these representative analogues, compound 39 (R547) has the best CDK inhibit&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0606138&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0606138" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0606138&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0606138" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0606138&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0606138" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm0606138&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0606138&amp;href=/doi/10.1021/jm0606138" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm0606138" /></input><a href="/doi/pdf/10.1021/jm0606138" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (263 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm0606138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm0606138%26sid%3Dliteratum%253Aachs%26pmid%3D17064073%26genre%3Darticle%26aulast%3DChu%26date%3D2006%26atitle%3DDiscovery%2Bof%2B%255B4-Amino-2-%25281-methanesulfonylpiperidin-4-ylamino%2529pyrimidin-5-yl%255D%25282%252C3-difluoro-6-%2Bmethoxyphenyl%2529methanone%2B%2528R547%2529%252C%2BA%2BPotent%2Band%2BSelective%2BCyclin-Dependent%2BKinase%2BInhibitor%2Bwith%2BSignificant%2Bin%2BVivo%2BAntitumor%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D49%26issue%3D22%26spage%3D6549%26epage%3D6560%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291305" title="Cell physiology">Cell physiology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/49/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138n00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138n00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The cyclin-dependent kinases (CDKs) and their cyclin partners are key regulators of the cell cycle. Since deregulation of CDKs is found with high frequency in many human cancer cells, pharmacological inhibition of CDKs with small molecules has the potential to provide an effective strategy for the treatment of cancer. The 2,4-diamino-5-ketopyrimidines <b>6</b> reported here represent a novel class of potent and ATP-competitive inhibitors that selectively target the cyclin-dependent kinase family. This diaminopyrimidine core with a substituted 4-piperidine moiety on the C2-amino position and 2-methoxybenzoyl at the C5 position has been identified as the critical structure responsible for the CDK inhibitory activity. Further optimization has led to a good number of analogues that show potent inhibitory activities against CDK1, CDK2, and CDK4 but are inactive against a large panel of serine/threonine and tyrosine kinases (<i>K</i><sub>i</sub> > 10 μM). As one of these representative analogues, compound <b>39 </b>(R547) has the best CDK inhibitory activities (<i>K</i><sub>i</sub> = 0.001, 0.003, and 0.001 μM for CDK1, CDK2, and CDK4, respectively) and excellent in vitro cellular potency, inhibiting the growth of various human tumor cell lines including an HCT116 cell line (IC<sub>50</sub> = 0.08 μM). An X-ray crystal structure of <b>39 </b>bound to CDK2 has been determined in this study, revealing a binding mode that is consistent with our SAR. Compound <b>39</b> demonstrates significant in vivo efficacy in the HCT116 human colorectal tumor xenograft model in nude mice with up to 95% tumor growth inhibition. On the basis of its superior overall profile, <b>39</b> was chosen for further evaluation and has progressed into Phase I clinical trial for the treatment of cancer. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm0606138AF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Phone, 973-235-5183; Fax, 973-235-7239; E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="f9819097d493909cd79a918cb98b969a919cd79a9694d7">[email protected]</a> </p></span></div><div class="fnGroupItem" id="jm0606138AF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  Department of Discovery Chemistry.</p></span></div><div class="fnGroupItem" id="jm0606138AF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Department of Discovery Oncology.</p></span></div><div class="fnGroupItem" id="jm0606138AF4"><span><h4><span class="NLM_fn-symbol">§</span></h4></span><span><p class="last">  Department of Non-Clinical Drug Safety.</p></span></div><div class="fnGroupItem" id="jm0606138AF5"><span><h4><span class="NLM_fn-symbol">‖</span></h4></span><span><p class="last">  Department of Discovery Technologies.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclin-dependent kinases (CDKs) are a family of serine-threonine protein kinases that govern the initiation, progression, and completion of the cell cycle. Activity of the CDKs allows the orderly transition between phases of the cell cycle. CDK activity is controlled by association with regulatory subunits (cyclins) and CDK inhibitor proteins, by their phosphorylation state and by ubiquitin-mediated proteolysis.<sup><a onclick="showRef(event, 'jm0606138b00001 jm0606138b00002 jm0606138b00003 jm0606138b00004'); return false;" href="javascript:void(0);" class="ref jm0606138b00001 jm0606138b00002 jm0606138b00003 jm0606138b00004">1-4</a></sup> Since the loss of cell cycle control leading to deregulated cell proliferation is one of the hallmarks of cancer, it is anticipated that the inhibition of CDKs will provide an effective approach to control tumor growth and therefore have an impact on cancer therapy. Inhibition of CDKs has been studied by many organizations and has been achieved using a variety of structural templates with varying degrees of selectivity and activities. Many of these discoveries, including extensive patent literature, have been reviewed.<sup><a onclick="showRef(event, 'jm0606138b00005 jm0606138b00006 jm0606138b00007 jm0606138b00008 jm0606138b00009 jm0606138b00010 jm0606138b00011 jm0606138b00012'); return false;" href="javascript:void(0);" class="ref jm0606138b00005 jm0606138b00006 jm0606138b00007 jm0606138b00008 jm0606138b00009 jm0606138b00010 jm0606138b00011 jm0606138b00012">5-12</a></sup></div><div class="NLM_p">CDK inhibitors such as flavopiridol (L868275) (<b>1</b>, Figure 1<a data-tab="pane-pcw-Figures" href="#jm0606138f00001" id="" class=" internalNav"></a>) and 7-hydroxystaurosporine (UCN-01) have been evaluated in clinical trials for some time.<sup><a onclick="showRef(event, 'jm0606138b00013'); return false;" href="javascript:void(0);" class="ref jm0606138b00013">13</a></sup> Recently, more selective CDK inhibitors such as roscovitine (<b>2</b>) (CYC-202)<sup><a onclick="showRef(event, 'jm0606138b00014'); return false;" href="javascript:void(0);" class="ref jm0606138b00014">14</a></sup> and BMS-387032 (<b>3</b>),<sup><a onclick="showRef(event, 'jm0606138b00015'); return false;" href="javascript:void(0);" class="ref jm0606138b00015">15</a></sup> targeting CDK2, and PD0332991 (<b>4</b>),<sup><a onclick="showRef(event, 'jm0606138b00016 jm0606138b00017'); return false;" href="javascript:void(0);" class="ref jm0606138b00016 jm0606138b00017">16,17</a></sup> targeting CDK4, have entered clinical trials. However, to date no small molecule inhibitor of any CDK or combination of CDKs has reached Phase III clinical trials as a single agent. <div id="_i4"><figure id="jm0606138f00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Selected CDK inhibitors flavopiridol (<b>1</b>), roscovitine (<b>2</b>), BMS-387032 (<b>3</b>), and PD0332991 (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Recent siRNA experiments in which inhibiting CDK2 failed to halt the proliferation of osteosarcomas and Rb-negative cervical cancers suggested that CDK2 may not be a good target for cancer therapy.<sup><a onclick="showRef(event, 'jm0606138b00018'); return false;" href="javascript:void(0);" class="ref jm0606138b00018">18</a></sup> CDK2 has also been found to be dispensable for regulating the inhibitory effects of p27<sup>Kip1</sup> and p21<sup>Cip1</sup> during the G<sub>1</sub> phase of the cell cycle.<sup><a onclick="showRef(event, 'jm0606138b00019'); return false;" href="javascript:void(0);" class="ref jm0606138b00019">19</a></sup> Additionally, CDK2 knockout mouse experiments have implied the ability of other kinases to circumvent CDK2 and allow other CDKs and other cyclin partners to substitute for certain stages of the cell cycle that are essential for cells to progress toward mitosis.<sup><a onclick="showRef(event, 'jm0606138b00020 jm0606138b00021'); return false;" href="javascript:void(0);" class="ref jm0606138b00020 jm0606138b00021">20,21</a></sup> Complex interactions within the cell cycle and data indicating that mice lacking all three D cyclins or both CDK4 or CDK6 survive until relatively late in the various stages of embryogenesis or even up to birth further cloud the overall picture.<sup><a onclick="showRef(event, 'jm0606138b00022 jm0606138b00023'); return false;" href="javascript:void(0);" class="ref jm0606138b00022 jm0606138b00023">22,23</a></sup> These and other studies suggest a need to rethink existing models of cell cycle control in development and tumorigenesis.<sup><a onclick="showRef(event, 'jm0606138b00024'); return false;" href="javascript:void(0);" class="ref jm0606138b00024">24</a></sup> The ability of CDKs and their cyclin partners to adjust, substitute, and compensate for one another leads to a clearer notion that the inhibition of more than one or two CDKs might be necessary to sustain the suppression of tumor growth in a clinical setting. The success of imatinib (Gleevec), initially thought to target only Abl tyrosine kinase but proved to be a somewhat less than targeted therapy, has suggested that inhibition of a number of targets by a single molecule could provide a useful therapy.<sup><a onclick="showRef(event, 'jm0606138b00025'); return false;" href="javascript:void(0);" class="ref jm0606138b00025">25</a></sup></div><div class="NLM_p last">Our goal was to identify small molecule inhibitors of CDKs with low nanomolar activities that were selective for the CDK family of kinases. We recently identified a series of diamino-<a name="jm004902206550" id="jm004902206550"></a> thiazole-based CDK4 inhibitors <b>5 </b>(Figure 2<a data-tab="pane-pcw-Figures" href="#jm0606138f00002" id="" class=" internalNav"></a>) that were selective against CDK1 and CDK2.<sup><a onclick="showRef(event, 'jm0606138b00026 jm0606138b00027'); return false;" href="javascript:void(0);" class="ref jm0606138b00026 jm0606138b00027">26,27</a></sup> One of these diaminothiazole analogues showed modest in vivo efficacy.<sup><a onclick="showRef(event, 'jm0606138b00028'); return false;" href="javascript:void(0);" class="ref jm0606138b00028">28</a></sup> In this report, we describe the discovery of a novel series of 2,4-diamino-5-ketopyrimidines <b>6</b> that provide highly potent inhibitors of the CDK family and block the cell cycle at both G<sub>1</sub> and G<sub>2</sub> check points. Optimization of this series resulted in the selection of a lead compound for advancement into clinical trials.<sup><a onclick="showRef(event, 'jm0606138b00029'); return false;" href="javascript:void(0);" class="ref jm0606138b00029">29</a></sup><div id="_i6"><figure id="jm0606138f00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00002.jpeg" id="_i7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Generic structures of diaminothiazole <b>5</b> and diaminopyrimidine <b>6</b> as CDK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Most 2,4-diamino-5-ketopyrimidine compounds described in this report were prepared following a four-step synthetic route outlined in Scheme 1<a data-tab="pane-pcw-Figures" href="#jm0606138h00001" id="" class=" internalNav"></a>. Starting from commercially available 4-amino-2-ethylsulfanylpyrimidine-5-carboxylic acid (<b>7</b>), standard amide bond coupling with <i>N,O</i>-dimethylhydroxylamine provided <i>N</i>-methoxy-<i>N</i>-methylamide <b>8 </b>as the key intermediate. Treatment of amide <b>8 </b>with appropriately functionalized aryllithium or Grignard reagents <b>9</b> afforded ketones <b>10</b>. Oxidation of <b>10 </b>using 2 equiv of <i>m</i>-chloroperoxybenzoic acid (<i>m</i>CPBA) gave ethyl sulfones <b>11</b>; alternatively, sulfoxides <b>12 </b>were obtained as the major product when 1 equiv of <i>m</i>CPBA was used. Displacement of the sulfone or sulfoxide in <b>11 </b>or<b> 12</b> with various aromatic or aliphatic amines under microwave conditions furnished 2,4-diamino-5-ketopyrimidine derivatives <b>6</b>. For the piperidinyl substituted 2,4-diamino-5-ketopyrimidine series <b>16</b>, some analogues were directly prepared with this four-step sequence when the appropriate amines were available, whereas the other derivatives were synthesized from intermediate <b>15</b> as shown in Scheme 2<a data-tab="pane-pcw-Figures" href="#jm0606138h00002" id="" class=" internalNav"></a>. Reaction of 4-amino-<i>N</i>-<i>tert</i>-(butoxycarbonyl)piperidine (<b>13</b>) with sulfone <b>11</b> or sulfoxide <b>12</b> provided <b>14</b> which, upon treatment with trifluoroacetic acid, gave piperidine <b>15</b>. Selective <i>N</i>-alkylation, acylation, or sulfonylation of the secondary amine in the piperidine ring of <b>15 </b>led to the desired 2,4-diamino-5-ketopyrimidines <b>16</b>. <div id="_i9"><figure id="jm0606138h00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138h00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138h00001.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  General Synthesis of 2,4-Diamino-5-ketopyrimidines<sup><i>a</i></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) MeONHMe·HCl, HOBt/HBTU, DiPEA, DMF, rt, 98%; (b) 3−4 equiv of ArLi or ArMgX, THF, −78 °C, 65∼90%; (c) <i>m</i>CPBA, CHCl<sub>3</sub>, 0 °C, 90−98%; (d) i-PrOH, 100−110 °C, microwave, 20 min, >90%.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138h00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138h00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm0606138h00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138h00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138h00002.jpeg" id="_i11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.  Synthesis of 4-Piperidinyl Substituted 2,4-Diamino-5-ketopyrimidines<sup><i>a</i></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) i-PrOH, 100∼110 °C, microwave, 20 min, >90%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, >95%; (c) R<sub>3</sub>X, R<sub>3</sub>COCl or R<sub>3</sub>SO<sub>2</sub>Cl, DiPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 90−98%.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138h00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138h00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Molecular modeling studies revealed that the 2,4-diamino-5-ketopyrimidine core has similar electrostatic characteristics in its donor−acceptor−donor (DAD) region as the diaminothiazole core. However, the replacement of the S atom by the C<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>N bond makes the new scaffold considerably more hydrophilic (Figure 3<a data-tab="pane-pcw-Figures" href="#jm0606138f00003" id="" class=" internalNav"></a>). Moreover, the expansion of ring size alters the geometry of the substituent vectors from the two scaffolds such that the distance between the two substituents attached to the diaminopyrimidine is significantly larger than that of the corresponding diaminothiazole (Figure 4<a data-tab="pane-pcw-Figures" href="#jm0606138f00004" id="" class=" internalNav"></a>). This subtle variation in hydrophilicity and geometric parameters suggested that we may find a different SAR between the two series. With this consideration in mind, a series of diaminopyrimidine analogues with small substituents on the A ring and 4-methylpiperazinyl on the B ring were prepared (Table 1<a class="ref showTableEvent internalNav" data-ID="jm0606138t00001" href="#jm0606138t00001"></a>). Pyrimidine <b>17 </b>with R<sub>1</sub> as 3-methoxy was inactive, while compound <b>18 </b>having R<sub>1</sub> as 3-fluoro showed modest CDK4 inhibitory activity (<i>K</i><sub>i</sub> = 0.450 μM). The 3-trifluoromethyl analogue <b>19</b> was inactive while <b>20</b>, having the trifluoromethyl at the C2 position, exhibited modest inhibition against CDK4 (<i>K</i><sub>i</sub> = 0.821 μM). The 2-methyl and 2-methoxy analogues <b>21 </b>and <b>22</b>, respectively, demonstrated increasing CDK4 inhibition, suggesting that electron-donating substituents were preferred at the C2 position. The 2-methoxy derivative <b>22 </b>with CDK4 inhibition of 0.159 μM (<i>K</i><sub>i</sub>) was 5-fold more potent than <b>20 </b>and inhibited CDK1 and CDK2 as well. <div id="_i13"><figure id="jm0606138f00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00003.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Electrostatic potential maps of diaminopyrimidine (on the left) and diaminothiazole (on the right). An isodensity surface is first obtained for the two molecules, and the surface is then assigned different colors according to their electrostatic potential. The red area denotes a region with the most negative potential and blue areas the most positive. The maps are calculated using Spartan‘02.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm0606138f00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00004.jpeg" id="_i15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Overlay of diaminopyrimidine (green) vs diaminothiazole (orange). Distances in angstrom (Å) between the centroids of the two phenyl substituents for each core structure are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm0606138t00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Identification of 2,4-Diamino-5-ketopyrimidines as Inhibitors of CDKs<i><sup>a</sup></i><sup></sup><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138u00001a.gif" alt="" id="_i16" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="3"><i>K</i><sub>i</sub> (μM)<sup>b</sup></td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">R<sub>1</sub></td><td class="colsep2 rowsep2">CDK4</td><td class="colsep2 rowsep2">CDK1</td><td class="colsep2 rowsep2">CDK2</td><td class="colsep2 rowsep2">IC<sub>50</sub> (μM)<sup>c</sup> HCT116 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>17</b></td><td class="colsep2 rowsep2">3-MeO </td><td class="colsep2 rowsep2">>1 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">ND<sup>d</sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>18</b></td><td class="colsep2 rowsep2">3-F </td><td class="colsep2 rowsep2">0.450 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">ND </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b></td><td class="colsep2 rowsep2">3-CF<sub>3</sub></td><td class="colsep2 rowsep2">>1 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">ND </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>20</b></td><td class="colsep2 rowsep2">2-CF<sub>3</sub></td><td class="colsep2 rowsep2">0.821 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">ND </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21</b></td><td class="colsep2 rowsep2">2-Me </td><td class="colsep2 rowsep2">0.584 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">16.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>22</b></td><td class="colsep2 rowsep2">2-MeO </td><td class="colsep2 rowsep2">0.159 </td><td class="colsep2 rowsep2">1.259 </td><td class="colsep2 rowsep2">5.141 </td><td class="colsep2 rowsep2">11.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See ref 32 for a description of assay conditions.<i><sup>b</sup></i><sup></sup> <i>K</i><sub>i</sub> values are reported as the mean of several determinations. The variability around the mean value was less than 50%.<i><sup>c</sup></i><sup></sup> Assay were run as singlets.<i><sup>d</sup></i><sup></sup> ND = not determined.</p></div></div></div><div class="NLM_p">After the establishment of 2,4-diaminopyrimidines as novel CDK inhibitors, the focus was then placed on optimizing the B ring to improve the CDK inhibitory activity while the 2-methoxy group was maintained on the A ring (Table 2<a class="ref showTableEvent internalNav" data-ID="jm0606138t00002" href="#jm0606138t00002"></a>). Systematic SAR exploration revealed that the non-aromatic 4-aminopiperidine group instead of an aromatic B ring (as in compounds <b>17</b><b>−</b><b>22</b>) was critical for improving potency of the diaminopyrimidine series. While the tertiary amine <b>24</b> was inactive, the secondary amine <b>23</b> showed modest enzyme inhibitory activity against CDK4 and weak inhibition against CDK1 and CDK2. Urea <b>25</b> with a non-basic NH improved both CDK1 and CDK2 inhibitory activities by 4-fold (<i>K</i><sub>i</sub> = 1.5 and 1.7 μM, respectively) while maintaining modest potency against CDK4 (<i>K</i><sub>i</sub> = 0.409 μΜ). Without the potential hydrogen-bond donor as in urea <b>25</b>, carbamate <b>26</b> exhibited a further 3−6-fold improvement in potency against CDK1, CDK2, and CDK4, resulting in a multi-targeted, submicromolar CDK inhibitor (<i>K</i><sub>i</sub> = 0.246, 0.597, and 0.110 μM, respectively). In an effort to improve both the potency and the physicochemical properties (data not shown) of the diaminopyrimidine series, we focused our attention on modifying the carbamate moiety of compound <b>26</b>. Amides <b>27 </b>and<b> 28 </b>were found to have equal to slightly more potent kinase inhibition against CDK1, CDK2, and CDK4 compared to carbamate <b>26</b>. However, with the introduction of a strongly polarized sulfonyl group, sulfonamides (<b>29</b> and <b>30</b>), demonstrated a significant increase in kinase inhibitory activity (CDK1, CDK2, and CDK4) and modest improvement in cellular potency against HCT116 human colon cell line. For example, methyl sulfonamide <b>29</b> was nearly 1 order of magnitude more potent than carbamate <b>26</b> in the kinase assays (<i>K</i><sub>i</sub> = 0.028, 0.024, and 0.014 μM for CDK1, CDK2, and CDK4, respectively) and resulted in favorable cell growth inhibition (HCT116, IC<sub>50</sub> = 1.6 μM). It was also noted that extending the alkyl group in <a name="jm004902206551" id="jm004902206551"></a> the amides (e.g. <b>27</b>, <b>28</b>) or sulfonamides (e.g. <b>29</b>, <b>30</b>) had a very limited impact on kinase inhibition, consistent with the observation from the crystal structure that the R<sub>2</sub> group points toward solvent (vide infra). With the substituted 4-piperidine identified as the most preferred B ring, a re-examination of the simple monosubstitution on the aromatic A ring was carried out through the preparation of a small number of analogues with variation at the C2 position (<b>31</b><b>−</b><b>33</b>). 2-Fluoro- and 2-methyl-substituted compounds (<b>31</b> and <b>32</b>, respectively) substantially reduced CDK inhibition compared with 2-methoxy analogue <b>26</b>. We believe that preorganization of the binding conformation of the ligand to CDK is promoted by the 2-methoxy group, which enforces non-coplanarity of the A ring with respect to the pyrimidine core. Surprisingly, the 2-ethoxy derivative <b>33</b> resulted in greater than 10-fold loss in CDK1, CDK2, and CDK4 inhibitory activity (vs amide <b>27</b>), suggesting that this binding pocket is not big enough to accommodate larger substitutions on the A ring. This was consistent with our earlier observation outlined in Table 1 and confirmed that the 2-methoxy was the optimal group for the C2 position of the aromatic A ring. <div class="NLM_table-wrap" id="jm0606138t00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Optimization of R<sub>1</sub> on Ring A and R on Piperidine Ring B in 2,4-Diamino-5-ketopyrimidines<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138u00002a.gif" alt="" id="_i17" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See ref 32 for a description of assay conditions.<i><sup>b,c</sup></i><sup></sup> <i>K</i><sub>i</sub> and IC<sub>50</sub> values are reported as the mean of several determinations. The variability around the mean value was less than 50%.<i><sup>d</sup></i><sup></sup> ND = not determined.</p></div></div></div><div class="NLM_p"><a name="jm004902206552" id="jm004902206552"></a>With the identification of 1-methanesulfonyl-4-piperidine as the optimal B ring and 2-methoxy as the most preferred group for the C2 position of the aromatic A ring, further exploration of other substitutions on the A ring was carried out (Table 3). Introduction of a fluorine to the C5 position of compound <b>29 </b>yielded a more potent CDK inhibitor (<b>35</b>) with <i>K</i><sub>i</sub> values of less than 10 nM with respect to CDK2 and CDK4, while the 4-fluoro analogue <b>34 </b>reduced the inhibition against CDK1, CDK2, and CDK4. Compound <b>35</b> also proved to be more potent in our cell-based assay (HCT116 cell line) with an IC<sub>50</sub> of 0.66 μM. A notable difference for the effect of substitution at the C5 position was that the chloro analogue <b>36 </b>was 10-fold less active in the cell-based assay than the corresponding fluoride <b>35</b>, suggesting the size of the substituent at this position may affect potency. Similar to the 5-fluoro analogue <b>35</b>, compound <b>37</b> with the fluorine at the C6 position also significantly increased CDK inhibitory activity and cellular potency (IC<sub>50</sub> = 0.30 μM, HCT116 cell line). Previous reports have indicated that 2,6-difluorophenyl substitution provides a beneficial effect on the potency of the CDK inhibiton.<sup><a onclick="showRef(event, 'jm0606138b00030 jm0606138b00031'); return false;" href="javascript:void(0);" class="ref jm0606138b00030 jm0606138b00031">30,31</a></sup> Interestingly, substitution of the 2-methoxy group in <b>37</b> with a fluorine atom resulting in the 2,6-difluoro analogue <b>38</b> proved to be inconsequential with respect to CDK inhibition and yet resulted in more than 10-fold loss in the cellular potency. This distinct difference confirmed the early observation that the 2-methoxy group is unique for this diaminopyrimidine series. Compound <b>39</b> possessing both 5- and 6-fluoro substitution culminated in an inhibitor with low, single-digit nanomolar potency against the CDKs (<i>K</i><sub>i</sub> = 0.001, 0.003, and 0.001 μM for CDK1, CDK2, and CDK4, respectively) and excellent cellular potency (IC<sub>50</sub> = 0.08 μM, HCT116 cell line). Another difluoro-substituted analogue <b>40</b>, with fluorines at both the C4 and C5 positions, had a potency equal to that of monofluoro derivative <b>35</b> but 6-fold less than that of compound <b>39</b>. A 4,5,6-trifluoro substitution was still tolerated, as seen in derivative<b> 41</b>, with a slight loss of the cellular potency compared to <b>39</b>. However, when the third fluorine substitution was at the C3 position (<b>42</b>), the CDK inhibitory activities dropped considerably. From these data we concluded that the 5,6-difluoro-2-methoxy substitution on the A ring is the most preferred pattern, resulting in excellent CDK inhibitory activities and in vitro cellular potency for the diaminopyrimidine series. </div><div class="NLM_p"><b>Kinase Selectivity Profile.</b> The most promising 2,4-diamino-5-ketopyrimidine analogues were examined in both our in-house kinase selectivity panel and the Upstate kinase selectivity screen.<sup><a onclick="showRef(event, 'jm0606138b00032'); return false;" href="javascript:void(0);" class="ref jm0606138b00032">32</a></sup> As shown in Table 4<a class="ref showTableEvent internalNav" data-ID="jm0606138t00003" href="#jm0606138t00003"></a><a class="ref showTableEvent internalNav" data-ID="jm0606138t00004" href="#jm0606138t00004"></a>, compound <b>39</b> was found to be a potent and ATP-competitive inhibitor of the CDK family of protein kinases. It strongly inhibits CDK1/cyclin B, CDK2/cyclin E, and CDK4/cyclin D and shows little or no inhibitory activity against a panel of 18 other serine/threonine kinases. Compound <b>39</b> was also effective in inhibiting the phosphorylation of retinoblastoma protein (pRb) in human tumor cells in a time dependent manner. Treatment of HCT116 cells with compound <b>39</b> inhibited phosphorylation at both the serine 795 and 780 sites on pRb, consistent with the two phosphorylation sites specifically phosphorylated by CDK4. Cell cycle block in <a name="jm004902206553" id="jm004902206553"></a> G<sub>1</sub> + G<sub>2</sub> inducing apoptosis in a dose-dependent manner in the same cell line has also been observed.<sup>32</sup><div class="NLM_table-wrap" id="jm0606138t00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Further Substitution Patterns on Aromatic Ring A of 2,4-Diamino-5-ketopyrimidines<i><sup>a</sup></i><sup></sup><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138u00003a.gif" alt="" id="_i18" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="3"><i>K</i><sub>i</sub> (μM)<i><sup>b</sup></i><sup></sup></td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">R<sub>2</sub></td><td class="colsep2 rowsep2">R<sub>3</sub></td><td class="colsep2 rowsep2">R<sub>4</sub></td><td class="colsep2 rowsep2">R<sub>5</sub></td><td class="colsep2 rowsep2">R<sub>6</sub></td><td class="colsep2 rowsep2">CDK4</td><td class="colsep2 rowsep2">CDK1</td><td class="colsep2 rowsep2">CDK2</td><td class="colsep2 rowsep2">IC<sub>50</sub> (μM)<i><sup>c</sup></i><sup></sup> HCT116 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>34</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.021 </td><td class="colsep2 rowsep2">0.193 </td><td class="colsep2 rowsep2">0.084 </td><td class="colsep2 rowsep2">3.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>35</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.007 </td><td class="colsep2 rowsep2">0.014 </td><td class="colsep2 rowsep2">0.007 </td><td class="colsep2 rowsep2">0.65 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>36</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.036 </td><td class="colsep2 rowsep2">0.133 </td><td class="colsep2 rowsep2">0.451 </td><td class="colsep2 rowsep2">7.0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">0.003 </td><td class="colsep2 rowsep2">0.017 </td><td class="colsep2 rowsep2">0.013 </td><td class="colsep2 rowsep2">0.30 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">0.017 </td><td class="colsep2 rowsep2">0.038 </td><td class="colsep2 rowsep2">0.015 </td><td class="colsep2 rowsep2">3.4 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">0.001 </td><td class="colsep2 rowsep2">0.001 </td><td class="colsep2 rowsep2">0.003 </td><td class="colsep2 rowsep2">0.08 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>40</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.006 </td><td class="colsep2 rowsep2">0.014 </td><td class="colsep2 rowsep2">0.006 </td><td class="colsep2 rowsep2">0.52 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">0.001 </td><td class="colsep2 rowsep2">0.005 </td><td class="colsep2 rowsep2">0.002 </td><td class="colsep2 rowsep2">0.22 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>42</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.267 </td><td class="colsep2 rowsep2">1.667 </td><td class="colsep2 rowsep2">0.495 </td><td class="colsep2 rowsep2">ND<i><sup>d</sup></i><sup></sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See ref 32 for a description of assay conditions.<i><sup>b,c</sup></i><sup></sup> <i>K</i><sub>i</sub> and IC<sub>50</sub> values are reported as the mean of several determinations. The variability around the mean value was less than 50%.<i><sup>d</sup></i><sup></sup> ND = not determined.</p></div></div><div class="NLM_table-wrap" id="jm0606138t00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  Kinase Selectivity Profile for Compound 39<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">kinases</td><td class="colsep2 rowsep2"><i>K</i><sub>i</sub> (μM)<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">kinases</td><td class="colsep2 rowsep2"><i>K</i><sub>i</sub> (μM)<i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">CDK4/cyclin D </td><td class="colsep2 rowsep2">0.001 ± 0.0001 </td><td class="colsep2 rowsep2">GSK3β </td><td class="colsep2 rowsep2">8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">CDK2/cyclin E </td><td class="colsep2 rowsep2">0.003 ± 0.0008 </td><td class="colsep2 rowsep2">KDR </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">CDK1/cyclin B </td><td class="colsep2 rowsep2">0.002 ± 0.0008 </td><td class="colsep2 rowsep2">FGFR </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKA </td><td class="colsep2 rowsep2">>5 </td><td class="colsep2 rowsep2">EGFR </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKB </td><td class="colsep2 rowsep2">>5 </td><td class="colsep2 rowsep2">PDGF </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKCα </td><td class="colsep2 rowsep2">>5 </td><td class="colsep2 rowsep2">MAPK2 </td><td class="colsep2 rowsep2">>50 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKCβ </td><td class="colsep2 rowsep2">>5 </td><td class="colsep2 rowsep2">IGFR </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">FYN </td><td class="colsep2 rowsep2">>5 </td><td class="colsep2 rowsep2">SRC </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">EPHB3 </td><td class="colsep2 rowsep2">>5 </td><td class="colsep2 rowsep2">FAK </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">SGK </td><td class="colsep2 rowsep2">>5 </td><td class="colsep2 rowsep2">AURORA </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">p38 </td><td class="colsep2 rowsep2">>50 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See ref 32 for a description of assay conditions and inhibitory activity data against additional kinases.<i><sup>b</sup></i><sup></sup> <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + <i>S</i>/<i>K</i><sub>m</sub>) where S is the substrate ATP concentration and <i>K</i><sub>m</sub> is the Michaelis−Menten constant for ATP; mean of at least two separate determinations.</p></div></div></div><div class="NLM_p"><b>Structural Study of Inhibitors bound to CDK2.</b> The crystal structure of compound <b>39 </b>bound to CDK2, shown in Figure 5<a data-tab="pane-pcw-Figures" href="#jm0606138f00005" id="" class=" internalNav"></a>, revealed a binding motif whereby the hinge region (residues Phe80-Glu81-Phe82-Leu83) makes key hydrogen-bond interactions with the two donors in the donor−acceptor−donor (DAD) portion of the diaminopyrimidine core. The central nitrogen acceptor is 3.7 Å away from the backbone NH of Leu83. The B ring piperidine makes hydrophobic contacts similar to those seen in many kinase inhibitors,<sup>34</sup> with the sulfonamide making both direct and water-mediated hydrogen bonds to Lys89, Asp86, and the backbone carbonyl of His84. The 2,6-disubstitution pattern on the A ring forces it out of the plane of the pyrimidine core and allows the difluoro to pack into the hydrophobic pocket near Phe80 and the alkyl chain of Lys33. <div id="_i19"><figure id="jm0606138f00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00005.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 The 1.85 Å crystal structure of compound <b>39</b> bound in the ATP binding pocket of CDK2 (no cyclin). Nitrogen atoms are in blue, oxygen atoms in red, sulfur in orange, and fluorine in green, and key hydrogen bonds are depicted. Bridging waters play a crucial role in the enhanced binding of this compound to the enzyme. The figure was made with program PyMOL.<sup><a onclick="showRef(event, 'jm0606138b00033'); return false;" href="javascript:void(0);" class="ref jm0606138b00033">33</a></sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p"><b>Pharmacokinetics Study. </b>To assess the preliminary pharmacokinetic (PK) properties of this class of 2,4-diamino-5-ketopyrimidines, several representative lead analogues including compounds <b>29</b>,<b> 35</b>, and<b> 39</b> were administered orally and intravenously (iv) to female nude mice. The mean plasma concentration versus time profiles after an oral dose of 100 mg/kg are shown in Figure 6<a data-tab="pane-pcw-Figures" href="#jm0606138f00006" id="" class=" internalNav"></a>. All three compounds were rapidly absorbed and their <i>C</i><sub>max</sub> was reached within 1 h. Over the 4 h period, the observed drug concentration of compound <b>29 </b>decreased substantially. But the concentrations of the 5-fluoro analogue<b> 35 </b>remained above or close to its IC<sub>90</sub> level (IC<sub>90</sub> = 1.8 μM or 762 ng/mL in HCT116 cell line). The plasma exposure of the 5,6-difluoro analogue<b> 39 </b>greatly exceeded (about 10-fold at 8 h post dose) its IC<sub>90</sub> values (IC<sub>90</sub> = 0.17 μM or 75 ng/mL in HCT116 cell line). Sufficient drug exposure can be expected from a dose regiment of 50 and 75 mg/kg three times per week in the experimental animals. The clearance (CL) and the volume of distribution (<i>V</i><sub>ss</sub>) of these three compounds also improved as the number of substitutions on the aromatic A ring increased (Table 5<a class="ref showTableEvent internalNav" data-ID="jm0606138t00005" href="#jm0606138t00005"></a>).                                                        <div id="_i21"><figure id="jm0606138f00006" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00006.jpeg" id="_i22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 6 Mean plasma concentration versus time profiles of selected compounds <b>29</b>, <b>35</b>, and <b>39</b> following oral administration (100 mg/kg) in female athymic nontumor bearing mice. The error bars represent the percent coefficient of variation. The dashed lines A (for <b>35</b>) and B (for <b>39</b>) represent the in vitro IC<sub>90</sub> values of the cell inhibition in the HCT116 cell line (IC<sub>90</sub> = 762 ng/mL and 75 ng/mL for compounds<b> 35</b> and <b>39</b>, respectively):  compound <b>29</b> (open square), compound <b>35</b> (open circle), compound <b>39</b> (filled triangle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm0606138t00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  Mouse PK Data Following Single IV Administration (10 mg/kg) of Selected Compounds<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">CL (mL/min/kg)</td><td class="colsep2 rowsep2"><i>V</i><sub>ss</sub> (mL/kg) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>29</b></td><td class="colsep2 rowsep2">47.1 </td><td class="colsep2 rowsep2">401 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>35</b></td><td class="colsep2 rowsep2">48.3 </td><td class="colsep2 rowsep2">885 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">38.6 </td><td class="colsep2 rowsep2">1070</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Based on mean data from three mice/time point.</p></div></div></div><div class="NLM_p">As summarized in Table 6<a class="ref showTableEvent internalNav" data-ID="jm0606138t00006" href="#jm0606138t00006"></a>, the systemic plasma clearance of compound <b>39</b> in female athymic non-tumor bearing mice was 38.6 mL/min/kg. A 100 mg/kg oral dose resulted in a half-life (<i>t</i><sub>1/2</sub>) of 2.8 h, and the measured oral bioavailability (<i>F</i><sub>po</sub>) of compound <b>39</b> in this study was approximately 21%. The observed large volume of distribution (1070 mL/kg) suggests deep tissue penetration. The pharmacokinetic profile of <a name="jm004902206554" id="jm004902206554"></a> compound <b>39 </b>along with the excellent in vitro cellular potency warranted the advancement of these 2,4-diamino-5-ketopyrimidine analogues into in vivo efficacy studies. <div class="NLM_table-wrap" id="jm0606138t00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  Pharmacokinetic Properties of Compound <b>39</b> in Mice<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">parameter</td><td class="colsep2 rowsep2">unit</td><td class="colsep2 rowsep2">iv administration</td><td class="colsep2 rowsep2">po administration </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dose </td><td class="colsep2 rowsep2">mg/kg </td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">100 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>C</i><sub>max</sub></td><td class="colsep2 rowsep2">ng/mL </td><td class="colsep2 rowsep2">7310 </td><td class="colsep2 rowsep2">2700 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>T</i><sub>max</sub></td><td class="colsep2 rowsep2">h </td><td class="colsep2 rowsep2">0.083 </td><td class="colsep2 rowsep2">0.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">AUC<sub>(</sub><sub>0</sub><sub>-</sub><i><sub>t</sub></i><sub>)</sub></td><td class="colsep2 rowsep2">ng h/mL </td><td class="colsep2 rowsep2">4152 </td><td class="colsep2 rowsep2">8169 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>T</i><sub>1/2</sub></td><td class="colsep2 rowsep2">h </td><td class="colsep2 rowsep2">0.39 </td><td class="colsep2 rowsep2">2.8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">CL </td><td class="colsep2 rowsep2">mL/min/kg </td><td class="colsep2 rowsep2">38.6 </td><td class="colsep2 rowsep2">− </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>V</i><sub>ss</sub></td><td class="colsep2 rowsep2">mL/kg </td><td class="colsep2 rowsep2">1070 </td><td class="colsep2 rowsep2">− </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>F</i><sub>po</sub></td><td class="colsep2 rowsep2">% </td><td class="colsep2 rowsep2">− </td><td class="colsep2 rowsep2">21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Based on mean data from three mice/time point.</p></div></div></div><div class="NLM_p last"><b>In Vivo </b><b>Antitumor</b><b> Activity.</b> Compound <b>39</b> was evaluated for its in vivo antitumor activity in female nude mice bearing established HCT116 human colorectal xenografts with a mean starting volume of about 100 mm<sup>3</sup> (Figure 7<a data-tab="pane-pcw-Figures" href="#jm0606138f00007" id="" class=" internalNav"></a>). In this study, compound <b>39</b> was administered orally three times per week on Monday, Wednesday, and Friday (M, W, F) as a suspension in 1% Klucel LF in water with 0.1% Tween 80 for 18 days (a total of eight doses). At the end of the two and a half week study, compound <b>39 </b>demonstrated significant in vivo antitumor activity in the absence of gross or histological indications of toxicity. A dose of 25 mg/kg three times per week inhibited HCT116 colorectal tumor growth by 52%, while doses of 50 and 75 mg/kg three times per week inhibited tumor growth by 95% and 94%, respectively, as compared to vehicle-treated mice. A more extensive biochemical and biological characterization of compound <b>39</b>, including a comprehensive in vivo efficacy evaluation, will be published separately.<sup>32</sup><div id="_i23"><figure id="jm0606138f00007" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00007.jpeg" id="_i24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 7 Effect of compound <b>39</b> on HCT116 human colorectal tumor xenograft growth. Statistical analysis was determined by the rank sum test and one-way Anova and a post-hoc Bonferroni <i>t</i>-test. * = Statistically significant as compared to the vehicle-treated group, where <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have reported the discovery of a novel class of 2,4-diamino-5-ketopyrimidines (<b>6</b>) as potent, selective, and ATP-competitive CDK inhibitors. The SAR of the diaminopyrimidine core proved to be unique in that it favors a 2-methoxyphenyl substitution on the A ring rather than a 2,6-difluoro substitution. Further lead optimization resulted in the identification of compound <b>39</b> as a potent inhibitor of CDK1, CDK2, and CDK4 (<i>K</i><sub>i</sub> = 0.001−0.003 μM) which was selective against a large panel of related and unrelated serine/threonine and tyrosine kinases (<i>K</i><sub>i</sub> > 10 μM). It exhibited excellent in vitro cellular potency, inhibiting the growth of HCT116 human colorectal tumor cell line. Furthermore, compound <b>39</b> demonstrated significant in vivo efficacy against the HCT116 human colorectal tumor xenograft model. On the basis of its superior overall profile, compound <b>39</b> (R547)<sup>29</sup> was chosen as the clinical candidate and is currently in Phase I clinical trial for the treatment of cancer. An expanded SAR study of this novel series of 2,4-diamino-5-ketopyrimidine CDK inhibitors and the related biological evaluation of further lead compounds will be reported soon.                                                </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Chemistry. </b>All nonaqueous reactions were carried out under an argon or nitrogen atmosphere at room temperature, unless otherwise noted. All reagents and anhydrous solvents were used as obtained commercially without further purification or distillation, unless otherwise stated. Analytical thin-layer chromatography (TLC) was performed on EMD Chemicals silica gel 60 F<sub>254</sub> precoated plates (0.25 mm). Compounds were visualized by UV light and/or stained with either <i>p</i>-anisaldehyde, iodine, or phosphomolybdic acid solutions followed by heating. Analytical high-pressure liquid chromatography (HPLC) and LC−MS analyses were conducted using the following two instruments and conditions. Method 1:  Hewlett-Packard HP-1090 pump and HP-1090 PDA detector set at 215 nm with the MS detection performed with a Micromass Platform II mass spectrometer with electrospray ionization (ESI); Chromegabond WR C18 3 μm, 120 Å, 3.2 mm × 30 mm column; solvent A, H<sub>2</sub>O−0.02% TFA; solvent B, MeCN−0.02% TFA; flow rate = 2 mL/min; start 2% B, final 98% B in 4 min, linear gradient. Method 2<i>:</i> Waters 2795 pump and Waters 2996 photodiode array detector set at 214 nm with the MS detection performed with a Waters ZQ mass spectrometer (ESI); Epic Polar Hydrophilic 3 μm, 120 Å, 3.2 mm × 30 mm column; solvent A, H<sub>2</sub>O−0.03% HCO<sub>2</sub>H; solvent B, MeCN−0.03% HCO<sub>2</sub>H; flow rate = 2 mL/min; start 10% B, final 100% B in 3 min linear gradient, remaining for 1 min. Compounds were purified using either of the following methods. Flash column chromatography was performed on EM Science silica gel 60 (particle size of 32−63 μm, 60 Å). Preparative reverse-phase high-pressure liquid chromatography (RP HPLC) was performed using a Waters Delta prep 4000 pump/controller, a 486 detector set at 215 nm, and a LKB Ultrorac fraction collector. The sample was dissolved in a mixture of MeCN/20 mM aqueous NH<sub>4</sub>Ac, applied on a C-18 20 × 100 mm column and eluted at 30 mL/min with a 20 min linear gradient of 10%−90% B, where solvent A = H<sub>2</sub>O with 20 mM NH<sub>4</sub>Ac and solvent B = MeCN. The pooled fractions were concentrated under reduced pressure and lyophilized to afford the desired compounds. <sup>1</sup>H NMR spectra were recorded using a Varian Mercury 300 MHz or Varian Inova 400 MHz spectrometer and calibrated using an internal reference. The chemical shifts are in parts per million (δ) referenced to Me<sub>4</sub>Si (0.00 ppm) or CHCl<sub>3</sub> (7.26 ppm). High-resolution mass spectra (HMRS) were recorded on a Bruker Apex II FTICR mass spectrometers with a 4.7 T magnet (ES) or Micromass AutoSpec (EI) mass spectrometers. </div><div class="NLM_p"><b>Crystallization, Data Collection, and Refinement.</b> Crystals of CDK2 were grown at 4 °C by the vapor diffusion method. CDK2(1−298) at 12 mg/mL was mixed with and equilibrated against <a name="jm004902206555" id="jm004902206555"></a> 10% PEG 3350, 0.2 M ammonium phosphate, 0.1 M Bicine, pH 9.0. β-Mercaptoethanol (2%) was added to the reservoir after mixing of the drop. Crystals appeared overnight, after which <b>39</b> at 100 mM in DMSO was added to the drop. After soaking for 24 h, crystals were transferred to cryoprotectant containing 20% PEG 3350, 15% ethylene glycol, 0.2 M ammonium phosphate, 0.1 M Bicine, pH 9.0, and then cooled to liquid nitrogen temperature. Data were collected at beamline ×8C at the National Synchrotron Light Source at Brookhaven National Laboratories. The crystals belonged space group <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> with unit cell dimensions <i>a </i>= 53.5 Å, <i>b </i>= 71.65 Å, <i>c </i>= 71.7 Å. Data were processed to 1.85 Å with the HKL package<sup>35</sup> to an R-sym of 0.039. The structure was determined by the difference Fourier method and was refined with CNX (CNX v.2000.1, Molecular Simulations Inc.), with 0.05% of reflections in the test set, to a final R-factor/R-free of 0.208/0.237. Coordinates have been deposited to the PDB under accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FVD">2FVD</a>. </div><div class="NLM_p"><b>Pharmacokinetic Study Methods.</b> Female immunodeficient nude mice (13−14 weeks old) obtained from Charles River Laboratories (Wilmington, DE) were allowed to acclimate for a minimum of 72 h prior to study start. Mice received a single oral (100 mg/kg) or intravenous (10 mg/kg) dose of the test compound, and blood samples from three mice/time point were collected over a 24-h period in EDTA vials. The oral dose was administered as a suspension in 1% Klucel and 0.1% Tween 80, and the iv dose was administered as a solution in 10% PEG 400 and 90% hydroxypropyl-β-cylcodextrin (28%). Plasma samples were analyzed by LC/MS for the test compound, and noncompartmental PK analysis was performed on the mean plasma concentration−time profiles using WinNonlin (Pharsight) or Watson. </div><div class="NLM_p"><b>4-Amino-2-ethylsulfanylpyrimidine-5-carboxylic Acid Methoxymethylamide (8). </b>To a solution of 4-amino-2-ethylsulfanylpyrimidine-5-carboxylic acid (<b>7</b>) (1.00 g, 5.02 mmol) and diisopropylethylamine (2.79 g, 21.58 mmol, 4 equiv) in DMF (20 mL) were added 1-hydroxybenzotriazole (1.09 g, 8.07 mmol, 1.5 equiv) and <i>O</i>-benzotriazol-1-yl-<i>N,N,N</i><i>‘</i><i>,N</i><i>‘</i>-tetramethyluronium hexafluorophosphate (3.06 g, 8.07 mmol, 1.5 equiv) at 0 °C. After stirring for 15 min, <i>N,O</i>-dimethylhydroxylamine hydrochloride (790 mg, 8.10 mmol) was added and the reaction was allowed to stir at 0−20 °C for 2 h. The resulting reaction mixture was treated with H<sub>2</sub>O and extracted with EtOAc. The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified on silica gel with hexane/EtOAc (1:1) to give <b>8</b> as a white solid (1.19 g, 98% yield):  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.15 min (method 1, >95% purity), <i>t</i><sub>R</sub> = 0.89 min (method 2, >95% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.38 (t, 3H, <i>J</i> = 7.5 Hz), 3.11 (q, 2H, <i>J</i> = 7.5 Hz), 3.34 (s, 3H), 3.62 (s, 3H), 8.62 (s, 1H); HRMS for C<sub>9</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>S (M<sup>+</sup>) calcd 242.0837, observed 242.0836. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(2-methoxyphenyl)methanone (10c). </b>To a solution of 2-iodoanisole (20.0 g, 85.47 mmol) in anhydrous THF (130 mL) was added over 30 min a 1.6 M solution of <i>n</i>-butyllithium in hexane (51.0 mL, 81.6 mmol), and the mixture was stirred for a further 40 min at −78 °C to give a clear solution. A portion of this freshly prepared 2-methoxyphen-yllithium reagent (70.0 mL, ∼30 mmol, ∼3.5 equiv) was added slowly to a solution of amide<b> 8 </b>(2.07 g, 8.54 mmol) in anhydrous THF (30 mL) and the mixture was stirred at −78 °C for 1−2 h until the complete consumption of amide <b>8</b>. The resulting mixture was quenched with aqueous NH<sub>4</sub>Cl solution and extracted with EtOAc (3×). The combined organic extracts were washed with brine (2×), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified on silica gel with hexane/EtOAc (80/20 → 60/40) to give <b>10c</b> as a light yellow solid (1.85 g, 75% yield):  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.93 min (method 1, > 95% purity), <i>t</i><sub>R</sub> = 1.72 min (method 2, >95% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.38 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.13 (q, 2H, <i>J</i> = 7.4 Hz, SCH<sub>2</sub>), 3.78 (s, 3H, OCH<sub>3</sub>), 5.74 (br, 1H, NH), 6.98 (d, 1H, <i>J</i> = 8.6 Hz, aromatic), 7.04 (dt, 1H, <i>J</i> = 7.8 and 0.6 Hz, aromatic), 7.26 (m, 1H, aromatic), 7.46 (m, 1H, aromatic), 8.18 (s, 1H, aromatic), 8.77 (br, 1H, NH); HRMS for C<sub>14</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub>S (M + H)<sup>+</sup> calcd 290.0958, observed 290.0961. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(3-fluorophenyl)methanone (10a)</b> was prepared with the same procedure as described for <b>10c</b>: Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.06 min (method 1, 94% purity), <i>t</i><sub>R</sub> = 1.81 min (method 2, 95% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.40 (t, 3H, <i>J</i> = 7.3 Hz, CH<sub>3</sub>), 3.14 (q, 2H, <i>J</i> = 7.3 Hz, SCH<sub>2</sub>), 5.75 (br, 1 H, NH), 7.23−7.52 (m, 4 H, aromatic), 8.41 (s, 1 H, aromatic), 8.58 (br, 1 H, NH); HRMS for C<sub>13</sub>H<sub>13</sub>FN<sub>3</sub>OS (M + H<sup>+</sup>) calcd 278.0761, observed 278.0758. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)-</b><b><i>o</i></b><b>-tolylmethanone (10b)</b> was prepared with the same procedure as described for <b>10c</b>: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.38 (t, 3H, <i>J</i> = 7.2 Hz), 2.29 (s, 3H), 3.12 (q, 2H, <i>J</i> = 7.2 Hz), 5.76 (brd, 1H, NH), 7.17−7.29 (m, 3H, aromatic), 7.34−7.41 (m, 1H, aromatic), 8.14 (s, 1H, aromatic), 8.79 (brd, 1H, NH); HRMS for C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>OS (M+) calcd 273.0936, observed 273.0933. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(2-fluorophenyl)methanone (10d)</b> was prepared with the same procedure as described for <b>10c</b>: Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.00 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.78 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.39 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.14 (q, 2H, <i>J</i> = 7.4 Hz, SCH<sub>2</sub>), 5.80 (br, 1 H, NH), 7.18 (td, 1 H, <i>J</i><sub>ortho</sub> = <sup>3</sup><i>J</i><sub>HF</sub> = 8.4 Hz, <i>J</i><sub>meta</sub> = 1.1 Hz, aromatic), 7.29 (td, 1H, <i>J</i><sub>ortho</sub> = 7.6 Hz, <i>J</i><sub>meta</sub> = 1.1 Hz, aromatic), 7.43 (ddd, 1H, <i>J</i><sub>ortho</sub> = 7.6 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 6.8 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz, aromatic), 7.52 (m, 1H, aromatic), 8.27 (d, <sup>6</sup><i>J</i><sub>HF</sub> = 2.9 Hz, 1 H, aromatic), 8.70 (br, 1 H, NH); HRMS for C<sub>13</sub>H<sub>13</sub>FN<sub>3</sub>OS (M + H<sup>+</sup>) calcd 278.0758, observed 278.0761. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(2-ethoxyphenyl)methanone (10e)</b> was prepared with the same procedure as described for <b>10c</b>: white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.12 min (method 1, 98% purity), <i>t</i><sub>R</sub> = 1.86 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.25 (t, 3H, <i>J</i> = 7.1 Hz, CH<sub>3</sub>), 1.38 (t, 3H, <i>J </i>= 7.4 Hz, CH<sub>3</sub>), 3.12 (q, 2H, <i>J</i> = 7.4 Hz, SCH<sub>2</sub>), 4.03 (q, 2H, <i>J</i> = 7.1 Hz, 2 H, OCH<sub>2</sub>), 5.70 (br, 1 H, NH), 6.95 (d, 1H, <i>J</i> = 8.4 Hz, aromatic), 7.03 (dt, 1H, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 0.8 Hz, aromatic), 7.28 (dd, 1H, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz, aromatic), 7.34 (ddd, 1H, <i>J</i><sub>ortho</sub> = 8.4 Hz, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz, aromatic), 8.21 (s, 1 H, aromatic), 8.72 (br, 1 H, NH); HRMS for C<sub>15</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>S (M + H<sup>+</sup>) calcd 304.1114, observed 304.1117. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfanylpyrimidin-5-yl)(4-fluoro-2-meth-oxyphenyl)methanone (10f)</b> was prepared with the same procedure as described for <b>10c</b>: white solid; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.38 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.13 (q, 2H, <i>J</i> = 7.4 Hz, SCH<sub>2</sub>), 3.77 (s, 3H, OCH<sub>3</sub>), 5.78 (br, 1H, NH), 6.58−6.88 (m, 2H, aromatic), 7.18−7.39 (m, 1 H, aromatic), 8.17 (s, 1H, aromatic), 8.73 (br, 1 H, NH); LR-MS (M + H<sup>+</sup>) 308. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(5-fluoro-2-meth-oxyphenyl)methanone (10</b><b>g</b><b>)</b> was prepared with the same procedure as described for <b>10c</b>: white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.06 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.82 min (method 2, > 99% purity); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.27 (t, 3H, <i>J</i> = 7.3 Hz, CH<sub>3</sub>), 3.06 (q, 2H, <i>J</i> = 7.3 Hz, SCH<sub>2</sub>), 3.71 (s, 3 H, OCH<sub>3</sub>), 7.16 (dd, 1H, <i>J</i><sub>ortho</sub> = 9.2, <sup>4</sup><i>J</i><sub>HF</sub> = 4.4 Hz, aromatic), 7.20 (dd, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 8.4, <i>J</i><sub>meta</sub> = 3.2 Hz, aromatic), 7.34 (ddd, 1H, <i>J</i><sub>ortho</sub> = 9.2, <sup>3</sup><i>J</i><sub>HF</sub> = 8.7, <i>J</i><sub>meta</sub> = 3.2 Hz, aromatic), 7.97 (s, 1H, aromatic), 8.33 (br, 1 H, NH), 8.44 (br, 1 H,NH); HRMS for C<sub>14</sub>H<sub>15</sub>FN<sub>3</sub>O<sub>2</sub>S (M + H<sup>+</sup>) calcd 308.0864, observed 308.0863. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(5-chloro-2-meth-oxyphenyl)methanone (10h)</b> was prepared with the same procedure as described for <b>10c</b>: light yellow solid; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.27 (t, 3H, <i>J</i> = 7.2 Hz, CH<sub>3</sub>), 3.05 (q, 2H, <i>J</i> = 7.2 Hz, SCH<sub>2</sub>), 3.72 (s, 3H, OCH<sub>3</sub>), 7.17 (d, 1H, <i>J</i><sub>ortho</sub> = 8.7, aromatic), 7.36 (d, 1H, <i>J</i><sub>meta</sub> = 2.7 Hz, aromatic), 7.53 (dd, 1H, <i>J</i><sub>ortho</sub> = 8.7 Hz, <i>J</i><sub>meta</sub> = 2.4 Hz, aromatic), 7.97 (s, 1H, aromatic), 8.33 (br, 1 H, NH), 8.42 (br, 1 H,NH); HRMS for C<sub>14</sub>H<sub>15</sub>ClN<sub>3</sub>O<sub>2</sub>S (M + H<sup>+</sup>) calcd 324.0568, observed 324.0568. </div><div class="NLM_p"><b>(4-Amino-2-methylsulfanylpyrimidin-5-yl)(2-fluoro-6-methoxyphenyl)methanone (10i). </b>The aryllithium reagent was generated via deprotonation of 3-fluoroanisole in a similar manner as described for the preparation of <b>10c</b>, which was reacted with <b>8 </b>to give <b>10i</b> as a yellow oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.52 (s, 3H, SCH<sub>3</sub>), 3.78 (s, 3H, OCH<sub>3</sub>), 5.82 (br, 1H, NH), 6.73−6.83 (m, 2H, aromatic), 7.33−7.44 (m, 1H, aromatic), 8.17 (s, 1H, aromatic), 8.75 (br, 1H, NH); MS (M + H<sup>+</sup>) 307. </div><div class="NLM_p"><a name="jm004902206556" id="jm004902206556"></a><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(2,6-difluorophenyl)methanone (10j)</b> was prepared following a similar procedure as described for <b>10i</b>:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.39 (t, 3H, <i>J</i> = 7.3 Hz, CH<sub>3</sub>), 3.13 (q, 2H, <i>J</i> = 7.3 Hz, CH<sub>2</sub>), 5.83 (br, 1 H, NH), 7.01 (t, 2H, <i>J</i> = 7.9 Hz, 2 H, aromatic), 7.46 (tt, 1H, <i>J</i> = 8.4 and 6.4 Hz, aromatic), 8.21 (s, 1 H, aromatic), 8.68 (br, 1 H, NH); LR-MS (M + H<sup>+</sup>) 296. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone (10k) </b><b>and</b><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(4,5-difluoro-2-methoxyphenyl)methanone </b><b>(10</b><b>l</b><b>).</b> Following a similar procedure as described for <b>10c</b>, the reaction of the aryllithium reagent, generated from 2-bromo-4,5-difluoroanisole and <i>n</i>-butyllithium, with amide <b>8</b> was allowed to slowly warm to −35 °C for 2 h. The crude material was purified on prep HPLC to give isomers <b>10k </b>and<b> 10</b><b>l</b> in an approximate 8:1 ratio. </div><div class="NLM_p">For compound <b>10k</b>:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.12 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.90 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub><i>)</i> δ 1.39 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.14 (q, 2H, <i>J</i> = 7.4 Hz, SCH<sub>2</sub>), 3.75 (s, 3H, OCH<sub>3</sub>), 5.91 (br, 1 H, NH), 6.68 (ddd, 1H, <i>J</i><sub>ortho</sub> = 9.2 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 3.2 Hz, <sup>5</sup><i>J</i><sub>HF</sub> = 2.0 Hz, aromatic), 7.23 (q, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = <sup>4</sup><i>J</i><sub>HF</sub> = <i>J</i><sub>ortho</sub> = 9.2 Hz, aromatic), 8.16 (s, 1 H, aromatic), 8.75 (br, 1 H, NH); HRMS for C<sub>14</sub>H<sub>14</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub>S (M + H<sup>+</sup>) calcd 326.0770, observed 326.0771. </div><div class="NLM_p">For compound <b>10</b><b>l</b>:  <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.29 (t, 3H, <i>J</i> = 7.3 Hz, CH<sub>3</sub>), 3.08 (q, 2H, <i>J</i> = 7.3 Hz, SCH<sub>2</sub>), 3.74 (s, 3H, OCH<sub>3</sub>), 7.34 (dd, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 12.7 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 6.3 Hz, aromatic), 7.50 (t, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = <sup>4</sup><i>J</i><sub>HF</sub> = 9.7 Hz, aromatic), 8.06 (s, 1 H, aromatic), 8.34 (br, 1 H, NH), 8.43 (br, 1 H, NH); HRMS for C<sub>14</sub>H<sub>14</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub>S (M + H<sup>+</sup>) calcd 326.0770, observed 326.0772 </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(2,3,4-trifluoro-6-methoxyphenyl)methanone </b><b>(10m)</b> was prepared following a similar procedure as described for <b>10i</b>; the aryllithium reagent was generated from deprotonation of 3,4,5-trifluoroanisole and reacted with <b>8 </b>to give <b>10m</b>:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.39 (t, 3H, <i>J</i> = 7.3 Hz, CH<sub>3</sub>), 3.13 (q, 2H, <i>J</i> = 7.3 Hz, SCH<sub>2</sub>), 3.75 (s, 3H, OCH<sub>3</sub>), 5.85 (br, 1 H, NH), 6.61 (ddd, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 11.5 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 5.3 Hz, <sup>5</sup><i>J</i><sub>HF</sub> = 2.2 Hz, aromatic), 8.15 (s, 1H, aromatic), 8.67 (br, 1 H, NH); LR-MS (M + H<sup>+</sup>) 344. </div><div class="NLM_p"><b>(4-Amino-2-ethylsulfanylpyrimidin-5-yl)(3,4,5-trifluoro-2-methoxyphenyl)methanone (10n)</b> was prepared following a similar procedure as described for <b>10i</b>; the aryllithium reagent was generated from deprotonation of 2,3,4-trifluoroanisole and reacted with <b>8 </b>to give <b>10n</b>:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.39 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.14 (q, 2H, <i>J</i> = 7.4 Hz, SCH<sub>2</sub>), 3.91 (s, 3H, OCH<sub>3</sub>), 5.86 (br, 1H, NH), 6.78 (ddd, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 8.0 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 5.4 Hz, <sup>5</sup><i>J</i><sub>HF</sub> = 2.4 Hz, aromatic), 8.26 (d, 1H, <i>J</i> = 3.7 Hz, aromatic), 8.61 (br, 1 H, NH); LR-MS (M + H<sup>+</sup>) 344. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)(2-methoxyphenyl)methanone (11c). </b>To a cooled solution of <b>10c</b> (2.66 g, 9.19 mmol) in chloroform (120 mL) was added in three portions 3-chloroperoxybenzoic acid (∼77% purity, 5.20 g, ∼23 mmol, 2.5 equiv) and the mixture stirred at 0 °C for 1 h. The resulting mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (80 mL), washed with 10% aqueous sodium thiosulfate (2 × 30 mL) and brine (2 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified on silica gel with hexane/EtOAc (60/40) to give <b>11c</b> as a white solid (2.30, 78% yield):  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.42 (t, 3H, <i>J</i> = 7.5 Hz, CH<sub>3</sub>), 3.50 (q, 2H, <i>J</i> = 7.4 Hz, SO<sub>2</sub>CH<sub>2</sub>), 3.78 (s, 3H, OCH<sub>3</sub>), 6.30 (br, 1 H, NH), 7.01 (d, 1H, <i>J</i> = 8.3 Hz, aromatic), 7.10 (dt, 1H, <i>J</i><sub>ortho</sub> = 7.6 Hz, <i>J</i><sub>meta</sub> = 0.8 Hz, aromatic), 7.34 (dd, 1H, <i>J</i><sub>ortho</sub> = 7.6 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz, aromatic), 7.53 (m, 1H, aromatic), 8.50 (s, 1 H, aromatic), 8.93 (br, 1 H, NH); HRMS for C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>SNa (M + Na)<sup>+</sup> calcd 344.0675, observed 344.0679. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)(3-fluorophenyl)methanone (11a):  </b>Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.70 min (method 1, 90% purity), <i>t</i><sub>R</sub> = 1.46 min (method 2, 92% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.45 (t, 3H, <i>J</i> = 7.2 Hz, CH<sub>3</sub>), 3.53 (q, 2H, <i>J</i> = 7.2 Hz, SO<sub>2</sub>CH<sub>2</sub>), 6.34 (br, 1H, NH), 7.30−7.58 (m, 4 H, aromatic), 8.67 (br, 1H, NH), 8.72 (s, 1H, aromatic); HRMS for C<sub>13</sub>H<sub>12</sub>FN<sub>3</sub>O<sub>3</sub>S (M + ) calcd 309.0583, observed 309.0582. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)-</b><b><i>o</i></b><b>-tolylmethanone (11b):  </b><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.33 (t, 3H, <i>J</i> = 7.5 Hz), 2.25 (s, 3H), 3.44 (q, 2H, <i>J</i> = 7.5 Hz), 6.34 (brd, 1H, NH), 7.16−7.28 (m, 3H, aromatic), 7.35−7.41 (m, 1H, aromatic), 8.40 (s, 1H, aromatic), 8.93 (brd, 1H, NH); HRMS for C<sub>14</sub>H<sub>16</sub>N<sub>3</sub>O<sub>3</sub>S (M + H) + calcd 306.0907, observed 306.0910. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)(2-ethoxyphenyl)methanone (11e). </b>The same procedure was used as described for <b>11a</b>:  white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.82 min (method 1, 95% purity), <i>t</i><sub>R</sub> = 1.60 min (method 2, 98% purity); <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub><i>)</i> δ 1.16 (t, 3H, <i>J</i> = 7.0 Hz, CH<sub>3</sub>), 1.35 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.52 (q, 2H, <i>J</i> = 7.4 Hz, SO<sub>2</sub>CH<sub>2</sub>), 4.06 (q, 2H, <i>J</i> = 7.0 Hz, OCH<sub>2</sub>), 7.10 (dt, 1H, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 0.8 Hz, aromatic), 7.13 (d, 1 H, <i>J</i> = 8.6 Hz, aromatic), 7.40 (dd, 1H, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz, aromatic), 7.55 (ddd, 1H, <i>J</i><sub>ortho</sub> = 8.6 Hz, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz, aromatic), 8.38 (s, 1 H, aromatic); HRMS for C<sub>15</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub>S (M + H<sup>+</sup>) calcd 336.1013, observed 336.1016. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)(5-fluoro-2-methoxyphenyl)methanone (11</b><b>g</b><b>):  </b>white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.71 min (method 1, 87% purity), <i>t</i><sub>R</sub> = 1.49 min (method 2, 92% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.44 (t, 3H, <i>J</i> = 7.5 Hz, CH<sub>3</sub>), 3.55 (q, 2H, <i>J</i> = 7.5 Hz, SO<sub>2</sub>CH<sub>2</sub>), 3.77 (s, 3H, OCH<sub>3</sub>), 6.32 (br, 1 H, NH), 6.97 (dd, 1H, <sup>4</sup><i>J</i><sub>HF</sub> = 3.5 Hz, <i>J</i><sub>ortho</sub> = 8.6 Hz, aromatic), 7.09 (dd, 1H, <i>J</i><sub>meta</sub> = 2.8 Hz, <sup>3</sup><i>J</i><sub>HF</sub> = 7.9 Hz, aromatic), 7.22 (m, 1H, aromatic), 8.50 (s, 1 H, aromatic), 8.89 (br, 1 H, NH); HRMS for C<sub>14</sub>H<sub>15</sub>FN<sub>3</sub>O<sub>4</sub>S (M + H<sup>+</sup>) calcd 340.0762, observed 340.0762. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)(5-chloro-2-methoxyphenyl)methanone (11h):  </b>Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.89 min (method 1, 95% purity), <i>t</i><sub>R</sub> = 1.67 min (method 2, 92% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.43 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.51 (q, 2H, <i>J</i> = 7.4 Hz, SO<sub>2</sub>CH<sub>2</sub>), 3.77 (s, 3 H, OCH<sub>3</sub>), 6.32 (br, 1 H, NH), 6.96 (d, 1H, <i>J</i><sub>ortho</sub> = 8.8 Hz, aromatic), 7.32 (d, 1H, <i>J</i><sub>meta</sub> = 2.6 Hz, aromatic), 7.48 (dd, 1H, <i>J</i><sub>ortho</sub> = 8.8, <i>J</i><sub>meta</sub> = 2.6 Hz, aromatic), 8.48 (s, 1 H, aromatic), 8.88 (br, 1 H, NH); HRMS for C<sub>14</sub>H<sub>15</sub>ClN<sub>3</sub>O<sub>4</sub>S (M + H<sup>+</sup>) calcd 356.0467, observed 356.0466. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)(2,6-difluorophenyl)methanone (11j):  </b><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.43 (t, 3H, <i>J</i> = 7.5 Hz, CH<sub>3</sub>), 3.51 (q, 2H, <i>J</i> = 7.5 Hz, SO<sub>2</sub>CH<sub>2</sub>), 6.45 (br, 1 H, NH), 7.07 (t, 2H, <i>J</i><sub>ortho</sub> = <sup>3</sup><i>J</i><sub>HF</sub> = 8.0 Hz, aromatic), 7.54 (m, 1H, aromatic), 8.55 (s, 1 H, aromatic), 8.93 (br, 1 H, NH); HRMS for C<sub>13</sub>H<sub>12</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub>S (M + H)<sup>+</sup> calcd 328.0562, observed 328.0566. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone (11k):  </b>light yellow solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.82 min (method 1, 95% purity), <i>t</i><sub>R</sub> = 1.57 min (method 2, 98% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.43 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.51 (q, 2H, <i>J</i> = 7.4 Hz, SO<sub>2</sub>CH<sub>2</sub>), 3.77 (s, 3H, OCH<sub>3</sub>), 6.37 (br, 1H, NH), 6.72 (ddd, 1H, <i>J</i><sub>ortho</sub> = 9.4 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 3.1 Hz, <sup>5</sup><i>J</i><sub>HF</sub> = 1.9 Hz, aromatic), 7.30 (q, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = <sup>4</sup><i>J</i><sub>HF</sub> = <i>J</i><sub>ortho</sub> =9.4 Hz, aromatic), 8.48 (s, 1H, aromatic), 8.92 (br, 1 H, NH); HRMS for C<sub>14</sub>H<sub>14</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H<sup>+</sup>) calcd 358.0668, observed 358.0671. </div><div class="NLM_p"><b>(4-Amino-2-ethanesulfonylpyrimidin-5-yl)(4,5-difluoro-2-methoxyphenyl)methanone (11</b><b>l</b><b>):  </b>off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.82 min (method 1, 95% purity), <i>t</i><sub>R</sub> = 1.58 min (method 2, 93% purity); <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 1.65(t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 3.53 (q, 2H, <i>J</i> = 7.4 Hz, SO<sub>2</sub>CH<sub>2</sub>), 3.77 (s, 3H, OCH<sub>3</sub>), 7.18 (dd, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 12.1 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 6.2 Hz, aromatic), 7.39 (dd, 1H, <sup>4</sup><i>J</i><sub>HF</sub> = 8.8 Hz, <sup>3</sup><i>J</i><sub>HF</sub> = 12.1 Hz, aromatic), 8.44 (s, 1 H, aromatic); HRMS for C<sub>14</sub>H<sub>14</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S (M + H<sup>+</sup>) calcd 358.0668, observed 358.0672. </div><div class="NLM_p"><b>[4-Amino-2-[4-(4-methylpiperazin-1-yl)phenylamino]pyrimidin-5-yl](2-methoxyphenyl)met</b><b>hanone (22).</b> A suspension of <b>11c </b>(20.0 mg, 0.062 mmol), 4-(4-methylpiperazino)aniline (15.5 mg, 0.081 mmol, 1.3 equiv), and <i>p</i>-TsOH hydrate (15 mg, 0.078 mmol, 1.2 equiv) in <sup>i</sup>PrOH (2.5 mL) was placed in a sealed vessel and heated at 100−110 °C under microwave irradiation for 1 h. The resulting mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated NaHCO<sub>3</sub> solution (2×) and brine (2×), dried, and concentrated. The crude product was purified on silica gel with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (95:5) to give <b>22 </b>as a light yellow solid (23.6 mg, 91% yield):  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.35 min (method 1, 98% purity), <i>t</i><sub>R</sub> = 0.87 min (method 2, 99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.37 <a name="jm004902206557" id="jm004902206557"></a> (s, 3H, NCH<sub>3</sub>), 2.60 (brd, 4H, 2×CH<sub>2</sub>), 3.17 (m, 4H, 2×CH<sub>2</sub>), 3.78 (s, 3H, OCH<sub>3</sub>), 5.59 (brd, 1H, NH), 6.87−7.11 (m, 5H, 4 aromatic and 1 NH), 7.25 (m, 1H, aromatic), 7.37−7.49 (m, 3H, aromatic), 8.14 (s, 1H, aromatic), 8.84 (brd, 1H, NH); HRMS for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd 419.2195, observed 419.2190. </div><div class="NLM_p"><b>[4-Amino-2-[4-(4-methylpiperazin-1-yl)phenylamino]pyrimidin-5-yl](3-fluorophenyl)metha</b><b>none (18):  </b><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.30 (s, 3H, CH<sub>3</sub>), 2.54 (brd, 4H, 2×CH<sub>2</sub>), 3.13 (t, 4H, <i>J</i> = 4.8 Hz, 2×CH<sub>2</sub>), 5.57 (brd, 1H, NH), 6.86 (d, 2H, <i>J</i> = 8.8 Hz), 7.04 (brd, 1H, NH), 7.10−7.44 (m, 6H), 8.31(s, 1H), 8.63 (brs, 1H, NH); HRMS for C<sub>22</sub>H<sub>24</sub>FN<sub>6</sub>O (M + H)<sup>+</sup> calcd 407.1990, observed 407.1994. </div><div class="NLM_p"><b>[4-Amino-2-[4-(4-methylpiperazin-1-yl)phenylamino]pyrimidin-5-yl]-</b><b><i>o</i></b><b>-tolylmethanone </b><b>(21):  </b>Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.39 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 0.97 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.22 (s, 3H), 2.30 (s, 3H), 2.54 (m, 4H), 3.10−3.17 (m, 4H), 5.57 (brd, 1H, NH), 6.81−6.91 (m, 2H, aromatic), 7.07 (brd, 1H, NH), 7.12−7.21 (m, 3H, aromatic), 7.25−7.30 (m, 1H, aromatic), 7.36−7.43 (m, 2H, aromatic), 8.02 (s, 1H, aromatic), 8.82 (brd, 1H, NH); HRMS for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O (M + H<sup>+</sup>) calcd 403.2241, observed 403.2247. </div><div class="NLM_p"><b>4-[4-Amino-5-(2-methoxybenzoyl)pyrimidin-2-ylamino]piperidine-1-carboxylic Acid </b><b><i>tert</i></b><b>-Butyl Ester (14c).</b> A suspension of <b>11c </b>(1.88 g, 5.87 mmol) and 4-amino-<i>N</i>-<i>tert</i>-(butoxycarbonyl)piperidine (<b>13</b>) (1.41 g, 7.04 mmol, 1.2 equiv) in <sup>i</sup>PrOH (50 mL) was placed in a sealed vessel and heated at 110 °C under microwave conditions for 1.5 h. The resulting mixture was concentrated and the crude product was purified on silica gel with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (95/5) to give <b>14c</b> as a light yellow solid (2.23 g, 89% yield):  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.76 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.49 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.38 (m, 2H, CH<sub>2</sub>), 1.47 (s, 9H, t-Bu), 2.01 (m, 2H, CH<sub>2</sub>), 2.93 (m, 2H, NCH<sub>2</sub>), 3.80 (s, 3H, OCH<sub>3</sub>), 4.03 (brm, 3H, NCH<sub>2</sub> & NCH), 5.00−5.70 (br, 2H, NH), 6.97 (d, 1H, <i>J</i><sub>ortho</sub> = 8.6 Hz), 7.02 (dt, 1H, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> ∼ 0.8 Hz), 7.24 (m, 1H), 7.42 (m, 1H), 7.94−8.22 (br, 1H,), 8.61−9.01 (br, 1H, NH); HRMS for C<sub>22</sub>H<sub>30</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 428.2293, observed 428.2296. </div><div class="NLM_p"><b>4-[4-Amino-5-(5-fluoro-2-methoxybenzoyl)pyrimidin-2-ylamino]piperidine-1-carboxylic </b><b>Acid </b><b><i>tert</i></b><b>-Butyl Ester (14</b><b>g</b><b>):  </b>Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.82 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.65 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub><i>)</i> δ ppm 1.41 (m, 2H, 2×CH of 2CH<sub>2</sub>), 1.47 (s, 9H, t-Bu), 2.01(m, 2H, 2×CH of 2CH<sub>2</sub>), 2.92 (m, 2H, 2×NCH of 2NCH<sub>2</sub>), 3.77 (s, 3H, OCH<sub>3</sub>), 4.02 (br, 3H, NCH and 2×NCH of 2NCH<sub>2</sub>), 5.04−5.68 (br, 2H, NH's), 6.90 (dd, 1H, <sup>4</sup><i>J</i><sub>HF</sub> = 4.0 Hz, <i>J</i><sub>ortho</sub> = 9.0 Hz, aromatic), 6.98 (dd, 1H, <i>J</i><sub>meta</sub> = 3.1 Hz, <sup>3</sup><i>J</i><sub>HF</sub> = 7.9 Hz, aromatic), 7.11 (ddd, 1H, <i>J</i><sub>meta</sub> = 3.1 Hz, <sup>3</sup><i>J</i><sub>HF</sub> = 7.9 Hz, <i>J</i><sub>ortho</sub> = 9.0 Hz, aromatic), 7.97−8.22 (br, 1H, aromatic), 8.56−8.93 (br, 1H, NH); HRMS for C<sub>22</sub>H<sub>29</sub>FN<sub>5</sub>O<sub>4</sub> (M + H<sup>+</sup>) calcd 446.2198, observed 446.2196. </div><div class="NLM_p"><b>[4-Amino-2-(piperidin-4-ylamino)pyrimidin-5-yl](2-meth-oxyphenyl)methanone (23). </b>TFA (15 mL) was added to a stirred solution of compound <b>14c</b> (1.96 g, 4.58 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) at 0 °C. After the reaction mixture was stirred for 1 h, it was concentrated in vacuo to give <b>23</b> as a TFA salt (3.32 g, light yellow solid). A portion of this crude product was purified on HPLC to give <b>23</b> as a free base:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.11 min (method 1, 98% purity), <i>t</i><sub>R</sub> = 0.49 min (method 2, >99% purity); <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.23−1.41 (m, 2H, CH<sub>2</sub>), 1.88−2.05 (br, 2H, CH<sub>2</sub>), 2.58−2.75 (br, 2H, CH<sub>2</sub>), 2.94−3.11 (br, 2H, CH<sub>2</sub>), 3.72 (s, 3H, OCH<sub>3</sub>), 3.80−3.99 (m, 1H, CH), 4.99−5.57 (br, 2H, NH), 6.89 (d, 1H, <i>J</i> = 8.2 Hz), 6.94 (t, 1H, <i>J</i> = 7.5 Hz), 7.16 (dd, 1H, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz), 7.34 (dt, 1H, <i>J</i><sub>ortho</sub>= 8.2 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz), 7.91−8.12 (br, 1H, aromatic), 8.53−8.88 (br, 1H, NH); HRMS for C<sub>17</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd 328.1768, observed 328.1771. </div><div class="NLM_p"><b>[4-Amino-2-(piperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone </b><b>(15</b><b>g</b><b>):  </b>Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.10 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 0.59 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub><i>)</i> δ 1.42−1.80 (m, 2H, 2×CH of 2CH<sub>2</sub>), 2.00 (m, 1H, CH of 2CH<sub>2</sub>), 2.47 (m, 1H, CH of 2CH<sub>2</sub>), 2.82−3.09 (m, 2H, 2×NCH of 2NCH<sub>2</sub>), 3.16−3.40 (m, 2H, 2×NCH of 2NCH<sub>2</sub>), 3.71 (s, 3H, OCH<sub>3</sub>), 3.84−4.15 (br, 1H, NCH), 7.14 (m, 1H, aromatic), 7.30 (m, 1H, aromatic), 7.51 and 8.00 (2 br, 1H, NH), 7.79 and 8.18 (br d, 1H, NH), 7.86 and 7.88 (2 s, 1H, aromatic), 8.30 (br, 1H, NH), 8.46 (br, 1H, NH), 8.61 (br, 1H, NH); HRMS for C<sub>17</sub>H<sub>21</sub>FN<sub>5</sub>O<sub>2</sub> (M + H<sup>+</sup>) calcd 346.1674, observed 346.1673. </div><div class="NLM_p"><b>[4-Amino-2-(1-methylpiperidin-4-ylamino)pyrimidin-5-yl](2-methoxyphenyl)methanone </b><b>(24). </b>To a stirred mixture of compound <b>23</b> as the TFA salt (prepared above, 65.0 mg, ∼0.090 mmol calculated from compound <b>14c</b>) and K<sub>2</sub>CO<sub>3</sub> (75 mg, 0.54 mmol, 6 equiv) in anhydrous DMF (2 mL) was added iodomethane (23 mg, 0.16 mmol, 1.8 equiv). The reaction mixture was stirred at room temperature for 2.5 h before it was diluted with EtOAc (40 mL), washed with water and brine, dried, and concentrated. The residue was purified on HPLC to give amine<b> 24 </b>as a white solid (14.1 mg, 46% yield):  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.10 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 0.52 min (method 2, >99% purity); <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.50 (m, 2H, CH<sub>2</sub>), 1.95 (m, 2H, CH<sub>2</sub>), 2.07 (m, 2H, NCH<sub>2</sub>), 2.22 (s, 3H, NCH<sub>3</sub>), 2.71 (m, 2H, NCH<sub>2</sub>), 3.72 (s, 3H, OCH<sub>3</sub>), 3.79 (m, 1H, NCH), 4.97−5.65 (m, 2H, NH), 6.97 (d, 1H, <i>J</i><sub>ortho</sub> = 8.4 Hz), 7.01 (t, 1H, <i>J</i><sub>ortho</sub> = 7.4 Hz), 7.24 (m, 1H), 7.42 (m, 1H), 7.85−8.18 (br, 1H), 8.51−8.95 (br, 1H, NH); HRMS for C<sub>18</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd 342.1925, observed 342.1927. </div><div class="NLM_p"><b>4-[4-Amino-5-(2-methoxybenzoyl)pyrimidin-2-ylamino]piperidine-1-carboxylic Acid </b><b>Ethylamide (25). </b>To a stirred solution of compound <b>23</b> (65.0 mg, TFA salt prepared above, ∼0.090 mmol) and triethylamine (0.10 mL, 72.6 mg, 0.71 mmol, 8 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added ethyl isocyanate (8.0 mg, 0.11 mmol, 1.2 equiv) at 0 °C. The reaction mixture was stirred for 1 h before it was concentrated in vacuo. The residue was purified on silica gel with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (95/5) to give <b>25 </b>as a white solid (31.7 mg, 89% yield):  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.30 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.05 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.07 (br, 3H, CH<sub>3</sub>), 1.34 (m, 2H, CH<sub>2</sub>), 1.95 (m, 2H, CH<sub>2</sub>), 2.89 (m, 2H, NCH<sub>2</sub>), 3.20 (m, 2H, NCH<sub>2</sub>), 3.70 (s, 3H, OCH<sub>3</sub>), 3.81 (m, 2H, NCH<sub>2</sub>), 3.96 (m, 1H, NCH), 4.31 (br, 1H, NH), 4.87−5.68 (m, 2H, NH), 6.94−7.08 (m, 2H), 7.24 (m, 1H), 7.42 (m, 1H), 7.83−8.17 (br, 1H), 8.47−8.95 (br, 1H, NH); HRMS for C<sub>20</sub>H<sub>27</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 399.2139, observed 399.2143. </div><div class="NLM_p"><b>4-[4</b>-<b>Amino-5-(2-methoxybenzoyl)pyrimidin-2-ylamino]piperidine-1-carboxylic Acid Ethyl </b><b>Ester (26). </b>A suspension of <b>11c </b>(43.1 mg, 0.134 mmol) and ethyl 4-amino-1-piperidinecarboxylate (30.0 mg, 0.174 mmol, 1.3 equiv) in <sup>i</sup>PrOH (4 mL) was heated at 100−110 °C under microwave irradiation for 1 h. The resulting mixture was concentrated and the residue was purified on silica gel with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (95/5) to give <b>26</b> as a light yellow solid (47.1 mg, 88% yield):  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.52 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.29 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.27 (t, 3H, <i>J</i> = 7.1 Hz, CH<sub>3</sub>), 1.31−1.49 (m, 2H, 2×CH of 2CH<sub>2</sub>), 2.02 (m, 2H, 2×CH of 2CH<sub>2</sub>), 2.88−3.07 (m, 2H, 2×NCH of 2NCH<sub>2</sub>), 3.79 (s, 3H, OCH<sub>3</sub>), 3.95−4.19 (m, 3H, NCH and 2×NCH of 2NCH2), 4.13 (q, 2H, <i>J</i> = 7.1 Hz, OCH<sub>2</sub>), 5.02−5.67 (br, 2H, NH), 6.97 (d, 1H, <i>J</i><sub>ortho</sub> = 8.3 Hz, aromatic), 7.02 (t, 1H, <i>J</i> = 7.4 Hz, aromatic), 7.23 (d, 1H, <i>J</i><sub>ortho</sub> = 7.4 Hz, aromatic), 7.41 (t, 1H, <i>J</i> = 8.3 Hz, aromatic), 7.97−8.21 (br, 1H, aromatic), 8.60−9.00 (br, 1H, NH); HRMS for C<sub>20</sub>H<sub>26</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 400.1980, observed 400.1984. </div><div class="NLM_p"><b>1-[4-[4-Amino-5-(2-methoxybenzoyl)pyrimidin-2-ylamino]-piperidin-1-yl]ethanone (27). </b>Following a similar procedure as described for compound<b> 25</b>, the reaction of <b>23</b> with acetyl chloride gave <b>27 </b>as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.27 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 0.99 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.26−1.37 (m, 2H, CH<sub>2</sub>), 1.92−2.09 (m, 2H, CH<sub>2</sub>), 2.03 (s, 3H, CH<sub>3</sub>), 2.74, 3.13, 3.72, 4.43 (4x m, 4H, 2×NCH<sub>2</sub>), 3.72 (s, 3H, OCH<sub>3</sub>), 4.01 (brm, 1H, NCH), 4.93−5.61 (br, 2H, NH), 6.97 (d, 1H, <i>J</i><sub>ortho</sub> = 8.3 Hz), 7.02 (dt, 1H, <i>J</i><sub>ortho</sub> = 7.4 Hz, <i>J</i><sub>meta</sub> = ∼0.8 Hz), 7.24 (m, 1H), 7.34 (m, 1H), 7.96 (br, 1H), 8.79 (br, 1H, NH); HRMS for C<sub>19</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 370.1874, observed 370.1875. </div><div class="NLM_p"><b>1-[4-[4-Amino-5-(2-methoxybenzoyl)pyrimidin-2-ylamino]-piperidin-1-yl]butan-1-one (28):  </b>Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.45 min <a name="jm004902206558" id="jm004902206558"></a> (method 1, 98% purity), <i>t</i><sub>R</sub> = 1.18 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.98 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 1.39 (m, 2H, CH<sub>2</sub>), 1.67 (m, 2H, CH<sub>2</sub>), 2.09 (m, 2H, CH<sub>2</sub>), 2.32 (m, 2H, CH<sub>2</sub>), 2.82, 3.18, 3.83, 4.54 (4m, 4H, 2×NCH<sub>2</sub>), 3.80 (s, 3H, OCH<sub>3</sub>), 4.08 (br, 1H, NCH), 4.98−5.67 (br, 2H, NH), 6.97 (d, 1H, <i>J</i> = 8.1 Hz), 7.02 (dt, 1H, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 0.9 Hz), 7.24 (m, 1H), 7.42 (m, 1H), 7.98−8.21 (br, 1H), 8.57−9.03 (br, 1H, NH); HRMS for C<sub>21</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 398.2187, observed 398.2189. </div><div class="NLM_p"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-methoxyphenyl)met</b><b>hanone (29). </b>Following a similar procedure as described for compound<b> 25</b>, the reaction of <b>23</b> with methanesulfonyl chloride gave <b>29 </b>as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.35 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.09 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.55 (m, 2H, CH<sub>2</sub>), 2.06 (m, 2H, CH<sub>2</sub>), 2.73 (s, 3H, SCH<sub>3</sub>), 2.82 (m, 2H, NCH<sub>2</sub>), 3.68 (m, 2H, NCH<sub>2</sub>), 3.71 (s, 3H, OCH<sub>3</sub>), 3.93 (m, 1H, NCH), 4.89−5.64 (m, 2H, NH), 6.94−7.07 (m, 2H), 7.24 (dd, 1H, <i>J</i><sub>ortho</sub> = 7.5 Hz, <i>J</i><sub>meta</sub> = 1.7 Hz), 7.42 (m, 1H), 7.98 (br, 1H), 8.45−8.99 (br, 1H, NH); HRMS for C<sub>18</sub>H<sub>24</sub>N<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup> calcd 406.1544, observed 406.1546. </div><div class="NLM_p"><b>[4-Amino-2-(1-ethanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-methoxyphenyl)metha</b><b>none (30):</b> white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.40 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.20 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.38 (brt, 3H, CH<sub>3</sub>), 1.60 (m, 2H, CH<sub>2</sub>), 2.12 (m, 2H, CH<sub>2</sub>), 2.97 (q, 2H, <i>J</i> = 7.2 Hz, SCH<sub>2</sub>), 2.93−3.06 (m, 2H, NCH<sub>2</sub>), 3.78 (m, 2H, NCH<sub>2</sub>), 3.80 (s, 3H, OCH<sub>3</sub>), 4.02 (m, 1H, NCH), 4.95−5.71 (m, 2H, NH), 6.97 (d, 1H, <i>J</i><sub>ortho</sub> = 8.4 Hz), 7.02 (t, 1H, <i>J</i><sub>ortho</sub>=7.4 Hz), 7.24 (dd, 1H, <i>J</i><sub>ortho</sub> = 7.4 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz), 7.42 (dt, 1H, <i>J</i><sub>ortho</sub> = 8.4 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz), 8.06 (brs, 1H), 8.61−9.05 (br, 1H, NH); HRMS for C<sub>19</sub>H<sub>26</sub>N<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup> calcd 420.1700, observed 420.1704. </div><div class="NLM_p"><b>4-[4-Amino-5-(2-methylbenzoyl)pyrimidin-2-ylamino]piperidine-1-carboxylic Acid Ethyl </b><b>Ester (32):  </b>white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.63 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.38 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub><i>)</i> δ 1.27 (t, 3H, <i>J</i> = 7.4 Hz, CH<sub>3</sub>), 1.40 (m, 2H, 2×CH of 2CH<sub>2</sub>), 2.03 (m, 2H, 2×CH of 2CH<sub>2</sub>), 2.29 (s, 3H, CH<sub>3</sub>), 2.98 (m, 2H, 2×NCH of 2NCH<sub>2</sub>), 3.98−4.20 (m, 3H, NCH and 2×NCH of 2NCH<sub>2</sub>), 4.14 (q, 2H, <i>J</i> = 7.4 Hz, OCH<sub>2</sub>), 5.04−5.73 (4br, 2H, NH and NH of NH2), 7.17−7.38 (m, 4H, aromatic), 7.94−8.15 (2br, 1H, aromatic), 8.67−9.03 (2br, 1H, NH of NH2); HRMS for C<sub>20</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 384.2030, observed 384.2035. </div><div class="NLM_p"><b>1-[4-[4-Amino-5-(2-ethoxybenzoyl)pyrimidin-2-ylamino]piperidin-1-yl]ethanone (33). </b>Following a similar procedure as described for <b>14c</b>, the reaction of <b>11e </b>with 1-(4-aminopiperidin-1-yl)ethanone under microwave irradiation gave <b>33 </b>as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.15 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.10 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.28 (t, 3H, <i>J</i> = 7.0 Hz, CH<sub>3</sub>), 1.46 (m, 2H, CH<sub>2</sub>), 2.06 (m, 2H, CH<sub>2</sub>), 2.11 (s, 3H, CH<sub>3</sub>), 2.91, 3.23, 3.80, 4.46 (4m, 4H, 2×NCH<sub>2</sub>), 4.05 (q, 2H, <i>J</i> = 7.0 Hz, OCH<sub>2</sub>), 4.11 (m, 1H, NCH), 4.90−6.46 (m, 2H, NH), 6.95 (d, 1H, <i>J</i> = 8.4 Hz), 7.01 (t, 1H, <i>J</i> = 7.6 Hz), 7.16 (m, 1H), 7.33 (m, 1H), 7.90−8.29 (br, 1H), 8.57−9.17 (br, 1H, NH); HRMS for C<sub>20</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub> (M + H<sup>+</sup>) calcd 384.2030, observed 384.2035. </div><div class="NLM_p"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphe</b><b>nyl)methanone (35):</b> Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.46 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.24 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.63 (m, 2H, CH<sub>2</sub>), 2.15 (m, 2H, CH<sub>2</sub>), 2.81 (s, 3H, SCH<sub>3</sub>), 2.92 (m, 2H, NCH<sub>2</sub>), 3.74 (m, 2H, NCH<sub>2</sub>), 3.77 (s, 3H, OCH<sub>3</sub>), 4.01 (m, 1H, NCH), 5.01−5.71 (m, 2H, NH), 6.91 (dd, 1H, <i>J</i><sub>ortho</sub> = 9.1 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 4.0 Hz), 6.97 (dd, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 7.9 Hz, <i>J</i><sub>meta</sub> = 3.2 Hz), 7.11 (ddd, 1H, <i>J</i><sub>ortho</sub> = 9.1 Hz, <sup>3</sup><i>J</i><sub>HF</sub> = 7.9 Hz, <i>J</i><sub>meta</sub> = 3.2 Hz), 7.93−8.21 (br, 1H), 8.55−9.01 (br, 1H, NH); HRMS for C<sub>18</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup> calcd 424.1450, observed 424.1455. </div><div class="NLM_p"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-chloro-2-methoxyph</b><b>enyl)methanone (36).</b> Following a similar procedure as described for <b>14c</b>, reaction of <b>11h </b>and 1-methanesulfonylpiperidin-4-ylamine TFA salt (prepared as follows) gave <b>36</b> as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.63 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.38 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.69 (m, 2H, CH<sub>2</sub>), 2.14 (m, 2H, CH<sub>2</sub>), 2.83 (s, 3H, SCH<sub>3</sub>), 3.06 (m, 1H, NCH), 3.58−3.86 (m, 3H, 3×NCH), 3.78 (s, 3H, OCH<sub>3</sub>), 4.06 (m, 1H, NCH), 5.02−6.79 (br, 2H, NH), 6.93 (m, 1H), 7.23 (m, 1H), 7.40 (m, 1H), 7.90−8.20 (br, 1H), 8.59−9.09 (br, 1H, NH); HRMS for C<sub>18</sub>H<sub>23</sub>ClN<sub>5</sub>O<sub>4</sub>S (M + H<sup>+</sup>) calcd 440.1154, observed 440.1160. </div><div class="NLM_p"><b>Preparation of 1-Methanesulfonylpiperidin-4-ylamine.</b> Methanesulfonyl chloride (1.0 g, 8.8 mmol) was added to a stirred solution of commercially available piperidin-4-ylcarbamic acid <i>tert</i>-butyl ester (1.0 g, 5.0 mmol) and diisopropylethylamine (4 mL) in THF (40 mL) at 5 °C. The reaction mixture was allowed to warm to room temperature over 1 h before it was poured into water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 50 mL). The combined organic extracts were washed with 5% aqueous NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give a crude solid which was purified by trituration with ether/hexane to give (1-methanesulfonyl-piperidin-4-yl)carbamic acid <i>tert</i>-butyl ester as a white solid [MS (M + H<sup>+</sup>) 278]. This solid was suspended in CH<sub>2</sub>Cl<sub>2</sub> (15 mL), treated with TFA (5.3 mL), and stirred for 2 h at room temperature. The resulting mixture was concentrated and the residue was triturated with ether. The solid was filtered off, washed with ether, and dried in a vacuum to give a quantitative yield of 1-methanesulfonyl-piperidin-4-ylamine trifluoroacetate. A portion of the material was dissolved in EtOAc, washed with saturated aqueous NaHCO<sub>3</sub> solution and brine, dried, and concentrated to give the free base 1-methanesulfonylpiperidin-4-ylamine as a white waxy solid:  <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.24 (m, 2H, CH<sub>2</sub>), 1.73 (m, 2H, CH<sub>2</sub>), 1.88 (br, 1H, NH), 2.58−2.76 (m, 3H, NCH and NCH<sub>2</sub>), 2.81 (s, 3H, SCH<sub>3</sub>), 3.25−3.3.35 (br, 1H, NH), 3.40 (m, 2H, NCH<sub>2</sub>). </div><div class="NLM_p"><b>General Procedure for Preparation of Sulfoxides 12.</b> To a stirred solution of sulfide <b>10 </b>(1.8 mmol) in CHCl<sub>3</sub> (16 mL) at −15 °C was added portionwise mCPBA (70% purity, 2.1 mmol, 1.2 equiv). The mixture was stirred at the same temperature for 1 h before it was diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL); washed successively with 10% aqueous sodium thiosulfate (2 × 5 mL), 10% aqueous Na<sub>2</sub>CO<sub>3</sub> (2 × 5 mL), brine (2 × 5 mL); dried; and concentrated to give a quantitative yield of 9:1 ratio mixture (by NMR) of sulfoxide <b>12 </b>and sulfone <b>11</b>. This mixture was used for next reaction without further purification while pure sulfoxide <b>12 </b>in some examples was obtained by chromatographic purification of a small portion of the mixture. </div><div class="NLM_p"><b>4-[4-Amino-5-(2-fluorobenzoyl)pyrimidin-2-ylamino]piperidine-1-carboxylic Acid Ethyl </b><b>Ester (31). </b>Following a similar procedure as described for compound <b>26</b>, a mixture of sulfoxide <b>12d </b>(major) and sulfone <b>11d </b>(minor) was reacted with ethyl 4-amino-1-piperidinecarboxylate to give<b> 31 </b>as off-white soild:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.58 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.40 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ1.19 (t, 3H, <i>J</i> = 7.2 Hz, CH<sub>3</sub>), 1.34 (m, 2H, CH<sub>2</sub>), 1.95 (m, 2H, CH<sub>2</sub>), 2.91 (m, 2H, NCH<sub>2</sub>), 3.88−4.11 (m, 3H, NCH & NCH<sub>2</sub>), 4.06 (q, 2H, <i>J</i> = 7.2 Hz, OCH<sub>2</sub>), 4.94−5.76 (br, 2H, NH), 7.07 (t, 1H, <i>J</i> = 8.9 Hz), 7.17 (m, 1H), 7.32 (m, 1H), 7.39 (m, 1H), 7.92−8.25 (br, 1H), 8.43−8.97 (br, 1H, NH); HRMS for C<sub>19</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>F (M + H<sup>+</sup>) calcd 388.1780, observed 388.1783. </div><div class="NLM_p"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4-fluoro-2-methoxyphe</b><b>nyl)methanone (34).</b> Similar to the preparation of compound <b>31</b>, the reaction of a mixture of sulfoxide <b>12f </b>(major) and sulfone <b>11f </b>(minor) with 1-methanesulfonylpiperidin-4-ylamine TFA salt gave<b> 34</b>: white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.39 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.20 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.53 (m, 2H, CH<sub>2</sub>), 1.88 (m, 2H, CH<sub>2</sub>), 2.66−2.90 (m, 5H, NCH<sub>2</sub> & SCH<sub>3</sub>), 3.51 (m, 2H, NCH<sub>2</sub>), 3.73 (s, 3H, OCH<sub>3</sub>), 3.89 (m, 1H, NCH), 6.84 (dt, 1H, <i>J</i><sub>ortho</sub> = 8.6 Hz,<sup>3</sup><i>J</i><sub>HF</sub> = 8.6 Hz, <i>J</i><sub>meta</sub> = 2.3 Hz), 7.03 (dd, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 11.5 Hz, <i>J</i><sub>meta</sub> = 1.8 Hz), 7.24 (m, 1H), 7.40 and 7.68 (2brs, 1H, NH), 7.54 and 7.74 (2brd, 1H, NH), 7.79 and 7.86 (2s, 1H, aromatic), 8.29 and 8.49 (2brs, 1H, NH); HRMS for C<sub>18</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup> calcd 424.1450, observed 424.1453. </div><div class="NLM_p"><a name="jm004902206559" id="jm004902206559"></a><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphe</b><b>nyl)methanone (37):</b> Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.46 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.30 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.54 (m, 2H, CH<sub>2</sub>), 1.89 (m, 2H, CH<sub>2</sub>), 2.78 (m, 2H, NCH<sub>2</sub>), 2.83 and 2.87 (2s, 3H, SCH<sub>3</sub>), 3.52 (m, 2H, NCH<sub>2</sub>), 3.74 (s, 3H, OCH<sub>3</sub>), 3.90 (m, 1H, NCH), 6.90 (t, 1H, <i>J</i> = 8.5 Hz, aromatic), 6.97 (d, 1H, <i>J</i> = 8.0 Hz, aromatic), 7.46 (q, 1H, <i>J</i> = 8.0 Hz, aromatic), 7.52 and 7.75−7.90 (2br, 1H, NH), 7.64 and 7.75−7.90 (2br, 1H, NH), 7.79 and 7.86 (2s, 1H, aromatic), 8.25 and 8.44 (2br, 1H, NH); HRMS for C<sub>18</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup> calcd 424.1450, observed 424.1451. </div><div class="NLM_p"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,6-difluorophenyl)met</b><b>hanone (38):  </b>Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.58 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.40 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57 (m, 2H, CH<sub>2</sub>), 1.89 (m, 2H, CH<sub>2</sub>), 2.79 (m, 2H, NCH<sub>2</sub>), 2.84 and 2.87 (2s, 3H, SO<sub>2</sub>CH<sub>3</sub>), 3.52 (m, 2H, NCH<sub>2</sub>), 3.92 (m, 1H, NCH), 7.23 (t, 2H, <i>J</i><sub>ortho</sub> = 8.4 Hz, <sup>3</sup><i>J</i><sub>HF</sub> = 8.4 Hz, aromatic), 7.58 (m, 1H, aromatic), 7.65 and 7.94 (2br, 1H, NH), 7.78 and 8.00 (2br, 1H, NH), 7.72 and 7.99 (2br, 1H, aromatic), 8.82 and 8.43 (2br, 1H, NH); HRMS for C<sub>17</sub>H<sub>20</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>S (M + H)<sup>+</sup> calcd 412.1250, observed 412.1248. </div><div class="NLM_p"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6-methoxy</b><b>phenyl)methanone (39):</b> white solid; mp 218−219 °C; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.58 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.44 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.68 (m, 2H, CH<sub>2</sub>), 2.14 (m, 2H, CH<sub>2</sub>), 2.82 (s, 3H, SCH<sub>3</sub>), 3.02 (m, 1H, NCH), 3.64−3.82 (m, 3H, 3×NCH), 3.76 (s, 3H, OCH<sub>3</sub>), 4.05 (m, 1H, NCH), 5.06−6.37 (br, 2H, NH), 6.68 (br, 1H, aromatic), 7.21 (m, 1H, aromatic), 7.99 and 8.10 (2s, 1H, aromatic), 8.60 and 8.88 (2br, 1H, NH); HRMS for C<sub>18</sub>H<sub>22</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup> calcd 442.1355, observed 442.1358. </div><div class="NLM_p"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxy</b><b>phenyl)methanone (40):</b> white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.53 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.30 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.54 (m, 2H, CH<sub>2</sub>), 1.88 (m, 2H, CH<sub>2</sub>), 2.79 (m, 2H, NCH<sub>2</sub>), 2.84 and 2.86 (2s, 3H, SCH<sub>3</sub>), 3.51 (m, 2H, NCH<sub>2</sub>), 3.71 (s, 3H, OCH<sub>3</sub>), 3.90 (m, 1H, NCH), 7.29 (dd, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 13.0 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 6.7 Hz, aromatic), 7.39 (t, 1H, <sup>3</sup><i>J</i><sub>HF</sub> = 9.5 Hz, <sup>4</sup><i>J</i><sub>HF</sub> = 9.5 Hz, aromatic), 7.43 and 7.72 (2br, 1H, NH), 7.57 and 7.77 (2br, 1H, NH), 7.82 and7.89 (2s, 1H, aromatic), 8.24 and 8.44 (2br, 1H, NH); HRMS for C<sub>18</sub>H<sub>22</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup> calcd 442.1355, observed 442.1358. </div><div class="NLM_p"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3,4-trifluoro-6-metho</b><b>xyphenyl)methanone (41):</b> white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.70 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.51 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.55 (m, 2H, CH<sub>2</sub>), 1.89 (m, 2H, CH<sub>2</sub>), 2.78 (m, 2H, NCH<sub>2</sub>), 2.84 and 2.89 (2s, 3H, SCH<sub>3</sub>), 3.52 (m, 2H, NCH<sub>2</sub>), 3.73 (s, 3H, OCH<sub>3</sub>), 3.91 (br, 1H, NCH), 7.20 (m, 1H, aromatic), 7.56 and 7.84 (2br, 1H, NH), 7.71 and 7.90 (2br, 1H, NH), 7.95 and 8.02 (2s, 1H, aromatic), 8.20 and 8.39 (2br, 1H, NH); HRMS for C<sub>18</sub>H<sub>21</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup> calcd 460.1261, observed 460.1267. </div><div class="NLM_p last"><b>[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](3,4,5-trifluoro-2-metho</b><b>xyphenyl)methanone (42):</b> white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.75 min (method 1, >99% purity), <i>t</i><sub>R</sub> = 1.57 min (method 2, >99% purity); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.55 (m, 2H, CH<sub>2</sub>), 1.90 (m, 2H, CH<sub>2</sub>), 2.79 (m, 2H, NCH<sub>2</sub>), 2.84 and 2.87 (2s, 3H, SCH<sub>3</sub>), 3.53 (m, 2H, NCH<sub>2</sub>), 3.86 (s, 3H, OCH<sub>3</sub>), 3.93 (m, 1H, NCH), 7.08 (m, 1H, aromatic), 7.58 and 7.87 (2br, 1H, NH), 7.72 and 7.93 (2br, 1H, NH), 8.05 and 8.12 (2s, 1H, aromatic), 8.22 and 8.42 (2br, 1H, NH); HRMS for C<sub>18</sub>H<sub>21</sub>N<sub>5</sub>O<sub>4</sub>SF<sub>3</sub> (M + H)<sup>+</sup> calcd 460.1261, observed 460.1267. </div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin-Jie Chu</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wanda DePinto</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Bartkovitz</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sung-Sau So</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Binh T. Vu</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathryn Packman</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Lukacs</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingjie Ding</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nan Jiang</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ka Wang</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Petra Goelzer</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuefeng Yin</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa A. Smith</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian X. Higgins</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingsi Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qing Xiang</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Moliterni</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerald Kaplan</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bradford Graves</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen Lovey</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nader Fotouhi</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Discovery Oncology, Non-Clinical Drug Safety and Discovery Technologies, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm0606138" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Drs. Stacy Remiszewski, Li Chen, Paul Gillespie, Kin-Chun Luk, John Roberts, and Jefferson Tilley for all their support and helpful discussions. The authors are also grateful to Mr. Richard Margolis and Dr. Aruna Railkar for in vivo formulation, Mr. Ted Lambros for preparative HPLC purification, Mrs. Margret Jonca for analytical HPLC data, and Mr. Richard Szypula for HRMS analysis of all key intermediates and target compounds. </p></div><div class="refs-header-label"><a name="jm004902206560" id="jm004902206560"></a></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="jm0606138b00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm0606138b00001_1"><span><span class="NLM_string-ref">Morgan, D. O. Cyclin-dependent kinases:  Engines, clocks, and microprocessors. <i>  Annu. Rev. Cell. Dev. Biol.</i><b>1997</b>, <i>13</i>, 261−291.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Morgan%2C+D.+O.+Cyclin-dependent+kinases%3A%E2%80%89+Engines%2C+clocks%2C+and+microprocessors.+Annu.+Rev.+Cell.+Dev.+Biol.+1997%2C+13%2C+261%E2%88%92291.+Morgan%2C+D.+O.+Cyclin-dependent+kinases%3A%E2%80%89+Engines%2C+clocks%2C+and+microprocessors.+Annu.+Rev.+Cell.+Dev.+Biol.1997%2C+13%2C+261%E2%88%92291."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26jtitle%3DAnnu.%2520Rev.%2520Cell.%2520Dev.%2520Biol.%26date%3D1997%26volume%3D13%26spage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm0606138b00002_1"><span><span class="NLM_string-ref">Dyson, N. The regulation of E2F by pRB-family proteins. <i>  Genes Dev.</i><b>1998</b>, <i>12</i>, 2245−2262.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=2262&author=N+Dyson&title=The+regulation+of+E2F+by+pRB-family+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDyson%26aufirst%3DN%26atitle%3DThe%2520regulation%2520of%2520E2F%2520by%2520pRB-family%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D2262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm0606138b00003_1"><span><span class="NLM_string-ref">Sherr, C. J.; Roberts, J. M. CDK inhibitors:  Positive and negative regulators of G1-phase progression. <i>  Genes Dev.</i><b>1999</b>, <i>13</i>, 1501−1512.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1512&author=C.+J.+Sherr&author=J.+M.+Roberts&title=Positive+and+negative+regulators+of+G1-phase+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26atitle%3DPositive%2520and%2520negative%2520regulators%2520of%2520G1-phase%2520progression%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm0606138b00004_1"><span><span class="NLM_string-ref">Malumbres, M.; Barbacid, M. To cycle or not to cycle:  A critical decision in cancer. <i>  Nat. Rev. Cancer</i><b> 2001</b>, <i>1</i>, 222−231.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=231&author=M.+Malumbres&author=M+Barbacid&title=To+cycle+or+not+to+cycle%3A%E2%80%89+A+critical+decision+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DTo%2520cycle%2520or%2520not%2520to%2520cycle%253A%25E2%2580%2589%2520A%2520critical%2520decision%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm0606138b00005_1"><span><span class="NLM_string-ref">(a) Fischer, P. M.; Gianella-Borradori, A. Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. <i>  Exp. </i><i>Opin. Invest. Drugs </i><b>2005</b>, <i>14</i>, 457−477.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=477&author=P.+M.+Fischer&author=A+Gianella-Borradori&title=Recent+progress+in+the+discovery+and+development+of+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0606138b00005_2"><span><span class="NLM_string-ref">(b) Fischer, P. M. Cyclin-dependent kinase inhibitors:  Discovery, development and target rationale for different therapeutic applications. <i>  Drugs Future</i><b>2005</b>, <i>30</i>, 911−929.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=929&author=P.+M+Fischer&title=Cyclin-dependent+kinase+inhibitors%3A%E2%80%89+Discovery%2C+development+and+target+rationale+for+different+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00005_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520Discovery%252C%2520development%2520and%2520target%2520rationale%2520for%2520different%2520therapeutic%2520applications%26jtitle%3DDrugs%2520Future%26date%3D2005%26volume%3D30%26spage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm0606138b00006_1"><span><span class="NLM_string-ref">Collins, I.; Garrett, M. D. Targeting the cell division cycle in cancer:  CDK and cell cycle checkpoint kinase inhibitors. <i>  Curr. Opin. Pharm.</i><b>2005</b>, <i>5</i>, 366−373.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=373&author=I.+Collins&author=M.+D+Garrett&title=Targeting+the+cell+division+cycle+in+cancer%3A%E2%80%89+CDK+and+cell+cycle+checkpoint+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DTargeting%2520the%2520cell%2520division%2520cycle%2520in%2520cancer%253A%25E2%2580%2589%2520CDK%2520and%2520cell%2520cycle%2520checkpoint%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharm.%26date%3D2005%26volume%3D5%26spage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm0606138b00007_1"><span><span class="NLM_string-ref">Kong, N.; Fotouhi, N.; Wovkulich, P. M.; Roberts, J. Cell cycle inhibitors for the treatment of cancer. <i>  Drugs Future</i><b>2003</b>, <i>28</i>, 881−896.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=896&author=N.+Kong&author=N.+Fotouhi&author=P.+M.+Wovkulich&author=J+Roberts&title=Cell+cycle+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DN.%26atitle%3DCell%2520cycle%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DDrugs%2520Future%26date%3D2003%26volume%3D28%26spage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm0606138b00008_1"><span><span class="NLM_string-ref">Fischer, P. M.; Gianella-Borradori, A. CDK inhibitors in clinical development for the treatment of cancer. <i>  Exp. Opin. Invest. Drugs</i><b>2003</b>, <i>12</i>, 955−970.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=970&author=P.+M.+Fischer&author=A+Gianella-Borradori&title=CDK+inhibitors+in+clinical+development+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DCDK%2520inhibitors%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm0606138b00009_1"><span><span class="NLM_string-ref">Huwe, A.; Mazitschek, R.; Giannis, A. Small molecules as inhibitors of cyclin-dependent kinases. <i>  Angew. Chem. Int. Ed. Engl.</i><b>2003</b>, <i>42</i>, 2122−2138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2138&author=A.+Huwe&author=R.+Mazitschek&author=A+Giannis&title=Small+molecules+as+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuwe%26aufirst%3DA.%26atitle%3DSmall%2520molecules%2520as%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DAngew.%2520Chem.%2520Int.%2520Ed.%2520Engl.%26date%3D2003%26volume%3D42%26spage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00010"><div class="reference"><div class="NLM_citation" id="jm0606138b00010_1"><span><span class="NLM_string-ref">Toogood, P. L. Cyclin-dependent kinase inhibitors for treating cancer. <i>  Med. Res. Rev. </i><b>2001</b>, <i>21</i>, 487−498.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=498&author=P.+L+Toogood&title=Cyclin-dependent+kinase+inhibitors+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%2520for%2520treating%2520cancer%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm0606138b00011_1"><span><span class="NLM_string-ref">Fischer, P. M. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors. <i>  Curr. Opin. Drug Dis. </i><i>Dev.</i><b>2001</b>, <i>4</i>, 623−634.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=634&author=P.+M+Fischer&title=Recent+advances+and+new+directions+in+the+discovery+and+development+of+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM%26atitle%3DRecent%2520advances%2520and%2520new%2520directions%2520in%2520the%2520discovery%2520and%2520development%2520of%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Dis.%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm0606138b00012_1"><span><span class="NLM_string-ref">Pevarello, P.; Villa, M. Cyclin-dependent kinase inhibitors:  A survey of the recent patent literature. <i>  Expert Opin. Ther. Pat.</i><b>2005</b>, <i>15</i>, 675−703.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=703&author=P.+Pevarello&author=M+Villa&title=Cyclin-dependent+kinase+inhibitors%3A%E2%80%89+A+survey+of+the+recent+patent+literature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520A%2520survey%2520of%2520the%2520recent%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2005%26volume%3D15%26spage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm0606138b00013_1"><span><span class="NLM_string-ref">Senderowicz, A. M. The cell cycle as a target for cancer therapy:  Basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01. <i>  Oncologist</i><b>2002</b>, <i>7</i>, 12−19.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=19&author=A.+M+Senderowicz&title=The+cell+cycle+as+a+target+for+cancer+therapy%3A%E2%80%89+Basic+and+clinical+findings+with+the+small+molecule+inhibitors+flavopiridol+and+UCN-01"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSenderowicz%26aufirst%3DA.%2BM%26atitle%3DThe%2520cell%2520cycle%2520as%2520a%2520target%2520for%2520cancer%2520therapy%253A%25E2%2580%2589%2520Basic%2520and%2520clinical%2520findings%2520with%2520the%2520small%2520molecule%2520inhibitors%2520flavopiridol%2520and%2520UCN-01%26jtitle%3DOncologist%26date%3D2002%26volume%3D7%26spage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm0606138b00014_1"><span><span class="NLM_string-ref">McClue, S. J.; Blake, D.; Clarke, R.; Cowan, A.; Cummings, L.; Fischer, P. M.; MacKenzie, M.; Melville, J.; Stewart, K.; Wang, S.; Zhelev, N.; Zheleva, D.; Lane, D. P. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). <i>  Int. J. Cancer</i><b>2002</b>, <i>102</i>, 463−468.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=468&author=S.+J.+McClue&author=D.+Blake&author=R.+Clarke&author=A.+Cowan&author=L.+Cummings&author=P.+M.+Fischer&author=M.+MacKenzie&author=J.+Melville&author=K.+Stewart&author=S.+Wang&author=N.+Zhelev&author=D.+Zheleva&author=D.+P+Lane&title=In+vitro+and+in+vivo+antitumor+properties+of+the+cyclin+dependent+kinase+inhibitor+CYC202+%28R-roscovitine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcClue%26aufirst%3DS.%2BJ.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520properties%2520of%2520the%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520CYC202%2520%2528R-roscovitine%2529%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2002%26volume%3D102%26spage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm0606138b00015_1"><span><span class="NLM_string-ref">Misra, R. N.; Xiao, H.-y.; Kim, K. S.; Lu, S.; Han, W.-C.; Barbosa, S. A.; Hunt, J. T.; Rawlins, D. B.; Shan, W.; Ahmed, S. Z.; Qian, L.; Chen, B.-C.; Zhao, R.; Bednarz, M. S.; Kellar, K. A.; Mulheron, J. G.; Batorsky, R.; Roongta, U.; Kamath, A.; Marathe, P.; Ranadive, S. A.; Sack, J. S.; Tokarski, J. S.; Pavletich, N. P.; Lee, F. Y. F.; Webster, K. R.; Kimball, S. D. <i>  N</i>-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. <i>J. Med. Chem.</i><b>2004</b>, <i>47</i>, 1719−1728.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Misra%2C+R.+N.%3B+Xiao%2C+H.-y.%3B+Kim%2C+K.+S.%3B+Lu%2C+S.%3B+Han%2C+W.-C.%3B+Barbosa%2C+S.+A.%3B+Hunt%2C+J.+T.%3B+Rawlins%2C+D.+B.%3B+Shan%2C+W.%3B+Ahmed%2C+S.+Z.%3B+Qian%2C+L.%3B+Chen%2C+B.-C.%3B+Zhao%2C+R.%3B+Bednarz%2C+M.+S.%3B+Kellar%2C+K.+A.%3B+Mulheron%2C+J.+G.%3B+Batorsky%2C+R.%3B+Roongta%2C+U.%3B+Kamath%2C+A.%3B+Marathe%2C+P.%3B+Ranadive%2C+S.+A.%3B+Sack%2C+J.+S.%3B+Tokarski%2C+J.+S.%3B+Pavletich%2C+N.+P.%3B+Lee%2C+F.+Y.+F.%3B+Webster%2C+K.+R.%3B+Kimball%2C+S.+D.+N-%28Cycloalkylamino%29acyl-2-aminothiazole+inhibitors+of+cyclin-dependent+kinase+2.+N-%5B5-%5B%5B%5B5-%281%2C1-Dimethylethyl%29-2-oxazolyl%5Dmethyl%5Dthio%5D-2-thiazolyl%5D-4-piperidinecarboxamide+%28BMS-387032%29%2C+a+highly+efficacious+and+selective+antitumor+agent.+J.+Med.+Chem.+2004%2C+47%2C+1719%E2%88%921728.+Misra%2C+R.+N.%3B+Xiao%2C+H.-y.%3B+Kim%2C+K.+S.%3B+Lu%2C+S.%3B+Han%2C+W.-C.%3B+Barbosa%2C+S.+A.%3B+Hunt%2C+J.+T.%3B+Rawlins%2C+D.+B.%3B+Shan%2C+W.%3B+Ahmed%2C+S.+Z.%3B+Qian%2C+L.%3B+Chen%2C+B.-C.%3B+Zhao%2C+R.%3B+Bednarz%2C+M.+S.%3B+Kellar%2C+K.+A.%3B+Mulheron%2C+J.+G.%3B+Batorsky%2C+R.%3B+Roongta%2C+U.%3B+Kamath%2C+A.%3B+Marathe%2C+P.%3B+Ranadive%2C+S.+A.%3B+Sack%2C+J.+S.%3B+Tokarski%2C+J.+S.%3B+Pavletich%2C+N.+P.%3B+Lee%2C+F.+Y.+F.%3B+Webster%2C+K.+R.%3B+Kimball%2C+S.+D.+N-%28Cycloalkylamino%29acyl-2-aminothiazole+inhibitors+of+cyclin-dependent+kinase+2.+N-%5B5-%5B%5B%5B5-%281%2C1-Dimethylethyl%29-2-oxazolyl%5Dmethyl%5Dthio%5D-2-thiazolyl%5D-4-piperidinecarboxamide+%28BMS-387032%29%2C+a+highly+efficacious+and+selective+antitumor+agent.+J.+Med.+Chem.2004%2C+47%2C+1719%E2%88%921728."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm0606138b00016_1"><span><span class="NLM_string-ref">Toogood, P. L.; Harvey, P. J.; Repine, J. T.; Sheehan, D. J.; VanderWel, S. N.; Zhou, H.; Keller, P. R.; McNamara, D. J.; Sherry, D.; Zhu, T.; Brodfuehrer, J.; Choi, C.; Barvian, M. R.; Fry, D. W. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 2388−2406.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2406&author=P.+L.+Toogood&author=P.+J.+Harvey&author=J.+T.+Repine&author=D.+J.+Sheehan&author=S.+N.+VanderWel&author=H.+Zhou&author=P.+R.+Keller&author=D.+J.+McNamara&author=D.+Sherry&author=T.+Zhu&author=J.+Brodfuehrer&author=C.+Choi&author=M.+R.+Barvian&author=D.+W+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm0606138b00017_1"><span><span class="NLM_string-ref">Fry, D. W.; Harvey, P. J.; Keller, P. R.; Elliott, W. L.; Meade, M.; Trachet, E.; Albassam, M.; Zheng, X.; Leopold, W. R.; Pryer, N. K.; Toogood, P. L. Specific inhibition of cyclin-dependent kinase 4/6 by PD0332991 and associated antitumor activity in human tumor xenografts. <i>  Mol. Cancer Ther.</i><b>2004</b>, <i>3</i>, 1427−1438.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1438&author=D.+W.+Fry&author=P.+J.+Harvey&author=P.+R.+Keller&author=W.+L.+Elliott&author=M.+Meade&author=E.+Trachet&author=M.+Albassam&author=X.+Zheng&author=W.+R.+Leopold&author=N.+K.+Pryer&author=P.+L+Toogood&title=Specific+inhibition+of+cyclin-dependent+kinase+4%2F6+by+PD0332991+and+associated+antitumor+activity+in+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinase%25204%252F6%2520by%2520PD0332991%2520and%2520associated%2520antitumor%2520activity%2520in%2520human%2520tumor%2520xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm0606138b00018_1"><span><span class="NLM_string-ref">Tetsu, O.; McCormick, F. Proliferation of cancer cells despite CDK2 inhibition. <i>  Cancer Cell</i><b>2003</b>, <i>3</i>, 233−245.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=245&author=O.+Tetsu&author=F+McCormick&title=Proliferation+of+cancer+cells+despite+CDK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26atitle%3DProliferation%2520of%2520cancer%2520cells%2520despite%2520CDK2%2520inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm0606138b00019_1"><span><span class="NLM_string-ref">Malumbres, M.; Barbacid, M. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1. <i>  Cancer Cell</i><b>2005</b>, <i>7</i>, 591−598.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=598&author=M.+Malumbres&author=M.+Barbacid&author=+Cdk&title=is+dispensable+for+cell+cycle+inhibition+and+tumor+suppression+mediated+by+p27Kip1+and+p21Cip1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3Dis%2520dispensable%2520for%2520cell%2520cycle%2520inhibition%2520and%2520tumor%2520suppression%2520mediated%2520by%2520p27Kip1%2520and%2520p21Cip1%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00020"><div class="reference"><div class="NLM_citation" id="jm0606138b00020_1"><span><span class="NLM_string-ref">Berthet, C.; Aleem, E.; Coppola, V.; Tessarollo, L.; Kaldis, P. Cdk2 knockout mice are viable. <i>  Curr. Biol.</i><b>2003</b>, <i>13</i>, 1775−1785.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1785&author=C.+Berthet&author=E.+Aleem&author=V.+Coppola&author=L.+Tessarollo&author=P.+Kaldis&author=+Cdk&title=knockout+mice+are+viable"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerthet%26aufirst%3DC.%26atitle%3Dknockout%2520mice%2520are%2520viable%26jtitle%3DCurr.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D1785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm0606138b00021_1"><span><span class="NLM_string-ref">Ortega, S.; Prieto, I.; Odajima, J.; Martin, A.; Dubus, P.; Sotillo, R.; Barbero, J. L.; Malumbres, M.; Barbacid, M. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. <i>  Nat. Genet.</i><b>2003</b>, <i>35</i>, 25−31.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=31&author=S.+Ortega&author=I.+Prieto&author=J.+Odajima&author=A.+Martin&author=P.+Dubus&author=R.+Sotillo&author=J.+L.+Barbero&author=M.+Malumbres&author=M+Barbacid&title=Cyclin-dependent+kinase+2+is+essential+for+meiosis+but+not+for+mitotic+cell+division+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DS.%26atitle%3DCyclin-dependent%2520kinase%25202%2520is%2520essential%2520for%2520meiosis%2520but%2520not%2520for%2520mitotic%2520cell%2520division%2520in%2520mice%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D35%26spage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm0606138b00022_1"><span><span class="NLM_string-ref">Kozar, K.; Ciemerych, M. A.; Rebel, V. I.; Shigematsu, H.; Zagozdzon, A.; Sicinska, E.; Geng, Y.; Yu, Q.; Bhattacharya, S.; Bronson, R. T.; Akashi, K.; Sicinski, P. Mouse development and cell proliferation in the absence of D-cyclins. <i>  Cell</i><b>2004</b>, <i>118</i>, 477−491.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=491&author=K.+Kozar&author=M.+A.+Ciemerych&author=V.+I.+Rebel&author=H.+Shigematsu&author=A.+Zagozdzon&author=E.+Sicinska&author=Y.+Geng&author=Q.+Yu&author=S.+Bhattacharya&author=R.+T.+Bronson&author=K.+Akashi&author=P+Sicinski&title=Mouse+development+and+cell+proliferation+in+the+absence+of+D-cyclins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozar%26aufirst%3DK.%26atitle%3DMouse%2520development%2520and%2520cell%2520proliferation%2520in%2520the%2520absence%2520of%2520D-cyclins%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm0606138b00023_1"><span><span class="NLM_string-ref">Malumbres, M.; Sotillo, R.; Santamaria, D.; Galan, J.; Cerezo, A.; Ortega, S.; Dubus, P.; Barbacid, M. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. <i>  Cell</i><b>2004</b>, <i>118</i>, 493−504.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=504&author=M.+Malumbres&author=R.+Sotillo&author=D.+Santamaria&author=J.+Galan&author=A.+Cerezo&author=S.+Ortega&author=P.+Dubus&author=M+Barbacid&title=Mammalian+cells+cycle+without+the+D-type+cyclin-dependent+kinases+Cdk4+and+Cdk6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DMammalian%2520cells%2520cycle%2520without%2520the%2520D-type%2520cyclin-dependent%2520kinases%2520Cdk4%2520and%2520Cdk6%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm0606138b00024_1"><span><span class="NLM_string-ref">Deshpande, A.; Sicinski, P.; Hinds, P. W. Cyclins and cdks in development and cancer:  A perspective. <i>  Oncogene</i><b>2005</b>, <i>24</i>, 2909−2915.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=2915&author=A.+Deshpande&author=P.+Sicinski&author=P.+W+Hinds&title=Cyclins+and+cdks+in+development+and+cancer%3A%E2%80%89+A+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeshpande%26aufirst%3DA.%26atitle%3DCyclins%2520and%2520cdks%2520in%2520development%2520and%2520cancer%253A%25E2%2580%2589%2520A%2520perspective%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D2915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm0606138b00025_1"><span><span class="NLM_string-ref">Frantz, S. Drug discovery:  Playing dirty. <i>  Nature</i><b>2005</b>, <i>437</i>, 942−943.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Frantz%2C+S.+Drug+discovery%3A%E2%80%89+Playing+dirty.+Nature+2005%2C+437%2C+942%E2%88%92943.+Frantz%2C+S.+Drug+discovery%3A%E2%80%89+Playing+dirty.+Nature2005%2C+437%2C+942%E2%88%92943."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm0606138b00026_1"><span><span class="NLM_string-ref">(a) Chu, X.-J.; Ding, Q.; Jiang, N.; Kim, K.; Lovey, A.; McComas, W.; Mullin, J.; Tilley, J.; Preparation of benzoylaryldiaminothiazoles as inhibitors of cyclin-dependent kinase 4 with selectivity against Cdk2 and Cdk1<i>. </i>WO03097048A1, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28a%29+Chu%2C+X.-J.%3B+Ding%2C+Q.%3B+Jiang%2C+N.%3B+Kim%2C+K.%3B+Lovey%2C+A.%3B+McComas%2C+W.%3B+Mullin%2C+J.%3B+Tilley%2C+J.%3B+Preparation+of+benzoylaryldiaminothiazoles+as+inhibitors+of+cyclin-dependent+kinase+4+with+selectivity+against+Cdk2+and+Cdk1.+WO03097048A1%2C+2003.+%28a%29+Chu%2C+X.-J.%3B+Ding%2C+Q.%3B+Jiang%2C+N.%3B+Kim%2C+K.%3B+Lovey%2C+A.%3B+McComas%2C+W.%3B+Mullin%2C+J.%3B+Tilley%2C+J.%3B+Preparation+of+benzoylaryldiaminothiazoles+as+inhibitors+of+cyclin-dependent+kinase+4+with+selectivity+against+Cdk2+and+Cdk1.+WO03097048A1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0606138b00026_2"><span><span class="NLM_string-ref">(b) Chen, L.; Ding, Q.; Gillespie, P.; Kim, K.; Lovey, A.; McComas, W.; Mullin, J.; Perrotta, A. Preparation of 4-amino-5-benzoyl-2-(piperazinylphenylamino)thiazoles as inhibitors of cyclin-dependent kinase 4. WO 02057261A2, 2002.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=L.+Chen&author=Q.+Ding&author=P.+Gillespie&author=K.+Kim&author=A.+Lovey&author=W.+McComas&author=J.+Mullin&author=A.+Perrotta&title=Preparation+of+4-amino-5-benzoyl-2-%28piperazinylphenylamino%29thiazoles+as+inhibitors+of+cyclin-dependent+kinase+4.+WO+02057261A2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00026_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26btitle%3DPreparation%2520of%25204-amino-5-benzoyl-2-%2528piperazinylphenylamino%2529thiazoles%2520as%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204.%2520WO%252002057261A2%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm0606138b00027_1"><span><span class="NLM_string-ref">Lovey, A.; DePinto, W.; Ding, Q.; Jiang, N.; Kim, K.; Yin, X.; Chu, X.-J.; Bartkovitz, D.; Desai, B.; Smith, M.; Mullin, J.; McComas, W.; Graves, B.; Lukacs, C.; So, S.-S.; Chen, Y.; Xiang, Q. Design, synthesis, and biological evaluation of aminothiazoles as selective inhibitors of cyclin-dependent kinase 4. <i>  Abstracts of Papers</i>, 229<sup>th</sup> National Meeting of the American Chemical Society, San Diego, CA, March 13−17, 2005; American Chemical Society:  Washington, DC, 2005; Abstract MEDI-138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&conference=229th+National+Meeting+of+the+American+Chemical+Society&author=A.+Lovey&author=W.+DePinto&author=Q.+Ding&author=N.+Jiang&author=K.+Kim&author=X.+Yin&author=X.-J.+Chu&author=D.+Bartkovitz&author=B.+Desai&author=M.+Smith&author=J.+Mullin&author=W.+McComas&author=B.+Graves&author=C.+Lukacs&author=S.-S.+So&author=Y.+Chen&author=Q.+Xiang&author=+Design&title=and+biological+evaluation+of+aminothiazoles+as+selective+inhibitors+of+cyclin-dependent+kinase+4.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DLovey%26aufirst%3DA.%26atitle%3Dand%2520biological%2520evaluation%2520of%2520aminothiazoles%2520as%2520selective%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204.%2520Abstracts%2520of%2520Papers%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm0606138b00028_1"><span><span class="NLM_string-ref">DePinto, W.; Yin, X.; Smith, M.; Kolinsky, K.; Desai, B.; Rowan, K.; Wang, K.; Margolis, R.; Railkar, A.; Perrotta A.; Gillespie, P. The in vitro and in vivo effects of small molecule inhibitors of CDK4. <i>  Abstracts of </i><i>Papers</i>; 94<sup>th</sup> Annual Meeting of the American Association for Cancer Research, Washington, DC, July 12−16, 2003; American Association for Cancer Research:  Washington, DC, 2003; Abstract No. 3126.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=W.+DePinto&author=X.+Yin&author=M.+Smith&author=K.+Kolinsky&author=B.+Desai&author=K.+Rowan&author=K.+Wang&author=R.+Margolis&author=A.+Railkar&author=A.+Perrotta&author=P.+Gillespie&title=The+in+vitro+and+in+vivo+effects+of+small+molecule+inhibitors+of+CDK4.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDePinto%26aufirst%3DW.%26btitle%3DThe%2520in%2520vitro%2520and%2520in%2520vivo%2520effects%2520of%2520small%2520molecule%2520inhibitors%2520of%2520CDK4.%2520Abstracts%2520of%2520Papers%26date%3D2003%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm0606138b00029_1"><span><span class="NLM_string-ref">(a) Chu, X.-J.; Lovey, A.; DePinto, W.; Bartkovitz, D.; So, S.-S.; Vu, B.; Ding, Q.; Packman, K.; Yin, X.; Jiang, N.; Moliterni, J.; Kaplan, G.; Mullin, J.; Lukacs, C.; Graves, B.; Smith, M.; Chen, Y. The discovery of novel 2,4-diaminopyrimidines as potent and selective cyclin-dependent kinase inhibitors with in vivo activity. <i>  Abstracts of Papers; </i>96<sup>th</sup> Annual Meeting of the American Association for Cancer Research, Anaheim, CA, April 16−20, 2005; American Association for Cancer Research:  Washington, DC, 2005; Abstract No. 1221.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=X.-J.+Chu&author=A.+Lovey&author=W.+DePinto&author=D.+Bartkovitz&author=S.-S.+So&author=B.+Vu&author=Q.+Ding&author=K.+Packman&author=X.+Yin&author=N.+Jiang&author=J.+Moliterni&author=G.+Kaplan&author=J.+Mullin&author=C.+Lukacs&author=B.+Graves&author=M.+Smith&author=Y.+Chen&title=The+discovery+of+novel+2%2C4-diaminopyrimidines+as+potent+and+selective+cyclin-dependent+kinase+inhibitors+with+in+vivo+activity.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.-J.%26btitle%3DThe%2520discovery%2520of%2520novel%25202%252C4-diaminopyrimidines%2520as%2520potent%2520and%2520selective%2520cyclin-dependent%2520kinase%2520inhibitors%2520with%2520in%2520vivo%2520activity.%2520Abstracts%2520of%2520Papers%26date%3D2005%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0606138b00029_2"><span><span class="NLM_string-ref">(b) Bartkovitz, D.; Chu, X.-J.; Ding, Q.; Jiang, N.; Lovey, A.; Moliterni, J.; Mullin, J.; Vu, B.; Wovkulich, P. Preparation of (4-aminopyrimidin-5-yl)[(hetero)aryl]methanones as cyclin-dependent kinase inhibitors for treating solid tumors, WO2004069139A2, 2004.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=069139A&publication_year=2004&pages=2004&author=D.+Bartkovitz&author=X.-J.+Chu&author=Q.+Ding&author=N.+Jiang&author=A.+Lovey&author=J.+Moliterni&author=J.+Mullin&author=B.+Vu&author=P+Wovkulich&title=Preparation+of+%284-aminopyrimidin-5-yl%29%5B%28hetero%29aryl%5Dmethanones+as+cyclin-dependent+kinase+inhibitors+for+treating+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00029_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartkovitz%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520%25284-aminopyrimidin-5-yl%2529%255B%2528hetero%2529aryl%255Dmethanones%2520as%2520cyclin-dependent%2520kinase%2520inhibitors%2520for%2520treating%2520solid%2520tumors%26jtitle%3DWO%26date%3D2004%26volume%3D069139A%26spage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00030"><div class="reference"><div class="NLM_citation" id="jm0606138b00030_1"><span><span class="NLM_string-ref">Chong, W. K. M.; Duvadie, R. K. Preparation of 5-amino-3-substituted-pyrazolo[4,5-<i>d</i>]thiazole compounds as inhibitors of cyclin-dependent kinases. WO2002012250A2, 2002.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=012250A&publication_year=2002&pages=2002&author=W.+K.+M.+Chong&author=R.+K+Duvadie&title=Preparation+of+5-amino-3-substituted-pyrazolo%5B4%2C5-d%5Dthiazole+compounds+as+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChong%26aufirst%3DW.%2BK.%2BM.%26atitle%3DPreparation%2520of%25205-amino-3-substituted-pyrazolo%255B4%252C5-d%255Dthiazole%2520compounds%2520as%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DWO%26date%3D2002%26volume%3D012250A%26spage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm0606138b00031_1"><span><span class="NLM_string-ref">Misra, R. N.; Xiao, H.-Y.; Rawlins, D. B.; Shan, W.; Kellar, K. A.; Mulheron, J. G.; Sack, J. S.; Tokarski, J. S.; Kimball, S. D.; Webster, K. R. 1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine inhibitors of cyclin-dependent kinases:  Highly potent 2,6-difluorophenacyl analogues<i>. Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 2405−2408.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2408&author=R.+N.+Misra&author=H.-Y.+Xiao&author=D.+B.+Rawlins&author=W.+Shan&author=K.+A.+Kellar&author=J.+G.+Mulheron&author=J.+S.+Sack&author=J.+S.+Tokarski&author=S.+D.+Kimball&author=K.+R.+Webster&author=+Pyrazolo&title=inhibitors+of+cyclin-dependent+kinases%3A%E2%80%89+Highly+potent+2%2C6-difluorophenacyl+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26atitle%3Dinhibitors%2520of%2520cyclin-dependent%2520kinases%253A%25E2%2580%2589%2520Highly%2520potent%25202%252C6-difluorophenacyl%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm0606138b00032_1"><span><span class="NLM_string-ref">DePinto, W.; Chu, X.-J.; Yin, X.; Smith, M.; Packman, K.; Goelzer, P.; Lovey, A.; Chen, Y.; Qian, H.; Hamid, R.; Xiang, Q.; Tovar, C.; Blain, R.; Nevins, T.; Higgins, B.; Luistro, L.; Kolinsky, K.; Felix, B.; Hussain, S.; Heimbrook, D. In vitro and in vivo activity of R547:  A potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials. <i>  Mol. </i><i>Cancer Ther.</i><b>2006</b>, in press.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+DePinto&author=X.-J.+Chu&author=X.+Yin&author=M.+Smith&author=K.+Packman&author=P.+Goelzer&author=A.+Lovey&author=Y.+Chen&author=H.+Qian&author=R.+Hamid&author=Q.+Xiang&author=C.+Tovar&author=R.+Blain&author=T.+Nevins&author=B.+Higgins&author=L.+Luistro&author=K.+Kolinsky&author=B.+Felix&author=S.+Hussain&author=D.+Heimbrook&title=vitro+and+in+vivo+activity+of+R547%3A%E2%80%89+A+potent+and+selective+cyclin-dependent+kinase+inhibitor+currently+in+phase+I+clinical+trials.+Mol.+Cancer+Ther."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDePinto%26aufirst%3DW.%26btitle%3Dvitro%2520and%2520in%2520vivo%2520activity%2520of%2520R547%253A%25E2%2580%2589%2520A%2520potent%2520and%2520selective%2520cyclin-dependent%2520kinase%2520inhibitor%2520currently%2520in%2520phase%2520I%2520clinical%2520trials.%2520Mol.%2520Cancer%2520Ther.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm0606138b00033_1"><span><span class="NLM_string-ref">DeLano, W. L. The PyMOL Molecular Graphics System 2002, DeLanoScientific, San Carlos, CA; <a class="ext-link" href="http://www.pymol.org" target="_blank">http://www.pymol.org</a>.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=W.+L.+DeLano&title=The+PyMOL+Molecular+Graphics+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26btitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26date%3D2002%26pub%3DCAhttp%3A%2F%2Fwww.pymol.org" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm0606138b00034_1"><span><span class="NLM_string-ref">Vulpetti, A.; Pevarello, P. An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein−inhibitor complexes. <i>  Curr. Med. Chem. Anti-Cancer Agents</i><b>2005</b>, <i>5</i>, 561−573.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=573&author=A.+Vulpetti&author=P+Pevarello&title=An+analysis+of+the+binding+modes+of+ATP-competitive+CDK2+inhibitors+as+revealed+by+X-ray+structures+of+protein%E2%88%92inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520modes%2520of%2520ATP-competitive%2520CDK2%2520inhibitors%2520as%2520revealed%2520by%2520X-ray%2520structures%2520of%2520protein%25E2%2588%2592inhibitor%2520complexes%26jtitle%3DCurr.%2520Med.%2520Chem.%2520Anti-Cancer%2520Agents%26date%3D2005%26volume%3D5%26spage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0606138b00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0606138b00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm0606138b00035_1"><span><span class="NLM_string-ref">Otwinowski, Z.; Minor, W. <i>  Methods Enzymol.</i><b>1997</b>, <i>276</i>, 307−326.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Otwinowski%2C+Z.%3B+Minor%2C+W.+Methods+Enzymol.+1997%2C+276%2C+307%E2%88%92326.+Otwinowski%2C+Z.%3B+Minor%2C+W.+Methods+Enzymol.1997%2C+276%2C+307%E2%88%92326."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm0606138b00001':['jm0606138b00001_1'],'jm0606138b00002':['jm0606138b00002_1'],'jm0606138b00003':['jm0606138b00003_1'],'jm0606138b00004':['jm0606138b00004_1'],'jm0606138b00005':['jm0606138b00005_1','jm0606138b00005_2'],'jm0606138b00006':['jm0606138b00006_1'],'jm0606138b00007':['jm0606138b00007_1'],'jm0606138b00008':['jm0606138b00008_1'],'jm0606138b00009':['jm0606138b00009_1'],'jm0606138b00010':['jm0606138b00010_1'],'jm0606138b00011':['jm0606138b00011_1'],'jm0606138b00012':['jm0606138b00012_1'],'jm0606138b00013':['jm0606138b00013_1'],'jm0606138b00014':['jm0606138b00014_1'],'jm0606138b00015':['jm0606138b00015_1'],'jm0606138b00016':['jm0606138b00016_1'],'jm0606138b00017':['jm0606138b00017_1'],'jm0606138b00018':['jm0606138b00018_1'],'jm0606138b00019':['jm0606138b00019_1'],'jm0606138b00020':['jm0606138b00020_1'],'jm0606138b00021':['jm0606138b00021_1'],'jm0606138b00022':['jm0606138b00022_1'],'jm0606138b00023':['jm0606138b00023_1'],'jm0606138b00024':['jm0606138b00024_1'],'jm0606138b00025':['jm0606138b00025_1'],'jm0606138b00026':['jm0606138b00026_1','jm0606138b00026_2'],'jm0606138b00027':['jm0606138b00027_1'],'jm0606138b00028':['jm0606138b00028_1'],'jm0606138b00029':['jm0606138b00029_1','jm0606138b00029_2'],'jm0606138b00030':['jm0606138b00030_1'],'jm0606138b00031':['jm0606138b00031_1'],'jm0606138b00032':['jm0606138b00032_1'],'jm0606138b00033':['jm0606138b00033_1'],'jm0606138b00034':['jm0606138b00034_1'],'jm0606138b00035':['jm0606138b00035_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 77 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Masahiro Ito, Toshio Tanaka, Akinori Toita, Noriko Uchiyama, Hironori Kokubo, Nao Morishita, Michael G. Klein, Hua Zou, Morio Murakami, Mitsuyo Kondo, Tomoya Sameshima, Shinsuke Araki, Satoshi Endo, Tomohiro Kawamoto, Gregg B. Morin, Samuel A. Aparicio, Atsushi Nakanishi, Hironobu Maezaki, <span class="NLM_string-name hlFld-ContribAuthor">Yasuhiro Imaeda</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Benzyl-1-(trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7710-7728. <a href="https://doi.org/10.1021/acs.jmedchem.8b00683" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00683%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-Benzyl-1-%252528trans-4-%252528%2525285-cyanopyridin-2-yl%252529amino%252529cyclohexyl%252529-1-arylurea%252BDerivatives%252Bas%252BNovel%252Band%252BSelective%252BCyclin-Dependent%252BKinase%252B12%252B%252528CDK12%252529%252BInhibitors%26aulast%3DIto%26aufirst%3DMasahiro%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30042018%26date%3D20082018%26date%3D01082018%26volume%3D61%26issue%3D17%26spage%3D7710%26epage%3D7728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priya  Mahajan</span>, <span class="hlFld-ContribAuthor ">Gousia  Chashoo</span>, <span class="hlFld-ContribAuthor ">Monika  Gupta</span>, <span class="hlFld-ContribAuthor ">Amit  Kumar</span>, <span class="hlFld-ContribAuthor ">Parvinder Pal  Singh</span>, and <span class="hlFld-ContribAuthor ">Amit  Nargotra</span>  . </span><span class="cited-content_cbyCitation_article-title">Fusion of Structure and Ligand Based Methods for Identification of Novel CDK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (8)
                                     , 1957-1969. <a href="https://doi.org/10.1021/acs.jcim.7b00293" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00293%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFusion%252Bof%252BStructure%252Band%252BLigand%252BBased%252BMethods%252Bfor%252BIdentification%252Bof%252BNovel%252BCDK2%252BInhibitors%26aulast%3DMahajan%26aufirst%3DPriya%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22052017%26date%3D03082017%26date%3D28082017%26date%3D19072017%26volume%3D57%26issue%3D8%26spage%3D1957%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pelin  Ayaz</span>, <span class="hlFld-ContribAuthor ">Dorothee  Andres</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Kwiatkowski</span>, <span class="hlFld-ContribAuthor ">Carl-Christian  Kolbe</span>, <span class="hlFld-ContribAuthor ">Philip  Lienau</span>, <span class="hlFld-ContribAuthor ">Gerhard  Siemeister</span>, <span class="hlFld-ContribAuthor ">Ulrich  Lücking</span>, and <span class="hlFld-ContribAuthor ">Christian M.  Stegmann</span>  . </span><span class="cited-content_cbyCitation_article-title">Conformational Adaption May Explain the Slow Dissociation Kinetics of Roniciclib (BAY 1000394), a Type I CDK Inhibitor with Kinetic Selectivity for CDK2 and CDK9. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , 1710-1719. <a href="https://doi.org/10.1021/acschembio.6b00074" title="DOI URL">https://doi.org/10.1021/acschembio.6b00074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00074%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DConformational%252BAdaption%252BMay%252BExplain%252Bthe%252BSlow%252BDissociation%252BKinetics%252Bof%252BRoniciclib%252B%252528BAY%252B1000394%252529%25252C%252Ba%252BType%252BI%252BCDK%252BInhibitor%252Bwith%252BKinetic%252BSelectivity%252Bfor%252BCDK2%252Band%252BCDK9%26aulast%3DAyaz%26aufirst%3DPelin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D23012016%26date%3D11042016%26date%3D19042016%26date%3D17062016%26volume%3D11%26issue%3D6%26spage%3D1710%26epage%3D1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rupa R.  Sawant</span>, <span class="hlFld-ContribAuthor ">Aditi M.  Jhaveri</span>, <span class="hlFld-ContribAuthor ">Alexander  Koshkaryev</span>, <span class="hlFld-ContribAuthor ">Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Farooq  Qureshi</span>, and <span class="hlFld-ContribAuthor ">Vladimir P.  Torchilin</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeted Transferrin-Modified Polymeric Micelles: Enhanced Efficacy in Vitro and in Vivo in Ovarian Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2014,</strong> <em>11 </em>
                                    (2)
                                     , 375-381. <a href="https://doi.org/10.1021/mp300633f" title="DOI URL">https://doi.org/10.1021/mp300633f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp300633f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp300633f%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DTargeted%252BTransferrin-Modified%252BPolymeric%252BMicelles%25253A%252BEnhanced%252BEfficacy%252Bin%252BVitro%252Band%252Bin%252BVivo%252Bin%252BOvarian%252BCarcinoma%26aulast%3DSawant%26aufirst%3DRupa%2BR.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D2013%26date%3D05112012%26date%3D10122013%26date%3D02102013%26date%3D19122013%26date%3D03022014%26date%3D10122013%26volume%3D11%26issue%3D2%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Shao</span>, <span class="hlFld-ContribAuthor ">Shenhua  Shi</span>, <span class="hlFld-ContribAuthor ">Shiliang  Huang</span>, <span class="hlFld-ContribAuthor ">Alison J.  Hole</span>, <span class="hlFld-ContribAuthor ">Abdullahi Y.  Abbas</span>, <span class="hlFld-ContribAuthor ">Sonja  Baumli</span>, <span class="hlFld-ContribAuthor ">Xiangrui  Liu</span>, <span class="hlFld-ContribAuthor ">Frankie  Lam</span>, <span class="hlFld-ContribAuthor ">David W.  Foley</span>, <span class="hlFld-ContribAuthor ">Peter M.  Fischer</span>, <span class="hlFld-ContribAuthor ">Martin  Noble</span>, <span class="hlFld-ContribAuthor ">Jane A.  Endicott</span>, <span class="hlFld-ContribAuthor ">Chris  Pepper</span>, and <span class="hlFld-ContribAuthor ">Shudong  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (3)
                                     , 640-659. <a href="https://doi.org/10.1021/jm301475f" title="DOI URL">https://doi.org/10.1021/jm301475f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301475f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301475f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252B4-%252528Thiazol-5-yl%252529-2-%252528phenylamino%252529pyrimidines%252BAre%252BHighly%252BActive%252BCDK9%252BInhibitors%25253A%252BSynthesis%25252C%252BX-ray%252BCrystal%252BStructures%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationship%25252C%252Band%252BAnticancer%252BActivities%26aulast%3DShao%26aufirst%3DHao%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D11102012%26date%3D25012013%26date%3D14022013%26date%3D09012013%26volume%3D56%26issue%3D3%26spage%3D640%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajâa  Boulahjar</span>, <span class="hlFld-ContribAuthor ">Aziz  Ouach</span>, <span class="hlFld-ContribAuthor ">Chiurato  Matteo</span>, <span class="hlFld-ContribAuthor ">Stephane  Bourg</span>, <span class="hlFld-ContribAuthor ">Myriam  Ravache</span>, <span class="hlFld-ContribAuthor ">Rémy le  Guével</span>, <span class="hlFld-ContribAuthor ">Séverine  Marionneau</span>, <span class="hlFld-ContribAuthor ">Thibauld  Oullier</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Christiane  Guguen-Guillouzo</span>, <span class="hlFld-ContribAuthor ">Saïd  Lazar</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Yves  Troin</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, and <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Tetrahydropyrido[1,2-a]isoindolone Derivatives (Valmerins): Potent Cyclin-Dependent Kinase/Glycogen Synthase Kinase 3 Inhibitors with Antiproliferative Activities and Antitumor Effects in Human Tumor Xenografts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9589-9606. <a href="https://doi.org/10.1021/jm3008536" title="DOI URL">https://doi.org/10.1021/jm3008536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3008536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3008536%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BTetrahydropyrido%25255B1%25252C2-a%25255Disoindolone%252BDerivatives%252B%252528Valmerins%252529%25253A%252BPotent%252BCyclin-Dependent%252BKinase%25252FGlycogen%252BSynthase%252BKinase%252B3%252BInhibitors%252Bwith%252BAntiproliferative%252BActivities%252Band%252BAntitumor%252BEffects%252Bin%252BHuman%252BTumor%252BXenografts%26aulast%3DBoulahjar%26aufirst%3DRaj%25C3%25A2a%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D18062012%26date%3D01112012%26date%3D26112012%26date%3D19102012%26volume%3D55%26issue%3D22%26spage%3D9589%26epage%3D9606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis S.  Vizirianakis</span>, <span class="hlFld-ContribAuthor ">Maria  Chatzopoulou</span>, <span class="hlFld-ContribAuthor ">Ioannis D.  Bonovolias</span>, <span class="hlFld-ContribAuthor ">Ioannis  Nicolaou</span>, <span class="hlFld-ContribAuthor ">Vassilis J.  Demopoulos</span>, and <span class="hlFld-ContribAuthor ">Asterios S.  Tsiftsoglou</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward the Development of Innovative Bifunctional Agents To Induce Differentiation and To Promote Apoptosis in Leukemia: Clinical Candidates and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (19)
                                     , 6779-6810. <a href="https://doi.org/10.1021/jm100189a" title="DOI URL">https://doi.org/10.1021/jm100189a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100189a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100189a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252Bthe%252BDevelopment%252Bof%252BInnovative%252BBifunctional%252BAgents%252BTo%252BInduce%252BDifferentiation%252Band%252BTo%252BPromote%252BApoptosis%252Bin%252BLeukemia%25253A%252BClinical%252BCandidates%252Band%252BPerspectives%26aulast%3DVizirianakis%26aufirst%3DIoannis%2BS.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D12022010%26date%3D20072010%26date%3D14102010%26volume%3D53%26issue%3D19%26spage%3D6779%26epage%3D6810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriella  Traquandi</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Nicoletta  Colombo</span>, <span class="hlFld-ContribAuthor ">Valter  Croci</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Antonio  Longo</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>, <span class="hlFld-ContribAuthor ">Achille  Panzeri</span>, <span class="hlFld-ContribAuthor ">Wilma  Pastori</span>, <span class="hlFld-ContribAuthor ">Paolo  Pevarello</span>, <span class="hlFld-ContribAuthor ">Daniele  Volpi</span>, <span class="hlFld-ContribAuthor ">Patrick  Roussel</span>, <span class="hlFld-ContribAuthor ">Anna  Vulpetti</span> and <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Potent Pyrazolo[4,3-h]quinazoline-3-carboxamides as Multi-Cyclin-Dependent Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2171-2187. <a href="https://doi.org/10.1021/jm901710h" title="DOI URL">https://doi.org/10.1021/jm901710h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901710h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901710h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPotent%252BPyrazolo%25255B4%25252C3-h%25255Dquinazoline-3-carboxamides%252Bas%252BMulti-Cyclin-Dependent%252BKinase%252BInhibitors%26aulast%3DTraquandi%26aufirst%3DGabriella%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D18112009%26date%3D08022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2171%26epage%3D2187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Nadia  Amboldi</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Alexander  Cameron</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Giovanni  Cervi</span>, <span class="hlFld-ContribAuthor ">Maristella  Colombo</span>, <span class="hlFld-ContribAuthor ">Francesco  Colotta</span>, <span class="hlFld-ContribAuthor ">Valter  Croci</span>, <span class="hlFld-ContribAuthor ">Roberto  D’Alessio</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>, <span class="hlFld-ContribAuthor ">Walter  Moretti</span>, <span class="hlFld-ContribAuthor ">Achille  Panzeri</span>, <span class="hlFld-ContribAuthor ">Wilma  Pastori</span>, <span class="hlFld-ContribAuthor ">Paolo  Pevarello</span>, <span class="hlFld-ContribAuthor ">Francesca  Quartieri</span>, <span class="hlFld-ContribAuthor ">Fulvia  Roletto</span>, <span class="hlFld-ContribAuthor ">Gabriella  Traquandi</span>, <span class="hlFld-ContribAuthor ">Paola  Vianello</span>, <span class="hlFld-ContribAuthor ">Anna  Vulpetti</span> and <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (16)
                                     , 5152-5163. <a href="https://doi.org/10.1021/jm9006559" title="DOI URL">https://doi.org/10.1021/jm9006559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9006559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9006559%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BN%25252C1%25252C4%25252C4-Tetramethyl-8-%25257B%25255B4-%2525284-methylpiperazin-1-yl%252529phenyl%25255Damino%25257D-4%25252C5-dihydro-1H-pyrazolo%25255B4%25252C3-h%25255Dquinazoline-3-carboxamide%252B%252528PHA-848125%252529%25252C%252Ba%252BPotent%25252C%252BOrally%252BAvailable%252BCyclin%252BDependent%252BKinase%252BInhibitor%26aulast%3DBrasca%26aufirst%3DMaria%2BGabriella%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D18052009%26date%3D15072009%26date%3D27082009%26volume%3D52%26issue%3D16%26spage%3D5152%26epage%3D5163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrzej  Skladanowski</span>, <span class="hlFld-ContribAuthor ">Przemyslaw  Bozko</span> and <span class="hlFld-ContribAuthor ">Michal  Sabisz</span>  . </span><span class="cited-content_cbyCitation_article-title">DNA Structure and Integrity Checkpoints during the Cell Cycle and Their Role in Drug Targeting and Sensitivity of Tumor Cells to Anticancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2009,</strong> <em>109 </em>
                                    (7)
                                     , 2951-2973. <a href="https://doi.org/10.1021/cr900026u" title="DOI URL">https://doi.org/10.1021/cr900026u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr900026u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr900026u%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DDNA%252BStructure%252Band%252BIntegrity%252BCheckpoints%252Bduring%252Bthe%252BCell%252BCycle%252Band%252BTheir%252BRole%252Bin%252BDrug%252BTargeting%252Band%252BSensitivity%252Bof%252BTumor%252BCells%252Bto%252BAnticancer%252BTreatment%26aulast%3DSkladanowski%26aufirst%3DAndrzej%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D20%252001%25202009%26date%3D12062009%26date%3D08072009%26volume%3D109%26issue%3D7%26spage%3D2951%26epage%3D2973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aude  Echalier</span>, <span class="hlFld-ContribAuthor ">Karima  Bettayeb</span>, <span class="hlFld-ContribAuthor ">Yoan  Ferandin</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Monique  Clément</span>, <span class="hlFld-ContribAuthor ">Annie  Valette</span>, <span class="hlFld-ContribAuthor ">François  Liger</span>, <span class="hlFld-ContribAuthor ">Bernard  Marquet</span>, <span class="hlFld-ContribAuthor ">Jonathan C.  Morris</span>, <span class="hlFld-ContribAuthor ">Jane A.  Endicott</span>, <span class="hlFld-ContribAuthor ">Benoît  Joseph</span> and <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Meriolins (3-(Pyrimidin-4-yl)-7-azaindoles): Synthesis, Kinase Inhibitory Activity, Cellular Effects, and Structure of a CDK2/Cyclin A/Meriolin Complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (4)
                                     , 737-751. <a href="https://doi.org/10.1021/jm700940h" title="DOI URL">https://doi.org/10.1021/jm700940h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm700940h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm700940h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMeriolins%252B%2525283-%252528Pyrimidin-4-yl%252529-7-azaindoles%252529%25253A%252BSynthesis%25252C%252BKinase%252BInhibitory%252BActivity%25252C%252BCellular%252BEffects%25252C%252Band%252BStructure%252Bof%252Ba%252BCDK2%25252FCyclin%252BA%25252FMeriolin%252BComplex%26aulast%3DEchalier%26aufirst%3DAude%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D28%252002%25202008%26date%3D31%252001%25202008%26date%3D31%252007%25202007%26volume%3D51%26issue%3D4%26spage%3D737%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofian  Gatfaoui</span>, <span class="hlFld-ContribAuthor ">Noureddine  Issaoui</span>, <span class="hlFld-ContribAuthor ">Olfa  Noureddine</span>, <span class="hlFld-ContribAuthor ">Thierry  Roisnel</span>, <span class="hlFld-ContribAuthor ">Houda  Marouani</span>. </span><span class="cited-content_cbyCitation_article-title">Self assembly of a novel Cu(II) complex, (C6H9N2)2[CuCl4]: experimental, computational, and molecular docking survey. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2021,</strong> <em>1013 </em><a href="https://doi.org/10.1007/s13738-021-02195-y" title="DOI URL">https://doi.org/10.1007/s13738-021-02195-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-021-02195-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-021-02195-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DSelf%252Bassembly%252Bof%252Ba%252Bnovel%252BCu%252528II%252529%252Bcomplex%25252C%252B%252528C6H9N2%2525292%25255BCuCl4%25255D%25253A%252Bexperimental%25252C%252Bcomputational%25252C%252Band%252Bmolecular%252Bdocking%252Bsurvey%26aulast%3DGatfaoui%26aufirst%3DSofian%26date%3D2021%26date%3D2021%26volume%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanzhi  Liang</span>, <span class="hlFld-ContribAuthor ">Jintong  Du</span>, <span class="hlFld-ContribAuthor ">Reham M.  Elhassan</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2021,</strong> <em>30 </em>
                                    (1)
                                     , 61-76. <a href="https://doi.org/10.1080/13543784.2021.1850693" title="DOI URL">https://doi.org/10.1080/13543784.2021.1850693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2021.1850693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2021.1850693%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DRecent%252Bprogress%252Bin%252Bdevelopment%252Bof%252Bcyclin-dependent%252Bkinase%252B7%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DLiang%26aufirst%3DHanzhi%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D1%26spage%3D61%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Van den Kerkhof</span>, <span class="hlFld-ContribAuthor ">D.  Mabille</span>, <span class="hlFld-ContribAuthor ">S.  Hendrickx</span>, <span class="hlFld-ContribAuthor ">P.  Leprohon</span>, <span class="hlFld-ContribAuthor ">C. E.  Mowbray</span>, <span class="hlFld-ContribAuthor ">S.  Braillard</span>, <span class="hlFld-ContribAuthor ">M.  Ouellette</span>, <span class="hlFld-ContribAuthor ">L.  Maes</span>, <span class="hlFld-ContribAuthor ">G.  Caljon</span>. </span><span class="cited-content_cbyCitation_article-title">Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (9)
                                     <a href="https://doi.org/10.1128/AAC.00152-20" title="DOI URL">https://doi.org/10.1128/AAC.00152-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00152-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00152-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DAntileishmanial%252BAminopyrazoles%25253A%252BStudies%252Binto%252BMechanisms%252Band%252BStability%252Bof%252BExperimental%252BDrug%252BResistance%26aulast%3DVan%2Bden%2BKerkhof%26aufirst%3DM.%26date%3D2020%26volume%3D64%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik B  Faber</span>, <span class="hlFld-ContribAuthor ">Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Gunda I  Georg</span>. </span><span class="cited-content_cbyCitation_article-title">Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception†. </span><span class="cited-content_cbyCitation_journal-name">Biology of Reproduction</span><span> <strong>2020,</strong> <em>103 </em>
                                    (2)
                                     , 357-367. <a href="https://doi.org/10.1093/biolre/ioaa107" title="DOI URL">https://doi.org/10.1093/biolre/ioaa107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/biolre/ioaa107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbiolre%2Fioaa107%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%2520of%2520Reproduction%26atitle%3DReview%252Bof%252Brationale%252Band%252Bprogress%252Btoward%252Btargeting%252Bcyclin-dependent%252Bkinase%252B2%252B%252528CDK2%252529%252Bfor%252Bmale%252Bcontraception%2525E2%252580%2525A0%26aulast%3DFaber%26aufirst%3DErik%2BB%26date%3D2020%26date%3D2020%26volume%3D103%26issue%3D2%26spage%3D357%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marwa H.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Maher A.  El‐Hashash</span>, <span class="hlFld-ContribAuthor ">Magda I.  Marzouk</span>, <span class="hlFld-ContribAuthor ">Abeer M.  El‐Naggar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antitumor activity of some nitrogen heterocycles bearing pyrimidine moiety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>2 </em><a href="https://doi.org/10.1002/jhet.4061" title="DOI URL">https://doi.org/10.1002/jhet.4061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4061%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantitumor%252Bactivity%252Bof%252Bsome%252Bnitrogen%252Bheterocycles%252Bbearing%252Bpyrimidine%252Bmoiety%26aulast%3DAhmed%26aufirst%3DMarwa%2BH.%26date%3D2020%26date%3D2020%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minmin  Wang</span>, <span class="hlFld-ContribAuthor ">Tianyu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoxing  Wu</span>, <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin-dependent kinase 7 inhibitors in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (9)
                                     , 813-833. <a href="https://doi.org/10.4155/fmc-2019-0334" title="DOI URL">https://doi.org/10.4155/fmc-2019-0334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0334%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCyclin-dependent%252Bkinase%252B7%252Binhibitors%252Bin%252Bcancer%252Btherapy%26aulast%3DWang%26aufirst%3DMinmin%26date%3D2020%26volume%3D12%26issue%3D9%26spage%3D813%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit  Tahlan</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Kumar</span>, <span class="hlFld-ContribAuthor ">Kalavathy  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Siong Meng  Lim</span>, <span class="hlFld-ContribAuthor ">Syed Adnan Ali  Shah</span>, <span class="hlFld-ContribAuthor ">Vasudevan  Mani</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Narasimhan</span>. </span><span class="cited-content_cbyCitation_article-title">In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">BMC Chemistry</span><span> <strong>2019,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13065-019-0608-5" title="DOI URL">https://doi.org/10.1186/s13065-019-0608-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13065-019-0608-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13065-019-0608-5%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Chemistry%26atitle%3DIn-silico%252Bmolecular%252Bdesign%252Bof%252Bheterocyclic%252Bbenzimidazole%252Bscaffolds%252Bas%252Bprospective%252Banticancer%252Bagents%26aulast%3DTahlan%26aufirst%3DSumit%26date%3D2019%26date%3D2019%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinky  Mehta</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Kumar</span>, <span class="hlFld-ContribAuthor ">Rakesh Kumar  Marwaha</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Narasimhan</span>, <span class="hlFld-ContribAuthor ">Kalavathy  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Siong Meng  Lim</span>, <span class="hlFld-ContribAuthor ">Syed Adnan Ali  Shah</span>, <span class="hlFld-ContribAuthor ">Vasudevan  Mani</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular docking and biological potentials of new 2-(4-(2-chloroacetyl) piperazin-1-yl)-N-(2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl)acetamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">BMC Chemistry</span><span> <strong>2019,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13065-019-0629-0" title="DOI URL">https://doi.org/10.1186/s13065-019-0629-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13065-019-0629-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13065-019-0629-0%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Chemistry%26atitle%3DSynthesis%25252C%252Bmolecular%252Bdocking%252Band%252Bbiological%252Bpotentials%252Bof%252Bnew%252B2-%2525284-%2525282-chloroacetyl%252529%252Bpiperazin-1-yl%252529-N-%2525282-%2525284-chlorophenyl%252529-4-oxoquinazolin-3%2525284H%252529-yl%252529acetamide%252Bderivatives%26aulast%3DMehta%26aufirst%3DShinky%26date%3D2019%26date%3D2019%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Polishchuk</span>, <span class="hlFld-ContribAuthor ">Alina  Kutlushina</span>, <span class="hlFld-ContribAuthor ">Dayana  Bashirova</span>, <span class="hlFld-ContribAuthor ">Olena  Mokshyna</span>, <span class="hlFld-ContribAuthor ">Timur  Madzhidov</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (23)
                                     , 5834. <a href="https://doi.org/10.3390/ijms20235834" title="DOI URL">https://doi.org/10.3390/ijms20235834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20235834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20235834%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DVirtual%252BScreening%252BUsing%252BPharmacophore%252BModels%252BRetrieved%252Bfrom%252BMolecular%252BDynamic%252BSimulations%26aulast%3DPolishchuk%26aufirst%3DPavel%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D23%26spage%3D5834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshihiko  Hirozane</span>, <span class="hlFld-ContribAuthor ">Masashi  Toyofuku</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Yogo</span>, <span class="hlFld-ContribAuthor ">Yukiya  Tanaka</span>, <span class="hlFld-ContribAuthor ">Tomoya  Sameshima</span>, <span class="hlFld-ContribAuthor ">Ikuo  Miyahisa</span>, <span class="hlFld-ContribAuthor ">Masato  Yoshikawa</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based rational design of staurosporine-based fluorescent probe with broad-ranging kinase affinity for kinase panel application. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (21)
                                     , 126641. <a href="https://doi.org/10.1016/j.bmcl.2019.126641" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126641%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Brational%252Bdesign%252Bof%252Bstaurosporine-based%252Bfluorescent%252Bprobe%252Bwith%252Bbroad-ranging%252Bkinase%252Baffinity%252Bfor%252Bkinase%252Bpanel%252Bapplication%26aulast%3DHirozane%26aufirst%3DYoshihiko%26date%3D2019%26volume%3D29%26issue%3D21%26spage%3D126641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuefei  Ma</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingming  Li</span>, <span class="hlFld-ContribAuthor ">Shufen  Li</span>, <span class="hlFld-ContribAuthor ">Yunlin  Ma</span>, <span class="hlFld-ContribAuthor ">Wen  Jin</span>, <span class="hlFld-ContribAuthor ">Kankan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Overexpressed long noncoding RNA CRNDE with distinct alternatively spliced isoforms in multiple cancers. </span><span class="cited-content_cbyCitation_journal-name">Frontiers of Medicine</span><span> <strong>2019,</strong> <em>13 </em>
                                    (3)
                                     , 330-343. <a href="https://doi.org/10.1007/s11684-017-0557-0" title="DOI URL">https://doi.org/10.1007/s11684-017-0557-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11684-017-0557-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11684-017-0557-0%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520of%2520Medicine%26atitle%3DOverexpressed%252Blong%252Bnoncoding%252BRNA%252BCRNDE%252Bwith%252Bdistinct%252Balternatively%252Bspliced%252Bisoforms%252Bin%252Bmultiple%252Bcancers%26aulast%3DMa%26aufirst%3DXuefei%26date%3D2019%26date%3D2019%26volume%3D13%26issue%3D3%26spage%3D330%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirill P.  Cheremnykh</span>, <span class="hlFld-ContribAuthor ">Victor A.  Savelyev</span>, <span class="hlFld-ContribAuthor ">Mikhail A.  Pokrovskii</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Baev</span>, <span class="hlFld-ContribAuthor ">Tatyana G.  Tolstikova</span>, <span class="hlFld-ContribAuthor ">Andrey G.  Pokrovskii</span>, <span class="hlFld-ContribAuthor ">Elvira E.  Shults</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, cytotoxicity, and molecular modeling study of 2,4,6-trisubstituted pyrimidines with anthranilate ester moiety. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (4)
                                     , 545-558. <a href="https://doi.org/10.1007/s00044-019-02314-8" title="DOI URL">https://doi.org/10.1007/s00044-019-02314-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02314-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02314-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bcytotoxicity%25252C%252Band%252Bmolecular%252Bmodeling%252Bstudy%252Bof%252B2%25252C4%25252C6-trisubstituted%252Bpyrimidines%252Bwith%252Banthranilate%252Bester%252Bmoiety%26aulast%3DCheremnykh%26aufirst%3DKirill%2BP.%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D4%26spage%3D545%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">2-Aminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 237-283. <a href="https://doi.org/10.1002/9781118686263.ch7" title="DOI URL">https://doi.org/10.1002/9781118686263.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch7%26sid%3Dliteratum%253Aachs%26atitle%3D2-Aminopyrimidines%26date%3D2018%26date%3D2018%26spage%3D237%26epage%3D283%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, , <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>, <span class="hlFld-ContribAuthor ">Jane A.  Endicott</span>, <span class="hlFld-ContribAuthor ">Martin E.M.  Noble</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of cyclin-dependent protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Essays in Biochemistry</span><span> <strong>2017,</strong> <em>61 </em>
                                    (5)
                                     , 439-452. <a href="https://doi.org/10.1042/EBC20170040" title="DOI URL">https://doi.org/10.1042/EBC20170040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/EBC20170040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FEBC20170040%26sid%3Dliteratum%253Aachs%26jtitle%3DEssays%2520in%2520Biochemistry%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bcyclin-dependent%252Bprotein%252Bkinase%252Binhibitors%26aulast%3Dvan%2BMontfort%26aufirst%3DRob%2BL.M.%26date%3D2017%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3D439%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James  Turkson</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer Drug Discovery and Anticancer Drug Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 695-707. <a href="https://doi.org/10.1007/978-1-59745-458-2_36" title="DOI URL">https://doi.org/10.1007/978-1-59745-458-2_36</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-59745-458-2_36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-59745-458-2_36%26sid%3Dliteratum%253Aachs%26atitle%3DCancer%252BDrug%252BDiscovery%252Band%252BAnticancer%252BDrug%252BDevelopment%26aulast%3DTurkson%26aufirst%3DJames%26date%3D2017%26date%3D2016%26spage%3D695%26epage%3D707%26pub%3DSpringer%2520New%2520York%26atitle%3DThe%252BMolecular%252BBasis%252Bof%252BHuman%252BCancer%26aulast%3DColeman%26aufirst%3DWilliam%2BB.%26date%3D2017%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Václav  Bazgier</span>, <span class="hlFld-ContribAuthor ">Karel  Berka</span>, <span class="hlFld-ContribAuthor ">Michal  Otyepka</span>, <span class="hlFld-ContribAuthor ">Pavel  Banáš</span>. </span><span class="cited-content_cbyCitation_article-title">Exponential repulsion improves structural predictability of molecular docking. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2016,</strong> <em>37 </em>
                                    (28)
                                     , 2485-2494. <a href="https://doi.org/10.1002/jcc.24473" title="DOI URL">https://doi.org/10.1002/jcc.24473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.24473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.24473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DExponential%252Brepulsion%252Bimproves%252Bstructural%252Bpredictability%252Bof%252Bmolecular%252Bdocking%26aulast%3DBazgier%26aufirst%3DV%25C3%25A1clav%26date%3D2016%26date%3D2016%26volume%3D37%26issue%3D28%26spage%3D2485%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomasz M.  Wróbel</span>, <span class="hlFld-ContribAuthor ">Michał  Kiełbus</span>, <span class="hlFld-ContribAuthor ">Agnieszka A.  Kaczor</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>, <span class="hlFld-ContribAuthor ">Zbigniew  Karczmarzyk</span>, <span class="hlFld-ContribAuthor ">Waldemar  Wysocki</span>, <span class="hlFld-ContribAuthor ">Andrzej  Fruziński</span>, <span class="hlFld-ContribAuthor ">Sylwia K.  Król</span>, <span class="hlFld-ContribAuthor ">Aneta  Grabarska</span>, <span class="hlFld-ContribAuthor ">Andrzej  Stepulak</span>, <span class="hlFld-ContribAuthor ">Dariusz  Matosiuk</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of nitroaryl urea derivatives with antiproliferative properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (4)
                                     , 608-618. <a href="https://doi.org/10.3109/14756366.2015.1057716" title="DOI URL">https://doi.org/10.3109/14756366.2015.1057716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2015.1057716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2015.1057716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnitroaryl%252Burea%252Bderivatives%252Bwith%252Bantiproliferative%252Bproperties%26aulast%3DWr%25C3%25B3bel%26aufirst%3DTomasz%2BM.%26date%3D2016%26date%3D2015%26volume%3D31%26issue%3D4%26spage%3D608%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. V.  Koroleva</span>, <span class="hlFld-ContribAuthor ">Zh. I.  Ignatovich</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Sinyutich</span>, <span class="hlFld-ContribAuthor ">K. N.  Gusak</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrimidine derivatives as protein kinases inhibitors. Molecular design, synthesis, and biologic activity. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>52 </em>
                                    (2)
                                     , 139-177. <a href="https://doi.org/10.1134/S1070428016020019" title="DOI URL">https://doi.org/10.1134/S1070428016020019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428016020019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428016020019%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAminopyrimidine%252Bderivatives%252Bas%252Bprotein%252Bkinases%252Binhibitors.%252BMolecular%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbiologic%252Bactivity%26aulast%3DKoroleva%26aufirst%3DE.%2BV.%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D2%26spage%3D139%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Jingxiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Weimin  Gao</span>, <span class="hlFld-ContribAuthor ">Lilei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanqiu  Pan</span>, <span class="hlFld-ContribAuthor ">Shuwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonghua  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2015,</strong> <em>16 </em>
                                    (12)
                                     , 9314-9340. <a href="https://doi.org/10.3390/ijms16059314" title="DOI URL">https://doi.org/10.3390/ijms16059314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms16059314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms16059314%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DInsights%252Bon%252BStructural%252BCharacteristics%252Band%252BLigand%252BBinding%252BMechanisms%252Bof%252BCDK2%26aulast%3DLi%26aufirst%3DYan%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D12%26spage%3D9314%26epage%3D9340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karunakar  Tanneeru</span>, <span class="hlFld-ContribAuthor ">Ashok Raja  Balla</span>, <span class="hlFld-ContribAuthor ">Lalitha  Guruprasad</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              3D structure modeling and inhibitor binding studies of human male germ cell-associated kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2015,</strong> <em>33 </em>
                                    (8)
                                     , 1710-1719. <a href="https://doi.org/10.1080/07391102.2014.968622" title="DOI URL">https://doi.org/10.1080/07391102.2014.968622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2014.968622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2014.968622%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252B3D%252Bstructure%252Bmodeling%252Band%252Binhibitor%252Bbinding%252Bstudies%252Bof%252Bhuman%252Bmale%252Bgerm%252Bcell-associated%252Bkinase%26aulast%3DTanneeru%26aufirst%3DKarunakar%26date%3D2015%26date%3D2014%26volume%3D33%26issue%3D8%26spage%3D1710%26epage%3D1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marion  Peyressatre</span>, <span class="hlFld-ContribAuthor ">Camille  Prével</span>, <span class="hlFld-ContribAuthor ">Morgan  Pellerano</span>, <span class="hlFld-ContribAuthor ">May  Morris</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2015,</strong> <em>7 </em>
                                    (1)
                                     , 179-237. <a href="https://doi.org/10.3390/cancers7010179" title="DOI URL">https://doi.org/10.3390/cancers7010179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers7010179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers7010179%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252BCyclin-Dependent%252BKinases%252Bin%252BHuman%252BCancers%25253A%252BFrom%252BSmall%252BMolecules%252Bto%252BPeptide%252BInhibitors%26aulast%3DPeyressatre%26aufirst%3DMarion%26date%3D2015%26date%3D2015%26volume%3D7%26issue%3D1%26spage%3D179%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frankie  Lam</span>, <span class="hlFld-ContribAuthor ">Abdullahi Y.  Abbas</span>, <span class="hlFld-ContribAuthor ">Hao  Shao</span>, <span class="hlFld-ContribAuthor ">Theodosia  Teo</span>, <span class="hlFld-ContribAuthor ">Julian  Adams</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Tracey D.  Bradshaw</span>, <span class="hlFld-ContribAuthor ">Peter M.  Fischer</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Walsby</span>, <span class="hlFld-ContribAuthor ">Chris  Pepper</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2014,</strong> <em>5 </em>
                                    (17)
                                     , 7691-7704. <a href="https://doi.org/10.18632/oncotarget.2296" title="DOI URL">https://doi.org/10.18632/oncotarget.2296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.2296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.2296%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DTargeting%252BRNA%252Btranscription%252Band%252Btranslation%252Bin%252Bovarian%252Bcancer%252Bcells%252Bwith%252Bpharmacological%252Binhibitor%252BCDKI-73%26aulast%3DLam%26aufirst%3DFrankie%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D17%26spage%3D7691%26epage%3D7704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junxia  Zheng</span>, <span class="hlFld-ContribAuthor ">Hao  Kong</span>, <span class="hlFld-ContribAuthor ">James M.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jialiang  Guo</span>, <span class="hlFld-ContribAuthor ">Yiqun  Chang</span>, <span class="hlFld-ContribAuthor ">Mengjia  Yang</span>, <span class="hlFld-ContribAuthor ">Gaokeng  Xiao</span>, <span class="hlFld-ContribAuthor ">Pinghua  Sun</span>, . </span><span class="cited-content_cbyCitation_article-title">Insight into the Interactions between Novel Isoquinolin-1,3-Dione Derivatives and Cyclin-Dependent Kinase 4 Combining QSAR and Molecular Docking. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (4)
                                     , e93704. <a href="https://doi.org/10.1371/journal.pone.0093704" title="DOI URL">https://doi.org/10.1371/journal.pone.0093704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0093704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0093704%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DInsight%252Binto%252Bthe%252BInteractions%252Bbetween%252BNovel%252BIsoquinolin-1%25252C3-Dione%252BDerivatives%252Band%252BCyclin-Dependent%252BKinase%252B4%252BCombining%252BQSAR%252Band%252BMolecular%252BDocking%26aulast%3DZheng%26aufirst%3DJunxia%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3De93704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sangaraiah  Nagarajan</span>, <span class="hlFld-ContribAuthor ">Poovan  Shanmugavelan</span>, <span class="hlFld-ContribAuthor ">Murugan  Sathishkumar</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Selvi</span>, <span class="hlFld-ContribAuthor ">Alagusundaram  Ponnuswamy</span>, <span class="hlFld-ContribAuthor ">Hariharan  Harikrishnan</span>, <span class="hlFld-ContribAuthor ">Vellasamy  Shanmugaiah</span>. </span><span class="cited-content_cbyCitation_article-title">An eco-friendly water mediated synthesis of 1,2,3-triazolyl-2-aminopyrimidine hybrids as highly potent anti-bacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2014,</strong> <em>25 </em>
                                    (3)
                                     , 419-422. <a href="https://doi.org/10.1016/j.cclet.2013.12.017" title="DOI URL">https://doi.org/10.1016/j.cclet.2013.12.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2013.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2013.12.017%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DAn%252Beco-friendly%252Bwater%252Bmediated%252Bsynthesis%252Bof%252B1%25252C2%25252C3-triazolyl-2-aminopyrimidine%252Bhybrids%252Bas%252Bhighly%252Bpotent%252Banti-bacterial%252Bagents%26aulast%3DNagarajan%26aufirst%3DSangaraiah%26date%3D2014%26volume%3D25%26issue%3D3%26spage%3D419%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongqi  Deng</span>, <span class="hlFld-ContribAuthor ">Gerald W.  Shipps</span>, <span class="hlFld-ContribAuthor ">Lianyun  Zhao</span>, <span class="hlFld-ContribAuthor ">M. Arshad  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Janeta  Popovici-Muller</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Curran</span>, <span class="hlFld-ContribAuthor ">Jose S.  Duca</span>, <span class="hlFld-ContribAuthor ">Alan W.  Hruza</span>, <span class="hlFld-ContribAuthor ">Thierry O.  Fischmann</span>, <span class="hlFld-ContribAuthor ">Vincent S.  Madison</span>, <span class="hlFld-ContribAuthor ">Rumin  Zhang</span>, <span class="hlFld-ContribAuthor ">Charles W.  McNemar</span>, <span class="hlFld-ContribAuthor ">Todd W.  Mayhood</span>, <span class="hlFld-ContribAuthor ">Rosalinda  Syto</span>, <span class="hlFld-ContribAuthor ">Allen  Annis</span>, <span class="hlFld-ContribAuthor ">Paul  Kirschmeier</span>, <span class="hlFld-ContribAuthor ">Emma M.  Lees</span>, <span class="hlFld-ContribAuthor ">David A.  Parry</span>, <span class="hlFld-ContribAuthor ">William T.  Windsor</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 199-203. <a href="https://doi.org/10.1016/j.bmcl.2013.11.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.11.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.11.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DModulating%252Bthe%252Binteraction%252Bbetween%252BCDK2%252Band%252Bcyclin%252BA%252Bwith%252Ba%252Bquinoline-based%252Binhibitor%26aulast%3DDeng%26aufirst%3DYongqi%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D199%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdulilah  Ece</span>, <span class="hlFld-ContribAuthor ">Fatma  Sevin</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of potential cyclin A/CDK2 inhibitors: a combination of 3D QSAR pharmacophore modeling, virtual screening, and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (12)
                                     , 5832-5843. <a href="https://doi.org/10.1007/s00044-013-0571-y" title="DOI URL">https://doi.org/10.1007/s00044-013-0571-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0571-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0571-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DThe%252Bdiscovery%252Bof%252Bpotential%252Bcyclin%252BA%25252FCDK2%252Binhibitors%25253A%252Ba%252Bcombination%252Bof%252B3D%252BQSAR%252Bpharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%25252C%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DEce%26aufirst%3DAbdulilah%26date%3D2013%26date%3D2013%26volume%3D22%26issue%3D12%26spage%3D5832%26epage%3D5843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James S.  Blachly</span>, <span class="hlFld-ContribAuthor ">John C.  Byrd</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging drug profile: cyclin-dependent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Leukemia & Lymphoma</span><span> <strong>2013,</strong> <em>54 </em>
                                    (10)
                                     , 2133-2143. <a href="https://doi.org/10.3109/10428194.2013.783911" title="DOI URL">https://doi.org/10.3109/10428194.2013.783911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/10428194.2013.783911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F10428194.2013.783911%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%2520%2526%2520Lymphoma%26atitle%3DEmerging%252Bdrug%252Bprofile%25253A%252Bcyclin-dependent%252Bkinase%252Binhibitors%26aulast%3DBlachly%26aufirst%3DJames%2BS.%26date%3D2013%26date%3D2013%26volume%3D54%26issue%3D10%26spage%3D2133%26epage%3D2143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rupa R.  Sawant</span>, <span class="hlFld-ContribAuthor ">Aditi M.  Jhaveri</span>, <span class="hlFld-ContribAuthor ">Alexander  Koshkaryev</span>, <span class="hlFld-ContribAuthor ">Farooq  Qureshi</span>, <span class="hlFld-ContribAuthor ">Vladimir P.  Torchilin</span>. </span><span class="cited-content_cbyCitation_article-title">The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2013,</strong> <em>21 </em>
                                    (7)
                                     , 630-638. <a href="https://doi.org/10.3109/1061186X.2013.789032" title="DOI URL">https://doi.org/10.3109/1061186X.2013.789032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/1061186X.2013.789032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F1061186X.2013.789032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DThe%252Beffect%252Bof%252Bdual%252Bligand-targeted%252Bmicelles%252Bon%252Bthe%252Bdelivery%252Band%252Befficacy%252Bof%252Bpoorly%252Bsoluble%252Bdrug%252Bfor%252Bcancer%252Btherapy%26aulast%3DSawant%26aufirst%3DRupa%2BR.%26date%3D2013%26date%3D2013%26volume%3D21%26issue%3D7%26spage%3D630%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">MONIKA  GUPTA</span>, <span class="hlFld-ContribAuthor ">A K  MADAN</span>. </span><span class="cited-content_cbyCitation_article-title">Diverse models for the prediction of CDK4 inhibitory activity of substituted 4-aminomethylene isoquinoline-1, 3-diones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Sciences</span><span> <strong>2013,</strong> <em>125 </em>
                                    (3)
                                     , 483-493. <a href="https://doi.org/10.1007/s12039-013-0410-1" title="DOI URL">https://doi.org/10.1007/s12039-013-0410-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12039-013-0410-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12039-013-0410-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Sciences%26atitle%3DDiverse%252Bmodels%252Bfor%252Bthe%252Bprediction%252Bof%252BCDK4%252Binhibitory%252Bactivity%252Bof%252Bsubstituted%252B4-aminomethylene%252Bisoquinoline-1%25252C%252B3-diones%26aulast%3DGUPTA%26aufirst%3DMONIKA%26date%3D2013%26date%3D2013%26volume%3D125%26issue%3D3%26spage%3D483%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Weimin  Gao</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Jinghui  Wang</span>, <span class="hlFld-ContribAuthor ">Jingxiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinfeng  Yang</span>, <span class="hlFld-ContribAuthor ">Shuwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2013,</strong> <em>9 </em>
                                    (9)
                                     , 2266. <a href="https://doi.org/10.1039/c3mb70186g" title="DOI URL">https://doi.org/10.1039/c3mb70186g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3mb70186g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3mb70186g%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DAn%252Bin%252Bsilico%252Bexploration%252Bof%252Bthe%252Binteraction%252Bmechanism%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Btype%252BCDK2%252Binhibitors%26aulast%3DLi%26aufirst%3DYan%26date%3D2013%26volume%3D9%26issue%3D9%26spage%3D2266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sereina  Riniker</span>, <span class="hlFld-ContribAuthor ">Luzi J.  Barandun</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>, <span class="hlFld-ContribAuthor ">Oliver  Krämer</span>, <span class="hlFld-ContribAuthor ">Andreas  Steffen</span>, <span class="hlFld-ContribAuthor ">Wilfred F.  van Gunsteren</span>. </span><span class="cited-content_cbyCitation_article-title">Free enthalpies of replacing water molecules in protein binding pockets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2012,</strong> <em>26 </em>
                                    (12)
                                     , 1293-1309. <a href="https://doi.org/10.1007/s10822-012-9620-8" title="DOI URL">https://doi.org/10.1007/s10822-012-9620-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-012-9620-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-012-9620-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DFree%252Benthalpies%252Bof%252Breplacing%252Bwater%252Bmolecules%252Bin%252Bprotein%252Bbinding%252Bpockets%26aulast%3DRiniker%26aufirst%3DSereina%26date%3D2012%26date%3D2012%26volume%3D26%26issue%3D12%26spage%3D1293%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ariamala  Gopalsamy</span>, <span class="hlFld-ContribAuthor ">Eric M.  Bennett</span>, <span class="hlFld-ContribAuthor ">Mengxiao  Shi</span>, <span class="hlFld-ContribAuthor ">Wei-Guo  Zhang</span>, <span class="hlFld-ContribAuthor ">Joel  Bard</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of pyrimidine derivatives as hSMG-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (21)
                                     , 6636-6641. <a href="https://doi.org/10.1016/j.bmcl.2012.08.107" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.08.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.08.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.08.107%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bpyrimidine%252Bderivatives%252Bas%252BhSMG-1%252Binhibitors%26aulast%3DGopalsamy%26aufirst%3DAriamala%26date%3D2012%26volume%3D22%26issue%3D21%26spage%3D6636%26epage%3D6641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mujahid Hussain  Bukhari</span>, <span class="hlFld-ContribAuthor ">Hamid Latif  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Matloob  Ahmad</span>, <span class="hlFld-ContribAuthor ">Tanvir  Hussain</span>, <span class="hlFld-ContribAuthor ">Mark G.  Moloney</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anti-bacterial activities of some novel pyrazolobenzothiazine-based chalcones and their pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2012,</strong> <em>21 </em>
                                    (10)
                                     , 2885-2895. <a href="https://doi.org/10.1007/s00044-011-9820-0" title="DOI URL">https://doi.org/10.1007/s00044-011-9820-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-011-9820-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-011-9820-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Banti-bacterial%252Bactivities%252Bof%252Bsome%252Bnovel%252Bpyrazolobenzothiazine-based%252Bchalcones%252Band%252Btheir%252Bpyrimidine%252Bderivatives%26aulast%3DBukhari%26aufirst%3DMujahid%2BHussain%26date%3D2012%26date%3D2011%26volume%3D21%26issue%3D10%26spage%3D2885%26epage%3D2895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jingying  Yan</span>, <span class="hlFld-ContribAuthor ">Lilin  Du</span>, <span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Shufang  Huang</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore identification, docking and “in silico” screening for novel CDK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2012,</strong> <em>37 </em>, 77-86. <a href="https://doi.org/10.1016/j.jmgm.2012.04.003" title="DOI URL">https://doi.org/10.1016/j.jmgm.2012.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2012.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2012.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPharmacophore%252Bidentification%25252C%252Bdocking%252Band%252B%2525E2%252580%25259Cin%252Bsilico%2525E2%252580%25259D%252Bscreening%252Bfor%252Bnovel%252BCDK1%252Binhibitors%26aulast%3DDong%26aufirst%3DXiaowu%26date%3D2012%26volume%3D37%26spage%3D77%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JM  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-angiogenic effects of water extract of a formula consisting of Pulsatilla koreana, Panax ginseng and Glycyrrhiza uralensis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chinese Integrative Medicine</span><span> <strong>2011,</strong> <em>9 </em>
                                    (9)
                                     , 1005-1013. <a href="https://doi.org/10.3736/jcim20110912" title="DOI URL">https://doi.org/10.3736/jcim20110912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3736/jcim20110912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3736%2Fjcim20110912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chinese%2520Integrative%2520Medicine%26atitle%3DAnti-angiogenic%252Beffects%252Bof%252Bwater%252Bextract%252Bof%252Ba%252Bformula%252Bconsisting%252Bof%252BPulsatilla%252Bkoreana%25252C%252BPanax%252Bginseng%252Band%252BGlycyrrhiza%252Buralensis%26aulast%3DKim%26aufirst%3DJM%26date%3D2011%26volume%3D9%26issue%3D9%26spage%3D1005%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangfang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Ma</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Shanna  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhengtao  Xiao</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonghua  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2011,</strong> <em>30 </em>, 67-81. <a href="https://doi.org/10.1016/j.jmgm.2011.06.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2011.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2011.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DDevelopment%252Bof%252Bin%252Bsilico%252Bmodels%252Bfor%252Bpyrazoles%252Band%252Bpyrimidine%252Bderivatives%252Bas%252Bcyclin-dependent%252Bkinase%252B2%252Binhibitors%26aulast%3DWang%26aufirst%3DFangfang%26date%3D2011%26volume%3D30%26spage%3D67%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karine A.  Cohen-Solal</span>, <span class="hlFld-ContribAuthor ">Kim T.  Merrigan</span>, <span class="hlFld-ContribAuthor ">Joseph L.-K.  Chan</span>, <span class="hlFld-ContribAuthor ">James S.  Goydos</span>, <span class="hlFld-ContribAuthor ">Wenjin  Chen</span>, <span class="hlFld-ContribAuthor ">David J.  Foran</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Ahmed  Lasfar</span>, <span class="hlFld-ContribAuthor ">Michael  Reiss</span>. </span><span class="cited-content_cbyCitation_article-title">Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition. </span><span class="cited-content_cbyCitation_journal-name">Pigment Cell & Melanoma Research</span><span> <strong>2011,</strong> <em>24 </em>
                                    (3)
                                     , 512-524. <a href="https://doi.org/10.1111/j.1755-148X.2011.00858.x" title="DOI URL">https://doi.org/10.1111/j.1755-148X.2011.00858.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1755-148X.2011.00858.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1755-148X.2011.00858.x%26sid%3Dliteratum%253Aachs%26jtitle%3DPigment%2520Cell%2520%2526%2520Melanoma%2520Research%26atitle%3DConstitutive%252BSmad%252Blinker%252Bphosphorylation%252Bin%252Bmelanoma%25253A%252Ba%252Bmechanism%252Bof%252Bresistance%252Bto%252Btransforming%252Bgrowth%252Bfactor-%2525CE%2525B2-mediated%252Bgrowth%252Binhibition%26aulast%3DCohen-Solal%26aufirst%3DKarine%2BA.%26date%3D2011%26date%3D2011%26volume%3D24%26issue%3D3%26spage%3D512%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joe B.  Perales</span>, <span class="hlFld-ContribAuthor ">Jennifer  Freeman</span>, <span class="hlFld-ContribAuthor ">Cyrus J.  Bacchi</span>, <span class="hlFld-ContribAuthor ">Tana  Bowling</span>, <span class="hlFld-ContribAuthor ">Robert  Don</span>, <span class="hlFld-ContribAuthor ">Eric  Gaukel</span>, <span class="hlFld-ContribAuthor ">Luke  Mercer</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Moore III</span>, <span class="hlFld-ContribAuthor ">Bakela  Nare</span>, <span class="hlFld-ContribAuthor ">Tien M.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Robert A.  Noe</span>, <span class="hlFld-ContribAuthor ">Ryan  Randolph</span>, <span class="hlFld-ContribAuthor ">Cindy  Rewerts</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Wring</span>, <span class="hlFld-ContribAuthor ">Nigel  Yarlett</span>, <span class="hlFld-ContribAuthor ">Robert T.  Jacobs</span>. </span><span class="cited-content_cbyCitation_article-title">SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (10)
                                     , 2816-2819. <a href="https://doi.org/10.1016/j.bmcl.2011.03.097" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.03.097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.03.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.03.097%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Bof%252B2-amino%252Band%252B2%25252C4-diamino%252Bpyrimidines%252Bwith%252Bin%252Bvivo%252Befficacy%252Bagainst%252BTrypanosoma%252Bbrucei%26aulast%3DPerales%26aufirst%3DJoe%2BB.%26date%3D2011%26volume%3D21%26issue%3D10%26spage%3D2816%26epage%3D2819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  Dobeš</span>, <span class="hlFld-ContribAuthor ">Jindřich  Fanfrlík</span>, <span class="hlFld-ContribAuthor ">Jan  Řezáč</span>, <span class="hlFld-ContribAuthor ">Michal  Otyepka</span>, <span class="hlFld-ContribAuthor ">Pavel  Hobza</span>. </span><span class="cited-content_cbyCitation_article-title">Transferable scoring function based on semiempirical quantum mechanical PM6-DH2 method: CDK2 with 15 structurally diverse inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2011,</strong> <em>25 </em>
                                    (3)
                                     , 223-235. <a href="https://doi.org/10.1007/s10822-011-9413-5" title="DOI URL">https://doi.org/10.1007/s10822-011-9413-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-011-9413-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-011-9413-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DTransferable%252Bscoring%252Bfunction%252Bbased%252Bon%252Bsemiempirical%252Bquantum%252Bmechanical%252BPM6-DH2%252Bmethod%25253A%252BCDK2%252Bwith%252B15%252Bstructurally%252Bdiverse%252Binhibitors%26aulast%3DDobe%25C5%25A1%26aufirst%3DPetr%26date%3D2011%26date%3D2011%26volume%3D25%26issue%3D3%26spage%3D223%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke  Mercer</span>, <span class="hlFld-ContribAuthor ">Tana  Bowling</span>, <span class="hlFld-ContribAuthor ">Joe  Perales</span>, <span class="hlFld-ContribAuthor ">Jennifer  Freeman</span>, <span class="hlFld-ContribAuthor ">Tien  Nguyen</span>, <span class="hlFld-ContribAuthor ">Cyrus  Bacchi</span>, <span class="hlFld-ContribAuthor ">Nigel  Yarlett</span>, <span class="hlFld-ContribAuthor ">Robert  Don</span>, <span class="hlFld-ContribAuthor ">Robert  Jacobs</span>, <span class="hlFld-ContribAuthor ">Bakela  Nare</span>, . </span><span class="cited-content_cbyCitation_article-title">2,4-Diaminopyrimidines as Potent Inhibitors of Trypanosoma brucei and Identification of Molecular Targets by a Chemical Proteomics Approach. </span><span class="cited-content_cbyCitation_journal-name">PLoS Neglected Tropical Diseases</span><span> <strong>2011,</strong> <em>5 </em>
                                    (2)
                                     , e956. <a href="https://doi.org/10.1371/journal.pntd.0000956" title="DOI URL">https://doi.org/10.1371/journal.pntd.0000956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0000956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0000956%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520Neglected%2520Tropical%2520Diseases%26atitle%3D2%25252C4-Diaminopyrimidines%252Bas%252BPotent%252BInhibitors%252Bof%252BTrypanosoma%252Bbrucei%252Band%252BIdentification%252Bof%252BMolecular%252BTargets%252Bby%252Ba%252BChemical%252BProteomics%252BApproach%26aulast%3DMercer%26aufirst%3DLuke%26date%3D2011%26date%3D2011%26volume%3D5%26issue%3D2%26spage%3De956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Lan</span>, <span class="hlFld-ContribAuthor ">Wan-Na  Chen</span>, <span class="hlFld-ContribAuthor ">Gao-Keng  Xiao</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and docking studies on pyrazolo[4,3-h]qinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (22)
                                     , 6764-6772. <a href="https://doi.org/10.1016/j.bmcl.2010.08.131" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.08.131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.08.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.08.131%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3D-QSAR%252Band%252Bdocking%252Bstudies%252Bon%252Bpyrazolo%25255B4%25252C3-h%25255Dqinazoline-3-carboxamides%252Bas%252Bcyclin-dependent%252Bkinase%252B2%252B%252528CDK2%252529%252Binhibitors%26aulast%3DLan%26aufirst%3DPing%26date%3D2010%26volume%3D20%26issue%3D22%26spage%3D6764%26epage%3D6772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert H.  Bradbury</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors: Approved Drugs and Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 295-344. <a href="https://doi.org/10.1002/0471266949.bmc214" title="DOI URL">https://doi.org/10.1002/0471266949.bmc214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc214%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%25253A%252BApproved%252BDrugs%252Band%252BClinical%252BCandidates%26aulast%3DBradbury%26aufirst%3DRobert%2BH.%26date%3D2010%26date%3D2010%26spage%3D295%26epage%3D344%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Søren M.  Johnson</span>, <span class="hlFld-ContribAuthor ">Chad D.  Torrice</span>, <span class="hlFld-ContribAuthor ">Jessica F.  Bell</span>, <span class="hlFld-ContribAuthor ">Kimberly B.  Monahan</span>, <span class="hlFld-ContribAuthor ">Qi  Jiang</span>, <span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Ramsey</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">Lishan  Su</span>, <span class="hlFld-ContribAuthor ">Daohong  Zhou</span>, <span class="hlFld-ContribAuthor ">Norman E.  Sharpless</span>. </span><span class="cited-content_cbyCitation_article-title">Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2010,</strong> <em>120 </em>
                                    (7)
                                     , 2528-2536. <a href="https://doi.org/10.1172/JCI41402" title="DOI URL">https://doi.org/10.1172/JCI41402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI41402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI41402%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DMitigation%252Bof%252Bhematologic%252Bradiation%252Btoxicity%252Bin%252Bmice%252Bthrough%252Bpharmacological%252Bquiescence%252Binduced%252Bby%252BCDK4%25252F6%252Binhibition%26aulast%3DJohnson%26aufirst%3DS%25C3%25B8ren%2BM.%26date%3D2010%26volume%3D120%26issue%3D7%26spage%3D2528%26epage%3D2536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Pellegatti</span>, <span class="hlFld-ContribAuthor ">Emeline  Vedrenne</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Leger</span>, <span class="hlFld-ContribAuthor ">Christian  Jarry</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">New heteroaromatic aminations on 5-aryl-1,2,4-triazines and 1,2,4,5-tetrazines by palladium catalysis. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2010,</strong> <em>66 </em>
                                    (24)
                                     , 4383-4389. <a href="https://doi.org/10.1016/j.tet.2010.03.099" title="DOI URL">https://doi.org/10.1016/j.tet.2010.03.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2010.03.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2010.03.099%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DNew%252Bheteroaromatic%252Baminations%252Bon%252B5-aryl-1%25252C2%25252C4-triazines%252Band%252B1%25252C2%25252C4%25252C5-tetrazines%252Bby%252Bpalladium%252Bcatalysis%26aulast%3DPellegatti%26aufirst%3DLaurent%26date%3D2010%26volume%3D66%26issue%3D24%26spage%3D4383%26epage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Locatelli</span>, <span class="hlFld-ContribAuthor ">Roberta  Bosotti</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Maria G.  Brasca</span>, <span class="hlFld-ContribAuthor ">Raffaele  Calogero</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Matteo  Bertolotti</span>, <span class="hlFld-ContribAuthor ">Emanuela  Scacheri</span>, <span class="hlFld-ContribAuthor ">Angela  Scaburri</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Thierry  De Baere</span>, <span class="hlFld-ContribAuthor ">Jean-Charles  Soria</span>, <span class="hlFld-ContribAuthor ">Vladimir  Lazar</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2010,</strong> <em>9 </em>
                                    (5)
                                     , 1265-1273. <a href="https://doi.org/10.1158/1535-7163.MCT-09-1163" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-09-1163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-09-1163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-09-1163%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTranscriptional%252BAnalysis%252Bof%252Ban%252BE2F%252BGene%252BSignature%252Bas%252Ba%252BBiomarker%252Bof%252BActivity%252Bof%252Bthe%252BCyclin-Dependent%252BKinase%252BInhibitor%252BPHA-793887%252Bin%252BTumor%252Band%252BSkin%252BBiopsies%252Bfrom%252Ba%252BPhase%252BI%252BClinical%252BStudy%26aulast%3DLocatelli%26aufirst%3DGiuseppe%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D5%26spage%3D1265%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong  Chen</span>, <span class="hlFld-ContribAuthor ">William  Plunkett</span>. </span><span class="cited-content_cbyCitation_article-title">Strategy to induce apoptosis and circumvent resistance in chronic lymphocytic leukaemia. </span><span class="cited-content_cbyCitation_journal-name">Best Practice & Research Clinical Haematology</span><span> <strong>2010,</strong> <em>23 </em>
                                    (1)
                                     , 155-166. <a href="https://doi.org/10.1016/j.beha.2010.01.003" title="DOI URL">https://doi.org/10.1016/j.beha.2010.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.beha.2010.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.beha.2010.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBest%2520Practice%2520%2526%2520Research%2520Clinical%2520Haematology%26atitle%3DStrategy%252Bto%252Binduce%252Bapoptosis%252Band%252Bcircumvent%252Bresistance%252Bin%252Bchronic%252Blymphocytic%252Bleukaemia%26aulast%3DChen%26aufirst%3DRong%26date%3D2010%26volume%3D23%26issue%3D1%26spage%3D155%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Clara  Albanese</span>, <span class="hlFld-ContribAuthor ">Rachele  Alzani</span>, <span class="hlFld-ContribAuthor ">Raffaella  Amici</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">James  Bischoff</span>, <span class="hlFld-ContribAuthor ">Daniela  Borghi</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Valter  Croci</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>, <span class="hlFld-ContribAuthor ">Marcella  Nesi</span>, <span class="hlFld-ContribAuthor ">Paolo  Orsini</span>, <span class="hlFld-ContribAuthor ">Wilma  Pastori</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Paolo  Pevarello</span>, <span class="hlFld-ContribAuthor ">Patrick  Roussel</span>, <span class="hlFld-ContribAuthor ">Mario  Varasi</span>, <span class="hlFld-ContribAuthor ">Daniele  Volpi</span>, <span class="hlFld-ContribAuthor ">Anna  Vulpetti</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2010,</strong> <em>18 </em>
                                    (5)
                                     , 1844-1853. <a href="https://doi.org/10.1016/j.bmc.2010.01.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.01.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.01.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252B6%25252C6-dimethyl%252Bpyrrolo%25255B3%25252C4-c%25255Dpyrazoles%25253A%252BIdentification%252Bof%252BPHA-793887%25252C%252Ba%252Bpotent%252BCDK%252Binhibitor%252Bsuitable%252Bfor%252Bintravenous%252Bdosing%26aulast%3DBrasca%26aufirst%3DMaria%2BGabriella%26date%3D2010%26volume%3D18%26issue%3D5%26spage%3D1844%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria A.  Argiriadi</span>, <span class="hlFld-ContribAuthor ">Anna M.  Ericsson</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Harris</span>, <span class="hlFld-ContribAuthor ">David L.  Banach</span>, <span class="hlFld-ContribAuthor ">David W.  Borhani</span>, <span class="hlFld-ContribAuthor ">David J.  Calderwood</span>, <span class="hlFld-ContribAuthor ">Megan D.  Demers</span>, <span class="hlFld-ContribAuthor ">Jennifer  DiMauro</span>, <span class="hlFld-ContribAuthor ">Richard W.  Dixon</span>, <span class="hlFld-ContribAuthor ">Jennifer  Hardman</span>, <span class="hlFld-ContribAuthor ">Silvia  Kwak</span>, <span class="hlFld-ContribAuthor ">Biqin  Li</span>, <span class="hlFld-ContribAuthor ">John A.  Mankovich</span>, <span class="hlFld-ContribAuthor ">Douglas  Marcotte</span>, <span class="hlFld-ContribAuthor ">Kelly D.  Mullen</span>, <span class="hlFld-ContribAuthor ">Baofu  Ni</span>, <span class="hlFld-ContribAuthor ">M.  Pietras</span>, <span class="hlFld-ContribAuthor ">Ramkrishna  Sadhukhan</span>, <span class="hlFld-ContribAuthor ">Silvino  Sousa</span>, <span class="hlFld-ContribAuthor ">Medha J.  Tomlinson</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Xiang</span>, <span class="hlFld-ContribAuthor ">Robert V.  Talanian</span>. </span><span class="cited-content_cbyCitation_article-title">2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (1)
                                     , 330-333. <a href="https://doi.org/10.1016/j.bmcl.2009.10.102" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.10.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.10.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2%25252C4-Diaminopyrimidine%252BMK2%252Binhibitors.%252BPart%252BI%25253A%252BObservation%252Bof%252Ban%252Bunexpected%252Binhibitor%252Bbinding%252Bmode%26aulast%3DArgiriadi%26aufirst%3DMaria%2BA.%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D330%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline  Courme</span>, <span class="hlFld-ContribAuthor ">Nohad  Gresh</span>, <span class="hlFld-ContribAuthor ">Michel  Vidal</span>, <span class="hlFld-ContribAuthor ">Christine  Lenoir</span>, <span class="hlFld-ContribAuthor ">Christiane  Garbay</span>, <span class="hlFld-ContribAuthor ">Jean-Claude  Florent</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Bertounesque</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of aryl phosphates based on pyrimidine and triazine scaffolds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>45 </em>
                                    (1)
                                     , 244-255. <a href="https://doi.org/10.1016/j.ejmech.2009.10.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2009.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2009.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2009.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Baryl%252Bphosphates%252Bbased%252Bon%252Bpyrimidine%252Band%252Btriazine%252Bscaffolds%26aulast%3DCourme%26aufirst%3DCaroline%26date%3D2010%26volume%3D45%26issue%3D1%26spage%3D244%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Józefa  Węsierska-Gądek</span>, <span class="hlFld-ContribAuthor ">Ivo  Chamrád</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">Novel potent pharmacological cyclin-dependent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2009,</strong> <em>1 </em>
                                    (9)
                                     , 1561-1581. <a href="https://doi.org/10.4155/fmc.09.110" title="DOI URL">https://doi.org/10.4155/fmc.09.110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.09.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.09.110%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bpotent%252Bpharmacological%252Bcyclin-dependent%252Bkinase%252Binhibitors%26aulast%3DW%25C4%2599sierska-G%25C4%2585dek%26aufirst%3DJ%25C3%25B3zefa%26date%3D2009%26volume%3D1%26issue%3D9%26spage%3D1561%26epage%3D1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José S  Duca</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances on structure-informed drug discovery of cyclin-dependent kinase-2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2009,</strong> <em>1 </em>
                                    (8)
                                     , 1453-1466. <a href="https://doi.org/10.4155/fmc.09.102" title="DOI URL">https://doi.org/10.4155/fmc.09.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.09.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.09.102%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bon%252Bstructure-informed%252Bdrug%252Bdiscovery%252Bof%252Bcyclin-dependent%252Bkinase-2%252Binhibitors%26aulast%3DDuca%26aufirst%3DJos%25C3%25A9%2BS%26date%3D2009%26volume%3D1%26issue%3D8%26spage%3D1453%26epage%3D1466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. A.  Aly</span>. </span><span class="cited-content_cbyCitation_article-title">Ethyl {4-[2-(saccharin-2-yl)acetylsulfamoyl]phenylazo}cyanoacetate in the synthesis of polyfunctionally heteroaromatic derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2009,</strong> <em>46 </em>
                                    (5)
                                     , 895-902. <a href="https://doi.org/10.1002/jhet.176" title="DOI URL">https://doi.org/10.1002/jhet.176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.176%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DEthyl%252B%25257B4-%25255B2-%252528saccharin-2-yl%252529acetylsulfamoyl%25255Dphenylazo%25257Dcyanoacetate%252Bin%252Bthe%252Bsynthesis%252Bof%252Bpolyfunctionally%252Bheteroaromatic%252Bderivatives%26aulast%3DAly%26aufirst%3DA.%2BA.%26date%3D2009%26volume%3D46%26issue%3D5%26spage%3D895%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Windy  Berkofsky-Fessler</span>, <span class="hlFld-ContribAuthor ">Tri Q.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Paul  Delmar</span>, <span class="hlFld-ContribAuthor ">Juliette  Molnos</span>, <span class="hlFld-ContribAuthor ">Charu  Kanwal</span>, <span class="hlFld-ContribAuthor ">Wanda  DePinto</span>, <span class="hlFld-ContribAuthor ">James  Rosinski</span>, <span class="hlFld-ContribAuthor ">Patricia  McLoughlin</span>, <span class="hlFld-ContribAuthor ">Steve  Ritland</span>, <span class="hlFld-ContribAuthor ">Mark  DeMario</span>, <span class="hlFld-ContribAuthor ">Krishna  Tobon</span>, <span class="hlFld-ContribAuthor ">John F.  Reidhaar-Olson</span>, <span class="hlFld-ContribAuthor ">Ruediger  Rueger</span>, <span class="hlFld-ContribAuthor ">Holly  Hilton</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2009,</strong> <em>8 </em>
                                    (9)
                                     , 2517-2525. <a href="https://doi.org/10.1158/1535-7163.MCT-09-0083" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-09-0083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-09-0083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-09-0083%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DPreclinical%252Bbiomarkers%252Bfor%252Ba%252Bcyclin-dependent%252Bkinase%252Binhibitor%252Btranslate%252Bto%252Bcandidate%252Bpharmacodynamic%252Bbiomarkers%252Bin%252Bphase%252BI%252Bpatients%26aulast%3DBerkofsky-Fessler%26aufirst%3DWindy%26date%3D2009%26date%3D2009%26volume%3D8%26issue%3D9%26spage%3D2517%26epage%3D2525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>, <span class="hlFld-ContribAuthor ">Ivo  Chamrád</span>, <span class="hlFld-ContribAuthor ">Radek  Jorda,</span>, <span class="hlFld-ContribAuthor ">Jiří  Kohoutek</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological targeting of CDK9 in cardiac hypertrophy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2009,</strong> <em>6 </em>, n/a-n/a. <a href="https://doi.org/10.1002/med.20172" title="DOI URL">https://doi.org/10.1002/med.20172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20172%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DPharmacological%252Btargeting%252Bof%252BCDK9%252Bin%252Bcardiac%252Bhypertrophy%26aulast%3DKrys%25CC%258Ctof%26aufirst%3DVladim%25C3%25ADr%26date%3D2009%26volume%3D6%26spage%3Dn%252Fa%26epage%3Dn%252Fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>, <span class="hlFld-ContribAuthor ">Maurizio  Botta</span>. </span><span class="cited-content_cbyCitation_article-title">Recent highlights in the synthesis of highly functionalized pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2009,</strong> <em>7 </em>
                                    (14)
                                     , 2841. <a href="https://doi.org/10.1039/b906445a" title="DOI URL">https://doi.org/10.1039/b906445a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b906445a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb906445a%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRecent%252Bhighlights%252Bin%252Bthe%252Bsynthesis%252Bof%252Bhighly%252Bfunctionalized%252Bpyrimidines%26aulast%3DRadi%26aufirst%3DMarco%26date%3D2009%26volume%3D7%26issue%3D14%26spage%3D2841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thimma  Rawalpally</span>, <span class="hlFld-ContribAuthor ">Yaohui  Ji</span>, <span class="hlFld-ContribAuthor ">Ashish  Shankar</span>, <span class="hlFld-ContribAuthor ">William  Edwards</span>, <span class="hlFld-ContribAuthor ">Joshua  Allen</span>, <span class="hlFld-ContribAuthor ">Yong  Jiang</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Cleary</span>, <span class="hlFld-ContribAuthor ">Michael E.  Pierce</span>. </span><span class="cited-content_cbyCitation_article-title">A Practical Method For Stabilizing Lithiated Halogenated Aromatic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2008,</strong> <em>12 </em>
                                    (6)
                                     , 1293-1298. <a href="https://doi.org/10.1021/op8001596" title="DOI URL">https://doi.org/10.1021/op8001596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op8001596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop8001596%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DA%252BPractical%252BMethod%252BFor%252BStabilizing%252BLithiated%252BHalogenated%252BAromatic%252BCompounds%26aulast%3DRawalpally%26aufirst%3DThimma%26date%3D2008%26date%3D2008%26volume%3D12%26issue%3D6%26spage%3D1293%26epage%3D1298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Zou</span>, <span class="hlFld-ContribAuthor ">Huan-Zhang  Xie</span>, <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>, <span class="hlFld-ContribAuthor ">Jin-Juan  Chen</span>, <span class="hlFld-ContribAuthor ">Ji-Xia  Ren</span>, <span class="hlFld-ContribAuthor ">Yu-Quan  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2008,</strong> <em>27 </em>
                                    (4)
                                     , 430-438. <a href="https://doi.org/10.1016/j.jmgm.2008.07.004" title="DOI URL">https://doi.org/10.1016/j.jmgm.2008.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2008.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2008.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DTowards%252Bmore%252Baccurate%252Bpharmacophore%252Bmodeling%25253A%252BMulticomplex-based%252Bcomprehensive%252Bpharmacophore%252Bmap%252Band%252Bmost-frequent-feature%252Bpharmacophore%252Bmodel%252Bof%252BCDK2%26aulast%3DZou%26aufirst%3DJun%26date%3D2008%26volume%3D27%26issue%3D4%26spage%3D430%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulrich  Jacquemard</span>, <span class="hlFld-ContribAuthor ">Nathalie  Dias</span>, <span class="hlFld-ContribAuthor ">Amélie  Lansiaux</span>, <span class="hlFld-ContribAuthor ">Christian  Bailly</span>, <span class="hlFld-ContribAuthor ">Cédric  Logé</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Robert</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2008,</strong> <em>16 </em>
                                    (9)
                                     , 4932-4953. <a href="https://doi.org/10.1016/j.bmc.2008.03.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2008.03.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2008.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2008.03.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252B3%25252C5-bis%2525282-indolyl%252529pyridine%252Band%252B3-%25255B%2525282-indolyl%252529-5-phenyl%25255Dpyridine%252Bderivatives%252Bas%252BCDK%252Binhibitors%252Band%252Bcytotoxic%252Bagents%26aulast%3DJacquemard%26aufirst%3DUlrich%26date%3D2008%26volume%3D16%26issue%3D9%26spage%3D4932%26epage%3D4953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.W.  Rewcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimidines and their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 117-272. <a href="https://doi.org/10.1016/B978-008044992-0.00702-1" title="DOI URL">https://doi.org/10.1016/B978-008044992-0.00702-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-008044992-0.00702-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-008044992-0.00702-1%26sid%3Dliteratum%253Aachs%26atitle%3DPyrimidines%252Band%252Btheir%252BBenzo%252BDerivatives%26aulast%3DRewcastle%26aufirst%3DG.W.%26date%3D2008%26spage%3D117%26epage%3D272%26pub%3DElsevier%26atitle%3DComprehensive%252BHeterocyclic%252BChemistry%252BIII%26date%3D2008%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcos  Malumbres</span>, <span class="hlFld-ContribAuthor ">Paolo  Pevarello</span>, <span class="hlFld-ContribAuthor ">Mariano  Barbacid</span>, <span class="hlFld-ContribAuthor ">James R.  Bischoff</span>. </span><span class="cited-content_cbyCitation_article-title">CDK inhibitors in cancer therapy: what is next?. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2008,</strong> <em>29 </em>
                                    (1)
                                     , 16-21. <a href="https://doi.org/10.1016/j.tips.2007.10.012" title="DOI URL">https://doi.org/10.1016/j.tips.2007.10.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2007.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2007.10.012%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DCDK%252Binhibitors%252Bin%252Bcancer%252Btherapy%25253A%252Bwhat%252Bis%252Bnext%25253F%26aulast%3DMalumbres%26aufirst%3DMarcos%26date%3D2008%26volume%3D29%26issue%3D1%26spage%3D16%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael P.  Dwyer</span>, <span class="hlFld-ContribAuthor ">Kamil  Paruch</span>, <span class="hlFld-ContribAuthor ">Carmen  Alvarez</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Doll</span>, <span class="hlFld-ContribAuthor ">Kerry  Keertikar</span>, <span class="hlFld-ContribAuthor ">Jose  Duca</span>, <span class="hlFld-ContribAuthor ">Thierry O.  Fischmann</span>, <span class="hlFld-ContribAuthor ">Alan  Hruza</span>, <span class="hlFld-ContribAuthor ">Vincent  Madison</span>, <span class="hlFld-ContribAuthor ">Emma  Lees</span>, <span class="hlFld-ContribAuthor ">David  Parry</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Seghezzi</span>, <span class="hlFld-ContribAuthor ">Nicole  Sgambellone</span>, <span class="hlFld-ContribAuthor ">Frances  Shanahan</span>, <span class="hlFld-ContribAuthor ">Derek  Wiswell</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Guzi</span>. </span><span class="cited-content_cbyCitation_article-title">Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2007,</strong> <em>17 </em>
                                    (22)
                                     , 6216-6219. <a href="https://doi.org/10.1016/j.bmcl.2007.09.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.09.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.09.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVersatile%252Btemplates%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnovel%252Bkinase%252Binhibitors%25253A%252BDiscovery%252Bof%252Bnovel%252BCDK%252Binhibitors%26aulast%3DDwyer%26aufirst%3DMichael%2BP.%26date%3D2007%26volume%3D17%26issue%3D22%26spage%3D6216%26epage%3D6219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronghui  Lin</span>, <span class="hlFld-ContribAuthor ">Peter J.  Connolly</span>, <span class="hlFld-ContribAuthor ">Yanhua  Lu</span>, <span class="hlFld-ContribAuthor ">George  Chiu</span>, <span class="hlFld-ContribAuthor ">Shengjian  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Shenlin  Huang</span>, <span class="hlFld-ContribAuthor ">Xun  Li</span>, <span class="hlFld-ContribAuthor ">Stuart L.  Emanuel</span>, <span class="hlFld-ContribAuthor ">Steven A.  Middleton</span>, <span class="hlFld-ContribAuthor ">Robert H.  Gruninger</span>, <span class="hlFld-ContribAuthor ">Mary  Adams</span>, <span class="hlFld-ContribAuthor ">Angel R.  Fuentes-Pesquera</span>, <span class="hlFld-ContribAuthor ">Lee M.  Greenberger</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2007,</strong> <em>17 </em>
                                    (15)
                                     , 4297-4302. <a href="https://doi.org/10.1016/j.bmcl.2007.05.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.05.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.05.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bpyrazolo%25255B3%25252C4-b%25255Dpyridine%252BCDK1%252Binhibitors%252Bas%252Banti-tumor%252Bagents%26aulast%3DLin%26aufirst%3DRonghui%26date%3D2007%26volume%3D17%26issue%3D15%26spage%3D4297%26epage%3D4302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronghui  Lin</span>, <span class="hlFld-ContribAuthor ">George  Chiu</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Peter J.  Connolly</span>, <span class="hlFld-ContribAuthor ">Shengjian  Li</span>, <span class="hlFld-ContribAuthor ">Yanhua  Lu</span>, <span class="hlFld-ContribAuthor ">Mary  Adams</span>, <span class="hlFld-ContribAuthor ">Angel R.  Fuentes-Pesquera</span>, <span class="hlFld-ContribAuthor ">Stuart L.  Emanuel</span>, <span class="hlFld-ContribAuthor ">Lee M.  Greenberger</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2007,</strong> <em>17 </em>
                                    (16)
                                     , 4557-4561. <a href="https://doi.org/10.1016/j.bmcl.2007.05.092" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.05.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.05.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.05.092%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252B3%25252C4-disubstituted%252Bpyrazole%252Banalogues%252Bas%252Banti-tumor%252BCDK%252Binhibitors%26aulast%3DLin%26aufirst%3DRonghui%26date%3D2007%26volume%3D17%26issue%3D16%26spage%3D4557%26epage%3D4561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoqing  Chen</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Nam T.  Le</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhao</span>, <span class="hlFld-ContribAuthor ">Achyutharao  Sidduri</span>, <span class="hlFld-ContribAuthor ">Jian Ping  Lou</span>, <span class="hlFld-ContribAuthor ">Christophe  Michoud</span>, <span class="hlFld-ContribAuthor ">Louis  Portland</span>, <span class="hlFld-ContribAuthor ">Nicole  Jackson</span>, <span class="hlFld-ContribAuthor ">Jin-Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Fred  Konzelmann</span>, <span class="hlFld-ContribAuthor ">Feng  Chi</span>, <span class="hlFld-ContribAuthor ">Christian  Tovar</span>, <span class="hlFld-ContribAuthor ">Qing  Xiang</span>, <span class="hlFld-ContribAuthor ">Yingsi  Chen</span>, <span class="hlFld-ContribAuthor ">Yang  Wen</span>, <span class="hlFld-ContribAuthor ">Lyubomir T.  Vassilev</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2007,</strong> <em>17 </em>
                                    (8)
                                     , 2134-2138. <a href="https://doi.org/10.1016/j.bmcl.2007.01.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.01.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.01.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.01.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bactivity%252Bof%252Bquinolinyl-methylene-thiazolinones%252Bas%252Bpotent%252Band%252Bselective%252Bcyclin-dependent%252Bkinase%252B1%252Binhibitors%26aulast%3DChen%26aufirst%3DShaoqing%26date%3D2007%26volume%3D17%26issue%3D8%26spage%3D2134%26epage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Marchetti</span>, <span class="hlFld-ContribAuthor ">Kerry L.  Sayle</span>, <span class="hlFld-ContribAuthor ">Johanne  Bentley</span>, <span class="hlFld-ContribAuthor ">William  Clegg</span>, <span class="hlFld-ContribAuthor ">Nicola J.  Curtin</span>, <span class="hlFld-ContribAuthor ">Jane A.  Endicott</span>, <span class="hlFld-ContribAuthor ">Bernard T.  Golding</span>, <span class="hlFld-ContribAuthor ">Roger J.  Griffin</span>, <span class="hlFld-ContribAuthor ">Karen  Haggerty</span>, <span class="hlFld-ContribAuthor ">Ross W.  Harrington</span>, <span class="hlFld-ContribAuthor ">Veronique  Mesguiche</span>, <span class="hlFld-ContribAuthor ">David R.  Newell</span>, <span class="hlFld-ContribAuthor ">Martin E. M.  Noble</span>, <span class="hlFld-ContribAuthor ">Rachel J.  Parsons</span>, <span class="hlFld-ContribAuthor ">David J.  Pratt</span>, <span class="hlFld-ContribAuthor ">Lan Z.  Wang</span>, <span class="hlFld-ContribAuthor ">Ian R.  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of 2-arylamino-4-cyclohexylmethoxy-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinase 2. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2007,</strong> <em>5 </em>
                                    (10)
                                     , 1577. <a href="https://doi.org/10.1039/b703241b" title="DOI URL">https://doi.org/10.1039/b703241b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b703241b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb703241b%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Bof%252B2-arylamino-4-cyclohexylmethoxy-5-nitroso-6-aminopyrimidine%252Binhibitors%252Bof%252Bcyclin-dependent%252Bkinase%252B2%26aulast%3DMarchetti%26aufirst%3DFrancesco%26date%3D2007%26volume%3D5%26issue%3D10%26spage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138n00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138n00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138f00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Selected CDK inhibitors flavopiridol (<b>1</b>), roscovitine (<b>2</b>), BMS-387032 (<b>3</b>), and PD0332991 (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138f00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00002.jpeg" id="rightTab-_i7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Generic structures of diaminothiazole <b>5</b> and diaminopyrimidine <b>6</b> as CDK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138h00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138h00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138h00001.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  General Synthesis of 2,4-Diamino-5-ketopyrimidines<sup><i>a</i></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) MeONHMe·HCl, HOBt/HBTU, DiPEA, DMF, rt, 98%; (b) 3−4 equiv of ArLi or ArMgX, THF, −78 °C, 65∼90%; (c) <i>m</i>CPBA, CHCl<sub>3</sub>, 0 °C, 90−98%; (d) i-PrOH, 100−110 °C, microwave, 20 min, >90%.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138h00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138h00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138h00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138h00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138h00002.jpeg" id="rightTab-_i11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.  Synthesis of 4-Piperidinyl Substituted 2,4-Diamino-5-ketopyrimidines<sup><i>a</i></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) i-PrOH, 100∼110 °C, microwave, 20 min, >90%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, >95%; (c) R<sub>3</sub>X, R<sub>3</sub>COCl or R<sub>3</sub>SO<sub>2</sub>Cl, DiPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 90−98%.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138h00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138h00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138f00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00003.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Electrostatic potential maps of diaminopyrimidine (on the left) and diaminothiazole (on the right). An isodensity surface is first obtained for the two molecules, and the surface is then assigned different colors according to their electrostatic potential. The red area denotes a region with the most negative potential and blue areas the most positive. The maps are calculated using Spartan‘02.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138f00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00004.jpeg" id="rightTab-_i15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Overlay of diaminopyrimidine (green) vs diaminothiazole (orange). Distances in angstrom (Å) between the centroids of the two phenyl substituents for each core structure are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138f00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00005.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 The 1.85 Å crystal structure of compound <b>39</b> bound in the ATP binding pocket of CDK2 (no cyclin). Nitrogen atoms are in blue, oxygen atoms in red, sulfur in orange, and fluorine in green, and key hydrogen bonds are depicted. Bridging waters play a crucial role in the enhanced binding of this compound to the enzyme. The figure was made with program PyMOL.<sup><a onclick="showRef(event, 'jm0606138b00033'); return false;" href="javascript:void(0);" class="ref jm0606138b00033">33</a></sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138f00006" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00006.jpeg" id="rightTab-_i22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 6 Mean plasma concentration versus time profiles of selected compounds <b>29</b>, <b>35</b>, and <b>39</b> following oral administration (100 mg/kg) in female athymic nontumor bearing mice. The error bars represent the percent coefficient of variation. The dashed lines A (for <b>35</b>) and B (for <b>39</b>) represent the in vitro IC<sub>90</sub> values of the cell inhibition in the HCT116 cell line (IC<sub>90</sub> = 762 ng/mL and 75 ng/mL for compounds<b> 35</b> and <b>39</b>, respectively):  compound <b>29</b> (open square), compound <b>35</b> (open circle), compound <b>39</b> (filled triangle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0606138f00007" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/medium/jm0606138f00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00007.jpeg" id="rightTab-_i24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 7 Effect of compound <b>39</b> on HCT116 human colorectal tumor xenograft growth. Statistical analysis was determined by the rank sum test and one-way Anova and a post-hoc Bonferroni <i>t</i>-test. * = Statistically significant as compared to the vehicle-treated group, where <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-22/jm0606138/production/images/large/jm0606138f00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0606138&amp;id=jm0606138f00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm004902206560" id="jm004902206560"></a></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm0606138b00001"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00001_1"><span><span class="NLM_string-ref">Morgan, D. O. Cyclin-dependent kinases:  Engines, clocks, and microprocessors. <i>  Annu. Rev. Cell. Dev. Biol.</i><b>1997</b>, <i>13</i>, 261−291.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Morgan%2C+D.+O.+Cyclin-dependent+kinases%3A%E2%80%89+Engines%2C+clocks%2C+and+microprocessors.+Annu.+Rev.+Cell.+Dev.+Biol.+1997%2C+13%2C+261%E2%88%92291.+Morgan%2C+D.+O.+Cyclin-dependent+kinases%3A%E2%80%89+Engines%2C+clocks%2C+and+microprocessors.+Annu.+Rev.+Cell.+Dev.+Biol.1997%2C+13%2C+261%E2%88%92291."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26jtitle%3DAnnu.%2520Rev.%2520Cell.%2520Dev.%2520Biol.%26date%3D1997%26volume%3D13%26spage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00002"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00002_1"><span><span class="NLM_string-ref">Dyson, N. The regulation of E2F by pRB-family proteins. <i>  Genes Dev.</i><b>1998</b>, <i>12</i>, 2245−2262.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=2262&author=N+Dyson&title=The+regulation+of+E2F+by+pRB-family+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDyson%26aufirst%3DN%26atitle%3DThe%2520regulation%2520of%2520E2F%2520by%2520pRB-family%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D2262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00003"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00003_1"><span><span class="NLM_string-ref">Sherr, C. J.; Roberts, J. M. CDK inhibitors:  Positive and negative regulators of G1-phase progression. <i>  Genes Dev.</i><b>1999</b>, <i>13</i>, 1501−1512.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1512&author=C.+J.+Sherr&author=J.+M.+Roberts&title=Positive+and+negative+regulators+of+G1-phase+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26atitle%3DPositive%2520and%2520negative%2520regulators%2520of%2520G1-phase%2520progression%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00004"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00004_1"><span><span class="NLM_string-ref">Malumbres, M.; Barbacid, M. To cycle or not to cycle:  A critical decision in cancer. <i>  Nat. Rev. Cancer</i><b> 2001</b>, <i>1</i>, 222−231.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=231&author=M.+Malumbres&author=M+Barbacid&title=To+cycle+or+not+to+cycle%3A%E2%80%89+A+critical+decision+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DTo%2520cycle%2520or%2520not%2520to%2520cycle%253A%25E2%2580%2589%2520A%2520critical%2520decision%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00005"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00005_1"><span><span class="NLM_string-ref">(a) Fischer, P. M.; Gianella-Borradori, A. Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. <i>  Exp. </i><i>Opin. Invest. Drugs </i><b>2005</b>, <i>14</i>, 457−477.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=477&author=P.+M.+Fischer&author=A+Gianella-Borradori&title=Recent+progress+in+the+discovery+and+development+of+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0606138b00005_2"><span><span class="NLM_string-ref">(b) Fischer, P. M. Cyclin-dependent kinase inhibitors:  Discovery, development and target rationale for different therapeutic applications. <i>  Drugs Future</i><b>2005</b>, <i>30</i>, 911−929.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=929&author=P.+M+Fischer&title=Cyclin-dependent+kinase+inhibitors%3A%E2%80%89+Discovery%2C+development+and+target+rationale+for+different+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00005_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520Discovery%252C%2520development%2520and%2520target%2520rationale%2520for%2520different%2520therapeutic%2520applications%26jtitle%3DDrugs%2520Future%26date%3D2005%26volume%3D30%26spage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00006"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00006_1"><span><span class="NLM_string-ref">Collins, I.; Garrett, M. D. Targeting the cell division cycle in cancer:  CDK and cell cycle checkpoint kinase inhibitors. <i>  Curr. Opin. Pharm.</i><b>2005</b>, <i>5</i>, 366−373.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=373&author=I.+Collins&author=M.+D+Garrett&title=Targeting+the+cell+division+cycle+in+cancer%3A%E2%80%89+CDK+and+cell+cycle+checkpoint+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DTargeting%2520the%2520cell%2520division%2520cycle%2520in%2520cancer%253A%25E2%2580%2589%2520CDK%2520and%2520cell%2520cycle%2520checkpoint%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharm.%26date%3D2005%26volume%3D5%26spage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00007"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00007_1"><span><span class="NLM_string-ref">Kong, N.; Fotouhi, N.; Wovkulich, P. M.; Roberts, J. Cell cycle inhibitors for the treatment of cancer. <i>  Drugs Future</i><b>2003</b>, <i>28</i>, 881−896.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=896&author=N.+Kong&author=N.+Fotouhi&author=P.+M.+Wovkulich&author=J+Roberts&title=Cell+cycle+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DN.%26atitle%3DCell%2520cycle%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DDrugs%2520Future%26date%3D2003%26volume%3D28%26spage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00008"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00008_1"><span><span class="NLM_string-ref">Fischer, P. M.; Gianella-Borradori, A. CDK inhibitors in clinical development for the treatment of cancer. <i>  Exp. Opin. Invest. Drugs</i><b>2003</b>, <i>12</i>, 955−970.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=970&author=P.+M.+Fischer&author=A+Gianella-Borradori&title=CDK+inhibitors+in+clinical+development+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DCDK%2520inhibitors%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00009"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00009_1"><span><span class="NLM_string-ref">Huwe, A.; Mazitschek, R.; Giannis, A. Small molecules as inhibitors of cyclin-dependent kinases. <i>  Angew. Chem. Int. Ed. Engl.</i><b>2003</b>, <i>42</i>, 2122−2138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2138&author=A.+Huwe&author=R.+Mazitschek&author=A+Giannis&title=Small+molecules+as+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuwe%26aufirst%3DA.%26atitle%3DSmall%2520molecules%2520as%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DAngew.%2520Chem.%2520Int.%2520Ed.%2520Engl.%26date%3D2003%26volume%3D42%26spage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm0606138b00010_1"><span><span class="NLM_string-ref">Toogood, P. L. Cyclin-dependent kinase inhibitors for treating cancer. <i>  Med. Res. Rev. </i><b>2001</b>, <i>21</i>, 487−498.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=498&author=P.+L+Toogood&title=Cyclin-dependent+kinase+inhibitors+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%2520for%2520treating%2520cancer%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00011"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00011_1"><span><span class="NLM_string-ref">Fischer, P. M. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors. <i>  Curr. Opin. Drug Dis. </i><i>Dev.</i><b>2001</b>, <i>4</i>, 623−634.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=634&author=P.+M+Fischer&title=Recent+advances+and+new+directions+in+the+discovery+and+development+of+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM%26atitle%3DRecent%2520advances%2520and%2520new%2520directions%2520in%2520the%2520discovery%2520and%2520development%2520of%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Dis.%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00012"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00012_1"><span><span class="NLM_string-ref">Pevarello, P.; Villa, M. Cyclin-dependent kinase inhibitors:  A survey of the recent patent literature. <i>  Expert Opin. Ther. Pat.</i><b>2005</b>, <i>15</i>, 675−703.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=703&author=P.+Pevarello&author=M+Villa&title=Cyclin-dependent+kinase+inhibitors%3A%E2%80%89+A+survey+of+the+recent+patent+literature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26atitle%3DCyclin-dependent%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520A%2520survey%2520of%2520the%2520recent%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2005%26volume%3D15%26spage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00013"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00013_1"><span><span class="NLM_string-ref">Senderowicz, A. M. The cell cycle as a target for cancer therapy:  Basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01. <i>  Oncologist</i><b>2002</b>, <i>7</i>, 12−19.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=19&author=A.+M+Senderowicz&title=The+cell+cycle+as+a+target+for+cancer+therapy%3A%E2%80%89+Basic+and+clinical+findings+with+the+small+molecule+inhibitors+flavopiridol+and+UCN-01"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSenderowicz%26aufirst%3DA.%2BM%26atitle%3DThe%2520cell%2520cycle%2520as%2520a%2520target%2520for%2520cancer%2520therapy%253A%25E2%2580%2589%2520Basic%2520and%2520clinical%2520findings%2520with%2520the%2520small%2520molecule%2520inhibitors%2520flavopiridol%2520and%2520UCN-01%26jtitle%3DOncologist%26date%3D2002%26volume%3D7%26spage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00014"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00014_1"><span><span class="NLM_string-ref">McClue, S. J.; Blake, D.; Clarke, R.; Cowan, A.; Cummings, L.; Fischer, P. M.; MacKenzie, M.; Melville, J.; Stewart, K.; Wang, S.; Zhelev, N.; Zheleva, D.; Lane, D. P. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). <i>  Int. J. Cancer</i><b>2002</b>, <i>102</i>, 463−468.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=468&author=S.+J.+McClue&author=D.+Blake&author=R.+Clarke&author=A.+Cowan&author=L.+Cummings&author=P.+M.+Fischer&author=M.+MacKenzie&author=J.+Melville&author=K.+Stewart&author=S.+Wang&author=N.+Zhelev&author=D.+Zheleva&author=D.+P+Lane&title=In+vitro+and+in+vivo+antitumor+properties+of+the+cyclin+dependent+kinase+inhibitor+CYC202+%28R-roscovitine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcClue%26aufirst%3DS.%2BJ.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520properties%2520of%2520the%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520CYC202%2520%2528R-roscovitine%2529%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2002%26volume%3D102%26spage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00015"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00015_1"><span><span class="NLM_string-ref">Misra, R. N.; Xiao, H.-y.; Kim, K. S.; Lu, S.; Han, W.-C.; Barbosa, S. A.; Hunt, J. T.; Rawlins, D. B.; Shan, W.; Ahmed, S. Z.; Qian, L.; Chen, B.-C.; Zhao, R.; Bednarz, M. S.; Kellar, K. A.; Mulheron, J. G.; Batorsky, R.; Roongta, U.; Kamath, A.; Marathe, P.; Ranadive, S. A.; Sack, J. S.; Tokarski, J. S.; Pavletich, N. P.; Lee, F. Y. F.; Webster, K. R.; Kimball, S. D. <i>  N</i>-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. <i>J. Med. Chem.</i><b>2004</b>, <i>47</i>, 1719−1728.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Misra%2C+R.+N.%3B+Xiao%2C+H.-y.%3B+Kim%2C+K.+S.%3B+Lu%2C+S.%3B+Han%2C+W.-C.%3B+Barbosa%2C+S.+A.%3B+Hunt%2C+J.+T.%3B+Rawlins%2C+D.+B.%3B+Shan%2C+W.%3B+Ahmed%2C+S.+Z.%3B+Qian%2C+L.%3B+Chen%2C+B.-C.%3B+Zhao%2C+R.%3B+Bednarz%2C+M.+S.%3B+Kellar%2C+K.+A.%3B+Mulheron%2C+J.+G.%3B+Batorsky%2C+R.%3B+Roongta%2C+U.%3B+Kamath%2C+A.%3B+Marathe%2C+P.%3B+Ranadive%2C+S.+A.%3B+Sack%2C+J.+S.%3B+Tokarski%2C+J.+S.%3B+Pavletich%2C+N.+P.%3B+Lee%2C+F.+Y.+F.%3B+Webster%2C+K.+R.%3B+Kimball%2C+S.+D.+N-%28Cycloalkylamino%29acyl-2-aminothiazole+inhibitors+of+cyclin-dependent+kinase+2.+N-%5B5-%5B%5B%5B5-%281%2C1-Dimethylethyl%29-2-oxazolyl%5Dmethyl%5Dthio%5D-2-thiazolyl%5D-4-piperidinecarboxamide+%28BMS-387032%29%2C+a+highly+efficacious+and+selective+antitumor+agent.+J.+Med.+Chem.+2004%2C+47%2C+1719%E2%88%921728.+Misra%2C+R.+N.%3B+Xiao%2C+H.-y.%3B+Kim%2C+K.+S.%3B+Lu%2C+S.%3B+Han%2C+W.-C.%3B+Barbosa%2C+S.+A.%3B+Hunt%2C+J.+T.%3B+Rawlins%2C+D.+B.%3B+Shan%2C+W.%3B+Ahmed%2C+S.+Z.%3B+Qian%2C+L.%3B+Chen%2C+B.-C.%3B+Zhao%2C+R.%3B+Bednarz%2C+M.+S.%3B+Kellar%2C+K.+A.%3B+Mulheron%2C+J.+G.%3B+Batorsky%2C+R.%3B+Roongta%2C+U.%3B+Kamath%2C+A.%3B+Marathe%2C+P.%3B+Ranadive%2C+S.+A.%3B+Sack%2C+J.+S.%3B+Tokarski%2C+J.+S.%3B+Pavletich%2C+N.+P.%3B+Lee%2C+F.+Y.+F.%3B+Webster%2C+K.+R.%3B+Kimball%2C+S.+D.+N-%28Cycloalkylamino%29acyl-2-aminothiazole+inhibitors+of+cyclin-dependent+kinase+2.+N-%5B5-%5B%5B%5B5-%281%2C1-Dimethylethyl%29-2-oxazolyl%5Dmethyl%5Dthio%5D-2-thiazolyl%5D-4-piperidinecarboxamide+%28BMS-387032%29%2C+a+highly+efficacious+and+selective+antitumor+agent.+J.+Med.+Chem.2004%2C+47%2C+1719%E2%88%921728."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00016"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00016_1"><span><span class="NLM_string-ref">Toogood, P. L.; Harvey, P. J.; Repine, J. T.; Sheehan, D. J.; VanderWel, S. N.; Zhou, H.; Keller, P. R.; McNamara, D. J.; Sherry, D.; Zhu, T.; Brodfuehrer, J.; Choi, C.; Barvian, M. R.; Fry, D. W. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 2388−2406.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2406&author=P.+L.+Toogood&author=P.+J.+Harvey&author=J.+T.+Repine&author=D.+J.+Sheehan&author=S.+N.+VanderWel&author=H.+Zhou&author=P.+R.+Keller&author=D.+J.+McNamara&author=D.+Sherry&author=T.+Zhu&author=J.+Brodfuehrer&author=C.+Choi&author=M.+R.+Barvian&author=D.+W+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00017"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00017_1"><span><span class="NLM_string-ref">Fry, D. W.; Harvey, P. J.; Keller, P. R.; Elliott, W. L.; Meade, M.; Trachet, E.; Albassam, M.; Zheng, X.; Leopold, W. R.; Pryer, N. K.; Toogood, P. L. Specific inhibition of cyclin-dependent kinase 4/6 by PD0332991 and associated antitumor activity in human tumor xenografts. <i>  Mol. Cancer Ther.</i><b>2004</b>, <i>3</i>, 1427−1438.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1438&author=D.+W.+Fry&author=P.+J.+Harvey&author=P.+R.+Keller&author=W.+L.+Elliott&author=M.+Meade&author=E.+Trachet&author=M.+Albassam&author=X.+Zheng&author=W.+R.+Leopold&author=N.+K.+Pryer&author=P.+L+Toogood&title=Specific+inhibition+of+cyclin-dependent+kinase+4%2F6+by+PD0332991+and+associated+antitumor+activity+in+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinase%25204%252F6%2520by%2520PD0332991%2520and%2520associated%2520antitumor%2520activity%2520in%2520human%2520tumor%2520xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00018"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00018_1"><span><span class="NLM_string-ref">Tetsu, O.; McCormick, F. Proliferation of cancer cells despite CDK2 inhibition. <i>  Cancer Cell</i><b>2003</b>, <i>3</i>, 233−245.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=245&author=O.+Tetsu&author=F+McCormick&title=Proliferation+of+cancer+cells+despite+CDK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26atitle%3DProliferation%2520of%2520cancer%2520cells%2520despite%2520CDK2%2520inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00019"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00019_1"><span><span class="NLM_string-ref">Malumbres, M.; Barbacid, M. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1. <i>  Cancer Cell</i><b>2005</b>, <i>7</i>, 591−598.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=598&author=M.+Malumbres&author=M.+Barbacid&author=+Cdk&title=is+dispensable+for+cell+cycle+inhibition+and+tumor+suppression+mediated+by+p27Kip1+and+p21Cip1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3Dis%2520dispensable%2520for%2520cell%2520cycle%2520inhibition%2520and%2520tumor%2520suppression%2520mediated%2520by%2520p27Kip1%2520and%2520p21Cip1%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm0606138b00020_1"><span><span class="NLM_string-ref">Berthet, C.; Aleem, E.; Coppola, V.; Tessarollo, L.; Kaldis, P. Cdk2 knockout mice are viable. <i>  Curr. Biol.</i><b>2003</b>, <i>13</i>, 1775−1785.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1785&author=C.+Berthet&author=E.+Aleem&author=V.+Coppola&author=L.+Tessarollo&author=P.+Kaldis&author=+Cdk&title=knockout+mice+are+viable"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerthet%26aufirst%3DC.%26atitle%3Dknockout%2520mice%2520are%2520viable%26jtitle%3DCurr.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D1785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00021"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00021_1"><span><span class="NLM_string-ref">Ortega, S.; Prieto, I.; Odajima, J.; Martin, A.; Dubus, P.; Sotillo, R.; Barbero, J. L.; Malumbres, M.; Barbacid, M. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. <i>  Nat. Genet.</i><b>2003</b>, <i>35</i>, 25−31.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=31&author=S.+Ortega&author=I.+Prieto&author=J.+Odajima&author=A.+Martin&author=P.+Dubus&author=R.+Sotillo&author=J.+L.+Barbero&author=M.+Malumbres&author=M+Barbacid&title=Cyclin-dependent+kinase+2+is+essential+for+meiosis+but+not+for+mitotic+cell+division+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DS.%26atitle%3DCyclin-dependent%2520kinase%25202%2520is%2520essential%2520for%2520meiosis%2520but%2520not%2520for%2520mitotic%2520cell%2520division%2520in%2520mice%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D35%26spage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00022"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00022_1"><span><span class="NLM_string-ref">Kozar, K.; Ciemerych, M. A.; Rebel, V. I.; Shigematsu, H.; Zagozdzon, A.; Sicinska, E.; Geng, Y.; Yu, Q.; Bhattacharya, S.; Bronson, R. T.; Akashi, K.; Sicinski, P. Mouse development and cell proliferation in the absence of D-cyclins. <i>  Cell</i><b>2004</b>, <i>118</i>, 477−491.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=491&author=K.+Kozar&author=M.+A.+Ciemerych&author=V.+I.+Rebel&author=H.+Shigematsu&author=A.+Zagozdzon&author=E.+Sicinska&author=Y.+Geng&author=Q.+Yu&author=S.+Bhattacharya&author=R.+T.+Bronson&author=K.+Akashi&author=P+Sicinski&title=Mouse+development+and+cell+proliferation+in+the+absence+of+D-cyclins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozar%26aufirst%3DK.%26atitle%3DMouse%2520development%2520and%2520cell%2520proliferation%2520in%2520the%2520absence%2520of%2520D-cyclins%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00023"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00023_1"><span><span class="NLM_string-ref">Malumbres, M.; Sotillo, R.; Santamaria, D.; Galan, J.; Cerezo, A.; Ortega, S.; Dubus, P.; Barbacid, M. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. <i>  Cell</i><b>2004</b>, <i>118</i>, 493−504.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=504&author=M.+Malumbres&author=R.+Sotillo&author=D.+Santamaria&author=J.+Galan&author=A.+Cerezo&author=S.+Ortega&author=P.+Dubus&author=M+Barbacid&title=Mammalian+cells+cycle+without+the+D-type+cyclin-dependent+kinases+Cdk4+and+Cdk6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DMammalian%2520cells%2520cycle%2520without%2520the%2520D-type%2520cyclin-dependent%2520kinases%2520Cdk4%2520and%2520Cdk6%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00024"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00024_1"><span><span class="NLM_string-ref">Deshpande, A.; Sicinski, P.; Hinds, P. W. Cyclins and cdks in development and cancer:  A perspective. <i>  Oncogene</i><b>2005</b>, <i>24</i>, 2909−2915.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=2915&author=A.+Deshpande&author=P.+Sicinski&author=P.+W+Hinds&title=Cyclins+and+cdks+in+development+and+cancer%3A%E2%80%89+A+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeshpande%26aufirst%3DA.%26atitle%3DCyclins%2520and%2520cdks%2520in%2520development%2520and%2520cancer%253A%25E2%2580%2589%2520A%2520perspective%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D2915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00025"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00025_1"><span><span class="NLM_string-ref">Frantz, S. Drug discovery:  Playing dirty. <i>  Nature</i><b>2005</b>, <i>437</i>, 942−943.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Frantz%2C+S.+Drug+discovery%3A%E2%80%89+Playing+dirty.+Nature+2005%2C+437%2C+942%E2%88%92943.+Frantz%2C+S.+Drug+discovery%3A%E2%80%89+Playing+dirty.+Nature2005%2C+437%2C+942%E2%88%92943."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00026"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00026_1"><span><span class="NLM_string-ref">(a) Chu, X.-J.; Ding, Q.; Jiang, N.; Kim, K.; Lovey, A.; McComas, W.; Mullin, J.; Tilley, J.; Preparation of benzoylaryldiaminothiazoles as inhibitors of cyclin-dependent kinase 4 with selectivity against Cdk2 and Cdk1<i>. </i>WO03097048A1, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28a%29+Chu%2C+X.-J.%3B+Ding%2C+Q.%3B+Jiang%2C+N.%3B+Kim%2C+K.%3B+Lovey%2C+A.%3B+McComas%2C+W.%3B+Mullin%2C+J.%3B+Tilley%2C+J.%3B+Preparation+of+benzoylaryldiaminothiazoles+as+inhibitors+of+cyclin-dependent+kinase+4+with+selectivity+against+Cdk2+and+Cdk1.+WO03097048A1%2C+2003.+%28a%29+Chu%2C+X.-J.%3B+Ding%2C+Q.%3B+Jiang%2C+N.%3B+Kim%2C+K.%3B+Lovey%2C+A.%3B+McComas%2C+W.%3B+Mullin%2C+J.%3B+Tilley%2C+J.%3B+Preparation+of+benzoylaryldiaminothiazoles+as+inhibitors+of+cyclin-dependent+kinase+4+with+selectivity+against+Cdk2+and+Cdk1.+WO03097048A1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0606138b00026_2"><span><span class="NLM_string-ref">(b) Chen, L.; Ding, Q.; Gillespie, P.; Kim, K.; Lovey, A.; McComas, W.; Mullin, J.; Perrotta, A. Preparation of 4-amino-5-benzoyl-2-(piperazinylphenylamino)thiazoles as inhibitors of cyclin-dependent kinase 4. WO 02057261A2, 2002.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=L.+Chen&author=Q.+Ding&author=P.+Gillespie&author=K.+Kim&author=A.+Lovey&author=W.+McComas&author=J.+Mullin&author=A.+Perrotta&title=Preparation+of+4-amino-5-benzoyl-2-%28piperazinylphenylamino%29thiazoles+as+inhibitors+of+cyclin-dependent+kinase+4.+WO+02057261A2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00026_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26btitle%3DPreparation%2520of%25204-amino-5-benzoyl-2-%2528piperazinylphenylamino%2529thiazoles%2520as%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204.%2520WO%252002057261A2%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00027"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00027_1"><span><span class="NLM_string-ref">Lovey, A.; DePinto, W.; Ding, Q.; Jiang, N.; Kim, K.; Yin, X.; Chu, X.-J.; Bartkovitz, D.; Desai, B.; Smith, M.; Mullin, J.; McComas, W.; Graves, B.; Lukacs, C.; So, S.-S.; Chen, Y.; Xiang, Q. Design, synthesis, and biological evaluation of aminothiazoles as selective inhibitors of cyclin-dependent kinase 4. <i>  Abstracts of Papers</i>, 229<sup>th</sup> National Meeting of the American Chemical Society, San Diego, CA, March 13−17, 2005; American Chemical Society:  Washington, DC, 2005; Abstract MEDI-138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&conference=229th+National+Meeting+of+the+American+Chemical+Society&author=A.+Lovey&author=W.+DePinto&author=Q.+Ding&author=N.+Jiang&author=K.+Kim&author=X.+Yin&author=X.-J.+Chu&author=D.+Bartkovitz&author=B.+Desai&author=M.+Smith&author=J.+Mullin&author=W.+McComas&author=B.+Graves&author=C.+Lukacs&author=S.-S.+So&author=Y.+Chen&author=Q.+Xiang&author=+Design&title=and+biological+evaluation+of+aminothiazoles+as+selective+inhibitors+of+cyclin-dependent+kinase+4.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DLovey%26aufirst%3DA.%26atitle%3Dand%2520biological%2520evaluation%2520of%2520aminothiazoles%2520as%2520selective%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204.%2520Abstracts%2520of%2520Papers%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00028"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00028_1"><span><span class="NLM_string-ref">DePinto, W.; Yin, X.; Smith, M.; Kolinsky, K.; Desai, B.; Rowan, K.; Wang, K.; Margolis, R.; Railkar, A.; Perrotta A.; Gillespie, P. The in vitro and in vivo effects of small molecule inhibitors of CDK4. <i>  Abstracts of </i><i>Papers</i>; 94<sup>th</sup> Annual Meeting of the American Association for Cancer Research, Washington, DC, July 12−16, 2003; American Association for Cancer Research:  Washington, DC, 2003; Abstract No. 3126.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=W.+DePinto&author=X.+Yin&author=M.+Smith&author=K.+Kolinsky&author=B.+Desai&author=K.+Rowan&author=K.+Wang&author=R.+Margolis&author=A.+Railkar&author=A.+Perrotta&author=P.+Gillespie&title=The+in+vitro+and+in+vivo+effects+of+small+molecule+inhibitors+of+CDK4.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDePinto%26aufirst%3DW.%26btitle%3DThe%2520in%2520vitro%2520and%2520in%2520vivo%2520effects%2520of%2520small%2520molecule%2520inhibitors%2520of%2520CDK4.%2520Abstracts%2520of%2520Papers%26date%3D2003%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00029"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00029_1"><span><span class="NLM_string-ref">(a) Chu, X.-J.; Lovey, A.; DePinto, W.; Bartkovitz, D.; So, S.-S.; Vu, B.; Ding, Q.; Packman, K.; Yin, X.; Jiang, N.; Moliterni, J.; Kaplan, G.; Mullin, J.; Lukacs, C.; Graves, B.; Smith, M.; Chen, Y. The discovery of novel 2,4-diaminopyrimidines as potent and selective cyclin-dependent kinase inhibitors with in vivo activity. <i>  Abstracts of Papers; </i>96<sup>th</sup> Annual Meeting of the American Association for Cancer Research, Anaheim, CA, April 16−20, 2005; American Association for Cancer Research:  Washington, DC, 2005; Abstract No. 1221.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=X.-J.+Chu&author=A.+Lovey&author=W.+DePinto&author=D.+Bartkovitz&author=S.-S.+So&author=B.+Vu&author=Q.+Ding&author=K.+Packman&author=X.+Yin&author=N.+Jiang&author=J.+Moliterni&author=G.+Kaplan&author=J.+Mullin&author=C.+Lukacs&author=B.+Graves&author=M.+Smith&author=Y.+Chen&title=The+discovery+of+novel+2%2C4-diaminopyrimidines+as+potent+and+selective+cyclin-dependent+kinase+inhibitors+with+in+vivo+activity.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.-J.%26btitle%3DThe%2520discovery%2520of%2520novel%25202%252C4-diaminopyrimidines%2520as%2520potent%2520and%2520selective%2520cyclin-dependent%2520kinase%2520inhibitors%2520with%2520in%2520vivo%2520activity.%2520Abstracts%2520of%2520Papers%26date%3D2005%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0606138b00029_2"><span><span class="NLM_string-ref">(b) Bartkovitz, D.; Chu, X.-J.; Ding, Q.; Jiang, N.; Lovey, A.; Moliterni, J.; Mullin, J.; Vu, B.; Wovkulich, P. Preparation of (4-aminopyrimidin-5-yl)[(hetero)aryl]methanones as cyclin-dependent kinase inhibitors for treating solid tumors, WO2004069139A2, 2004.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=069139A&publication_year=2004&pages=2004&author=D.+Bartkovitz&author=X.-J.+Chu&author=Q.+Ding&author=N.+Jiang&author=A.+Lovey&author=J.+Moliterni&author=J.+Mullin&author=B.+Vu&author=P+Wovkulich&title=Preparation+of+%284-aminopyrimidin-5-yl%29%5B%28hetero%29aryl%5Dmethanones+as+cyclin-dependent+kinase+inhibitors+for+treating+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00029_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartkovitz%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520%25284-aminopyrimidin-5-yl%2529%255B%2528hetero%2529aryl%255Dmethanones%2520as%2520cyclin-dependent%2520kinase%2520inhibitors%2520for%2520treating%2520solid%2520tumors%26jtitle%3DWO%26date%3D2004%26volume%3D069139A%26spage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm0606138b00030_1"><span><span class="NLM_string-ref">Chong, W. K. M.; Duvadie, R. K. Preparation of 5-amino-3-substituted-pyrazolo[4,5-<i>d</i>]thiazole compounds as inhibitors of cyclin-dependent kinases. WO2002012250A2, 2002.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=012250A&publication_year=2002&pages=2002&author=W.+K.+M.+Chong&author=R.+K+Duvadie&title=Preparation+of+5-amino-3-substituted-pyrazolo%5B4%2C5-d%5Dthiazole+compounds+as+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChong%26aufirst%3DW.%2BK.%2BM.%26atitle%3DPreparation%2520of%25205-amino-3-substituted-pyrazolo%255B4%252C5-d%255Dthiazole%2520compounds%2520as%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DWO%26date%3D2002%26volume%3D012250A%26spage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00031"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00031_1"><span><span class="NLM_string-ref">Misra, R. N.; Xiao, H.-Y.; Rawlins, D. B.; Shan, W.; Kellar, K. A.; Mulheron, J. G.; Sack, J. S.; Tokarski, J. S.; Kimball, S. D.; Webster, K. R. 1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine inhibitors of cyclin-dependent kinases:  Highly potent 2,6-difluorophenacyl analogues<i>. Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 2405−2408.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2408&author=R.+N.+Misra&author=H.-Y.+Xiao&author=D.+B.+Rawlins&author=W.+Shan&author=K.+A.+Kellar&author=J.+G.+Mulheron&author=J.+S.+Sack&author=J.+S.+Tokarski&author=S.+D.+Kimball&author=K.+R.+Webster&author=+Pyrazolo&title=inhibitors+of+cyclin-dependent+kinases%3A%E2%80%89+Highly+potent+2%2C6-difluorophenacyl+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26atitle%3Dinhibitors%2520of%2520cyclin-dependent%2520kinases%253A%25E2%2580%2589%2520Highly%2520potent%25202%252C6-difluorophenacyl%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00032"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00032_1"><span><span class="NLM_string-ref">DePinto, W.; Chu, X.-J.; Yin, X.; Smith, M.; Packman, K.; Goelzer, P.; Lovey, A.; Chen, Y.; Qian, H.; Hamid, R.; Xiang, Q.; Tovar, C.; Blain, R.; Nevins, T.; Higgins, B.; Luistro, L.; Kolinsky, K.; Felix, B.; Hussain, S.; Heimbrook, D. In vitro and in vivo activity of R547:  A potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials. <i>  Mol. </i><i>Cancer Ther.</i><b>2006</b>, in press.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+DePinto&author=X.-J.+Chu&author=X.+Yin&author=M.+Smith&author=K.+Packman&author=P.+Goelzer&author=A.+Lovey&author=Y.+Chen&author=H.+Qian&author=R.+Hamid&author=Q.+Xiang&author=C.+Tovar&author=R.+Blain&author=T.+Nevins&author=B.+Higgins&author=L.+Luistro&author=K.+Kolinsky&author=B.+Felix&author=S.+Hussain&author=D.+Heimbrook&title=vitro+and+in+vivo+activity+of+R547%3A%E2%80%89+A+potent+and+selective+cyclin-dependent+kinase+inhibitor+currently+in+phase+I+clinical+trials.+Mol.+Cancer+Ther."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDePinto%26aufirst%3DW.%26btitle%3Dvitro%2520and%2520in%2520vivo%2520activity%2520of%2520R547%253A%25E2%2580%2589%2520A%2520potent%2520and%2520selective%2520cyclin-dependent%2520kinase%2520inhibitor%2520currently%2520in%2520phase%2520I%2520clinical%2520trials.%2520Mol.%2520Cancer%2520Ther.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00033"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00033_1"><span><span class="NLM_string-ref">DeLano, W. L. The PyMOL Molecular Graphics System 2002, DeLanoScientific, San Carlos, CA; <a class="ext-link" href="http://www.pymol.org" target="_blank">http://www.pymol.org</a>.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=W.+L.+DeLano&title=The+PyMOL+Molecular+Graphics+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26btitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26date%3D2002%26pub%3DCAhttp%3A%2F%2Fwww.pymol.org" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00034"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00034_1"><span><span class="NLM_string-ref">Vulpetti, A.; Pevarello, P. An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein−inhibitor complexes. <i>  Curr. Med. Chem. Anti-Cancer Agents</i><b>2005</b>, <i>5</i>, 561−573.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=573&author=A.+Vulpetti&author=P+Pevarello&title=An+analysis+of+the+binding+modes+of+ATP-competitive+CDK2+inhibitors+as+revealed+by+X-ray+structures+of+protein%E2%88%92inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520modes%2520of%2520ATP-competitive%2520CDK2%2520inhibitors%2520as%2520revealed%2520by%2520X-ray%2520structures%2520of%2520protein%25E2%2588%2592inhibitor%2520complexes%26jtitle%3DCurr.%2520Med.%2520Chem.%2520Anti-Cancer%2520Agents%26date%3D2005%26volume%3D5%26spage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0606138b00035"><div class="reference"><strong class="refLabel"><a href="#jm0606138b00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm0606138b00035_1"><span><span class="NLM_string-ref">Otwinowski, Z.; Minor, W. <i>  Methods Enzymol.</i><b>1997</b>, <i>276</i>, 307−326.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Otwinowski%2C+Z.%3B+Minor%2C+W.+Methods+Enzymol.+1997%2C+276%2C+307%E2%88%92326.+Otwinowski%2C+Z.%3B+Minor%2C+W.+Methods+Enzymol.1997%2C+276%2C+307%E2%88%92326."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0606138b00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FVD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FVD','PDB','2FVD'); return false;">PDB: 2FVD</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm0606138&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2006.49.issue-22%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm0606138%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm0606138" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                263KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b401de8d4248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
